BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1206105 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(CNC(=O)c2cc(OC(F)(F)F)ccc2F)c1 InChI=1S/C23H18F4N6O3/c1-12-14(9-29-22(35)17-8-16(3-4-18(17)24)36-23(25,26)27)7-15(10-28-12)19-5-6-21-31-20(30-13(2)34)11-33(21)32-19/h3-8,10-11H,9H2,1-2H3,(H,29,35)(H,30,34) NPYFGWOGMZHZRB-UHFFFAOYSA-N 570934 US11440913, Example 1 Receptor-interacting serine/threonine-protein kinase 1 Human 101 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570934&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581018 473132152 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206106 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C27H26F2N6O6/c1-39-27-19(9-15(11-31-27)21-2-3-23-32-22(13-35(23)34-21)33-24(37)14-36)26(38)30-12-16-8-17(28)10-20(29)25(16)41-18-4-6-40-7-5-18/h2-3,8-11,13,18,36H,4-7,12,14H2,1H3,(H,30,38)(H,33,37) HBZSNBAQFMSSFY-UHFFFAOYSA-N 570935 US11440913, Example 2 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570935&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437120 473132153 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206107 COCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1ccccc1OC(F)(F)F InChI=1S/C24H21F3N6O5/c1-36-13-21(34)31-19-12-33-20(30-19)8-7-17(32-33)15-9-16(23(37-2)29-11-15)22(35)28-10-14-5-3-4-6-18(14)38-24(25,26)27/h3-9,11-12H,10,13H2,1-2H3,(H,28,35)(H,31,34) JBVCNKNOOZBGRW-UHFFFAOYSA-N 570936 US11440913, Example 3 Receptor-interacting serine/threonine-protein kinase 1 Human 30.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570936&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697477 473132154 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206108 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(F)cc(F)c1OCC1CC1 InChI=1S/C27H26F2N6O4/c1-3-24(36)33-22-13-35-23(32-22)7-6-21(34-35)16-9-19(27(38-2)31-11-16)26(37)30-12-17-8-18(28)10-20(29)25(17)39-14-15-4-5-15/h6-11,13,15H,3-5,12,14H2,1-2H3,(H,30,37)(H,33,36) WGGCMJCNPCVDNE-UHFFFAOYSA-N 570937 US11440913, Example 243::US11440913, Example 4 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570937&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697491 473132155 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206109 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(=O)C(C)C)cn2n1 InChI=1S/C28H28F2N6O4/c1-15(2)26(37)34-23-13-36-24(33-23)7-6-22(35-36)17-9-20(28(39-3)32-11-17)27(38)31-12-18-8-19(29)10-21(30)25(18)40-14-16-4-5-16/h6-11,13,15-16H,4-5,12,14H2,1-3H3,(H,31,38)(H,34,37) WPXFPCKFGXLIET-UHFFFAOYSA-N 570938 US11440913, Example 5 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570938&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580759 473132156 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206110 COc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)c(C)n2n1 InChI=1S/C24H20F4N6O4/c1-12-21(31-13(2)35)32-20-7-6-19(33-34(12)20)15-9-17(23(37-3)30-11-15)22(36)29-10-14-8-16(4-5-18(14)25)38-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) MNVYIOAEOMQIGL-UHFFFAOYSA-N 570939 US11440913, Example 6 Receptor-interacting serine/threonine-protein kinase 1 Human 25.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570939&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580848 473132157 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206111 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(=O)CC#N)cn2n1 InChI=1S/C27H23F2N7O4/c1-39-27-19(26(38)31-12-17-8-18(28)10-20(29)25(17)40-14-15-2-3-15)9-16(11-32-27)21-4-5-23-33-22(13-36(23)35-21)34-24(37)6-7-30/h4-5,8-11,13,15H,2-3,6,12,14H2,1H3,(H,31,38)(H,34,37) IXBBGCPQHNJCTO-UHFFFAOYSA-N 570940 US11440913, Example 7 Receptor-interacting serine/threonine-protein kinase 1 Human 14.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570940&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581034 473132158 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206112 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(=O)C(C)(C)C#N)cn2n1 InChI=1S/C29H27F2N7O4/c1-29(2,15-32)28(40)36-23-13-38-24(35-23)7-6-22(37-38)17-9-20(27(41-3)34-11-17)26(39)33-12-18-8-19(30)10-21(31)25(18)42-14-16-4-5-16/h6-11,13,16H,4-5,12,14H2,1-3H3,(H,33,39)(H,36,40) GHPZNOXKNSVAHY-UHFFFAOYSA-N 570941 US11440913, Example 8 Receptor-interacting serine/threonine-protein kinase 1 Human 39.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570941&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580931 473132159 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206113 C[C@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O3/c1-12-18(23(36)30-13(2)17-9-16(4-5-19(17)25)37-24(26,27)28)8-15(10-29-12)20-6-7-22-32-21(31-14(3)35)11-34(22)33-20/h4-11,13H,1-3H3,(H,30,36)(H,31,35)/t13-/m0/s1 HBLIJLAULCIWLO-ZDUSSCGKSA-N 570942 US11440913, Example 198::US11440913, Example 9-1 Receptor-interacting serine/threonine-protein kinase 1 Human 25.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570942&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437121 473132160 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206114 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O3/c1-12-18(23(36)30-13(2)17-9-16(4-5-19(17)25)37-24(26,27)28)8-15(10-29-12)20-6-7-22-32-21(31-14(3)35)11-34(22)33-20/h4-11,13H,1-3H3,(H,30,36)(H,31,35)/t13-/m1/s1 HBLIJLAULCIWLO-CYBMUJFWSA-N 570943 US11440913, Example 199::US11440913, Example 9-2 Receptor-interacting serine/threonine-protein kinase 1 Human 31.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570943&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697465 473132161 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206115 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O4/c1-3-21(35)32-19-12-34-20(31-19)7-6-18(33-34)14-9-16(23(37-2)30-11-14)22(36)29-10-13-8-15(4-5-17(13)25)38-24(26,27)28/h4-9,11-12H,3,10H2,1-2H3,(H,29,36)(H,32,35) JCVYLVCNYQQYOG-UHFFFAOYSA-N 570944 US11440913, Example 10::US11440913, Example 244 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570944&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697489 473132162 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206116 COc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)C(C)C)cn2n1 InChI=1S/C25H22F4N6O4/c1-13(2)22(36)33-20-12-35-21(32-20)7-6-19(34-35)15-9-17(24(38-3)31-11-15)23(37)30-10-14-8-16(4-5-18(14)26)39-25(27,28)29/h4-9,11-13H,10H2,1-3H3,(H,30,37)(H,33,36) NUEPWNCZZSTURU-UHFFFAOYSA-N 570945 US11440913, Example 11 Receptor-interacting serine/threonine-protein kinase 1 Human 20.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570945&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697497 473132163 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206117 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(Cl)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C22H15ClF4N6O3/c1-11(34)30-18-10-33-19(31-18)5-4-17(32-33)13-7-15(20(23)28-9-13)21(35)29-8-12-6-14(2-3-16(12)24)36-22(25,26)27/h2-7,9-10H,8H2,1H3,(H,29,35)(H,30,34) QNOUCRGBILTKAK-UHFFFAOYSA-N 570946 US11440913, Example 12 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570946&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697483 473132164 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206118 COc1nc(C)c(cc1C(=O)N[C@@H](C)c1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-13(16-7-5-6-8-20(16)38-25(26,27)28)29-23(36)18-11-17(14(2)30-24(18)37-4)19-9-10-22-32-21(31-15(3)35)12-34(22)33-19/h5-13H,1-4H3,(H,29,36)(H,31,35)/t13-/m0/s1 CXYFKSXFYQFGMV-ZDUSSCGKSA-N 570947 US11440913, Example 13-1 Receptor-interacting serine/threonine-protein kinase 1 Human 986 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570947&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437122 473132165 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206119 COc1nc(C)c(cc1C(=O)N[C@H](C)c1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-13(16-7-5-6-8-20(16)38-25(26,27)28)29-23(36)18-11-17(14(2)30-24(18)37-4)19-9-10-22-32-21(31-15(3)35)12-34(22)33-19/h5-13H,1-4H3,(H,29,36)(H,31,35)/t13-/m1/s1 CXYFKSXFYQFGMV-CYBMUJFWSA-N 570948 US11440913, Example 13-2 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570948&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437123 473132166 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206120 COc1ncc(cc1C(=O)NCc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H19F3N6O4/c1-13(33)29-19-12-32-20(30-19)8-7-17(31-32)15-9-16(22(35-2)28-11-15)21(34)27-10-14-5-3-4-6-18(14)36-23(24,25)26/h3-9,11-12H,10H2,1-2H3,(H,27,34)(H,29,33) PJKATLLHXWKCPC-UHFFFAOYSA-N 570949 BDBM571090::US11440913, Example 14 Receptor-interacting serine/threonine-protein kinase 1 Human 33.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570949&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581016 473132167 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206121 COc1ncc(cc1C(=O)NCc1cccc(F)c1OCC1CC1)-c1ccc2nc(NC(=O)C(C)(C)O)cn2n1 InChI=1S/C28H29FN6O5/c1-28(2,38)27(37)33-22-14-35-23(32-22)10-9-21(34-35)18-11-19(26(39-3)31-13-18)25(36)30-12-17-5-4-6-20(29)24(17)40-15-16-7-8-16/h4-6,9-11,13-14,16,38H,7-8,12,15H2,1-3H3,(H,30,36)(H,33,37) GWSPPVQVMLKCEK-UHFFFAOYSA-N 570950 US11440913, Example 15 Receptor-interacting serine/threonine-protein kinase 1 Human 83.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570950&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580977 473132168 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206122 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(cnc1C)C(=O)NCc1cc(F)cc(F)c1OCC1CC1 InChI=1S/C26H24F2N6O3/c1-14-20(22-5-6-24-32-23(31-15(2)35)12-34(24)33-22)8-18(11-29-14)26(36)30-10-17-7-19(27)9-21(28)25(17)37-13-16-3-4-16/h5-9,11-12,16H,3-4,10,13H2,1-2H3,(H,30,36)(H,31,35) USCAIYBKMBGYKE-UHFFFAOYSA-N 570951 US11440913, Example 16 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570951&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697471 473132169 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206123 COc1nc(C)c(cc1C(=O)NCc1ccccc1OC(C)CO)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H28N6O5/c1-15(14-33)37-22-8-6-5-7-18(22)12-27-25(35)20-11-19(16(2)28-26(20)36-4)21-9-10-24-30-23(29-17(3)34)13-32(24)31-21/h5-11,13,15,33H,12,14H2,1-4H3,(H,27,35)(H,29,34) WJEYMSKSXYRWNA-UHFFFAOYSA-N 570952 US11440913, Example 17 Receptor-interacting serine/threonine-protein kinase 1 Human 27.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570952&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580858 473132170 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206124 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F)C(F)(F)F InChI=1S/C23H15F7N6O3/c1-11(37)33-18-10-36-19(34-18)5-4-17(35-36)13-7-15(20(31-9-13)22(25,26)27)21(38)32-8-12-6-14(2-3-16(12)24)39-23(28,29)30/h2-7,9-10H,8H2,1H3,(H,32,38)(H,33,37) FZCDDBYFKVLHKA-UHFFFAOYSA-N 570953 US11440913, Example 18 Receptor-interacting serine/threonine-protein kinase 1 Human 145 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570953&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581005 473132171 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206125 COc1nc(C)c(cc1C(=O)NCc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13-16(18-8-9-21-31-20(30-14(2)34)12-33(21)32-18)10-17(23(29-13)36-3)22(35)28-11-15-6-4-5-7-19(15)37-24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) FGHDUBUMNALLNW-UHFFFAOYSA-N 570954 BDBM571228::US11440913, Example 178::US11440913, Example 19 Receptor-interacting serine/threonine-protein kinase 1 Human 12.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570954&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580816 473132172 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206126 CC(C)Oc1ccccc1CNC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H26N6O3/c1-15(2)34-22-8-6-5-7-18(22)12-27-25(33)20-11-19(13-26-16(20)3)21-9-10-24-29-23(28-17(4)32)14-31(24)30-21/h5-11,13-15H,12H2,1-4H3,(H,27,33)(H,28,32) KXTCLLGOOWCDMD-UHFFFAOYSA-N 570955 US11440913, Example 20 Receptor-interacting serine/threonine-protein kinase 1 Human 46.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570955&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580821 473132173 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206127 CC(=O)Nc1cn2nc(ccc2n1)-c1cncc(c1)C(=O)NCc1ccccc1OC1CCCC1 InChI=1S/C26H26N6O3/c1-17(33)29-24-16-32-25(30-24)11-10-22(31-32)19-12-20(14-27-13-19)26(34)28-15-18-6-2-5-9-23(18)35-21-7-3-4-8-21/h2,5-6,9-14,16,21H,3-4,7-8,15H2,1H3,(H,28,34)(H,29,33) VATGIGDYUWQSKZ-UHFFFAOYSA-N 570956 US11440913, Example 21 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570956&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580783 473132174 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206128 COc1ncc(cc1C(=O)NCc1ccccc1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H26N6O4/c1-16(33)29-23-14-32-24(30-23)10-9-21(31-32)19-11-20(26(35-2)28-13-19)25(34)27-12-18-5-3-4-6-22(18)36-15-17-7-8-17/h3-6,9-11,13-14,17H,7-8,12,15H2,1-2H3,(H,27,34)(H,29,33) KAAVNXZWKMOGOG-UHFFFAOYSA-N 570957 US11440913, Example 22 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570957&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 150771930 473132175 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206129 COc1ncc(cc1C(=O)NCCC(O)c1ccc(Cl)cc1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H23ClN6O4/c1-14(32)28-21-13-31-22(29-21)8-7-19(30-31)16-11-18(24(35-2)27-12-16)23(34)26-10-9-20(33)15-3-5-17(25)6-4-15/h3-8,11-13,20,33H,9-10H2,1-2H3,(H,26,34)(H,28,32) BVBVUVCXZGLARL-UHFFFAOYSA-N 570958 US11440913, Example 23 Receptor-interacting serine/threonine-protein kinase 1 Human 124 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570958&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 149840638 473132176 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206130 CC(CCNC(=O)c1cccc(c1)-c1ccc2nc(NC(=O)c3ccnc(F)c3)cn2n1)c1ccccc1 InChI=1S/C29H25FN6O2/c1-19(20-6-3-2-4-7-20)12-14-32-28(37)22-9-5-8-21(16-22)24-10-11-27-33-26(18-36(27)35-24)34-29(38)23-13-15-31-25(30)17-23/h2-11,13,15-19H,12,14H2,1H3,(H,32,37)(H,34,38) MJBHSOXJERWFAQ-UHFFFAOYSA-N 570959 US11440913, Example 24 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570959&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581027 473132177 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206131 COc1ncc(cc1C(=O)NCCC(C)c1ccccc1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H26N6O3/c1-16(18-7-5-4-6-8-18)11-12-26-24(33)20-13-19(14-27-25(20)34-3)21-9-10-23-29-22(28-17(2)32)15-31(23)30-21/h4-10,13-16H,11-12H2,1-3H3,(H,26,33)(H,28,32) QEPCBIAYRNYBTO-UHFFFAOYSA-N 570960 US11440913, Example 25 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570960&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580853 473132178 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206132 Cc1ncc(cc1C(=O)NCc1ccccc1Sc1ccccc1CO)-c1ccc2nc(NC(=O)C(C)(C)C#N)cn2n1 InChI=1S/C32H29N7O3S/c1-20-24(30(41)35-15-21-8-4-6-10-26(21)43-27-11-7-5-9-22(27)18-40)14-23(16-34-20)25-12-13-29-36-28(17-39(29)38-25)37-31(42)32(2,3)19-33/h4-14,16-17,40H,15,18H2,1-3H3,(H,35,41)(H,37,42) ZDCYKIDIIHZYDV-UHFFFAOYSA-N 570961 US11440913, Example 26 Receptor-interacting serine/threonine-protein kinase 1 Human 25.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570961&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697475 473132179 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206133 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)C(C)(C)C#N)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C27H23F4N7O3/c1-14-19(24(39)34-15(2)18-10-17(5-6-20(18)28)41-27(29,30)31)9-16(11-33-14)21-7-8-23-35-22(12-38(23)37-21)36-25(40)26(3,4)13-32/h5-12,15H,1-4H3,(H,34,39)(H,36,40)/t15-/m1/s1 JYNGGWXTLGTWHC-OAHLLOKOSA-N 570962 US11440913, Example 27 Receptor-interacting serine/threonine-protein kinase 1 Human 109 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570962&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697461 473132180 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206134 COc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)C(C)(C)C#N)cn2n1 InChI=1S/C26H21F4N7O4/c1-25(2,13-31)24(39)35-20-12-37-21(34-20)7-6-19(36-37)15-9-17(23(40-3)33-11-15)22(38)32-10-14-8-16(4-5-18(14)27)41-26(28,29)30/h4-9,11-12H,10H2,1-3H3,(H,32,38)(H,35,39) SVRQZYPFHZKADN-UHFFFAOYSA-N 570963 US11440913, Example 28 Receptor-interacting serine/threonine-protein kinase 1 Human 285 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570963&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697468 473132181 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206135 COc1ncc(cc1C(=O)NCc1cc(OCC2CC2)ccc1F)-c1ccc2nc(NC(=O)C(C)(C)C#N)cn2n1 InChI=1S/C29H28FN7O4/c1-29(2,16-31)28(39)35-24-14-37-25(34-24)9-8-23(36-37)19-11-21(27(40-3)33-13-19)26(38)32-12-18-10-20(6-7-22(18)30)41-15-17-4-5-17/h6-11,13-14,17H,4-5,12,15H2,1-3H3,(H,32,38)(H,35,39) ZNLVXBNOONNKMH-UHFFFAOYSA-N 570964 US11440913, Example 29 Receptor-interacting serine/threonine-protein kinase 1 Human 257 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570964&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697463 473132182 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206136 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(c(c1)C(=O)NCc1cc(ccc1F)C(F)(F)F)C(F)(F)F InChI=1S/C23H15F7N6O2/c1-11(37)33-18-10-36-19(34-18)5-4-17(35-36)13-7-15(20(31-9-13)23(28,29)30)21(38)32-8-12-6-14(22(25,26)27)2-3-16(12)24/h2-7,9-10H,8H2,1H3,(H,32,38)(H,33,37) WJTRCOBCYRLUAY-UHFFFAOYSA-N 570965 US11440913, Example 30 Receptor-interacting serine/threonine-protein kinase 1 Human 199 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570965&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697495 473132183 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206137 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(c(c1)C(=O)NCc1c(F)ccc(F)c1OCC1CC1)C(F)(F)F InChI=1S/C26H21F5N6O3/c1-13(38)34-21-11-37-22(35-21)7-6-20(36-37)15-8-16(24(32-9-15)26(29,30)31)25(39)33-10-17-18(27)4-5-19(28)23(17)40-12-14-2-3-14/h4-9,11,14H,2-3,10,12H2,1H3,(H,33,39)(H,34,38) BSCKOENPKYNJAC-UHFFFAOYSA-N 570966 US11440913, Example 31 Receptor-interacting serine/threonine-protein kinase 1 Human 82.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570966&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697498 473132184 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206138 COc1ncc(cc1C(=O)NCc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(=O)CC#N)cn2n1 InChI=1S/C24H18F3N7O4/c1-37-23-16(22(36)29-11-14-4-2-3-5-18(14)38-24(25,26)27)10-15(12-30-23)17-6-7-20-31-19(13-34(20)33-17)32-21(35)8-9-28/h2-7,10,12-13H,8,11H2,1H3,(H,29,36)(H,32,35) SXSPNDRJTMKYIG-UHFFFAOYSA-N 570967 US11440913, Example 32 Receptor-interacting serine/threonine-protein kinase 1 Human 78.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570967&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697496 473132185 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206139 COc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)CC#N)cn2n1 InChI=1S/C24H17F4N7O4/c1-38-23-16(22(37)30-10-13-8-15(2-3-17(13)25)39-24(26,27)28)9-14(11-31-23)18-4-5-20-32-19(12-35(20)34-18)33-21(36)6-7-29/h2-5,8-9,11-12H,6,10H2,1H3,(H,30,37)(H,33,36) DHSLFQOHEKUYLC-UHFFFAOYSA-N 570968 US11440913, Example 33 Receptor-interacting serine/threonine-protein kinase 1 Human 186 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570968&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 150033295 473132186 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206140 COc1ncc(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C23H18F4N6O4/c1-37-22-15(21(36)28-8-12-6-14(23(25,26)27)2-3-16(12)24)7-13(9-29-22)17-4-5-19-30-18(10-33(19)32-17)31-20(35)11-34/h2-7,9-10,34H,8,11H2,1H3,(H,28,36)(H,31,35) YBKIUGUNWWXXPN-UHFFFAOYSA-N 570969 US11440913, Example 34 Receptor-interacting serine/threonine-protein kinase 1 Human 96.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570969&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580758 473132187 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206141 COc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C23H18F4N6O5/c1-37-22-15(21(36)28-8-12-6-14(2-3-16(12)24)38-23(25,26)27)7-13(9-29-22)17-4-5-19-30-18(10-33(19)32-17)31-20(35)11-34/h2-7,9-10,34H,8,11H2,1H3,(H,28,36)(H,31,35) DAJXSIGPSLOUSP-UHFFFAOYSA-N 570970 US11440913, Example 35 Receptor-interacting serine/threonine-protein kinase 1 Human 25.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570970&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580925 473132188 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206142 COc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)C(C)(C)O)cn2n1 InChI=1S/C25H22F4N6O5/c1-24(2,38)23(37)33-19-12-35-20(32-19)7-6-18(34-35)14-9-16(22(39-3)31-11-14)21(36)30-10-13-8-15(4-5-17(13)26)40-25(27,28)29/h4-9,11-12,38H,10H2,1-3H3,(H,30,36)(H,33,37) BZCIXWQENGYAOK-UHFFFAOYSA-N 570971 US11440913, Example 36 Receptor-interacting serine/threonine-protein kinase 1 Human 48.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570971&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697474 473132189 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206143 COc1ccc(F)c(CNC(=O)c2cc(c(C)nc2C)-c2ccc3nc(NC(C)=O)cn3n2)c1 InChI=1S/C24H23FN6O3/c1-13-18(21-7-8-23-29-22(28-15(3)32)12-31(23)30-21)10-19(14(2)27-13)24(33)26-11-16-9-17(34-4)5-6-20(16)25/h5-10,12H,11H2,1-4H3,(H,26,33)(H,28,32) LKLDHBJFJZMRSU-UHFFFAOYSA-N 570972 US11440913, Example 37 Receptor-interacting serine/threonine-protein kinase 1 Human 67.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570972&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580866 473132190 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206144 Cc1nc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C24H20F4N6O4/c1-12-16(19-5-6-21-31-20(10-34(21)33-19)32-22(36)11-35)8-17(13(2)30-12)23(37)29-9-14-7-15(3-4-18(14)25)38-24(26,27)28/h3-8,10,35H,9,11H2,1-2H3,(H,29,37)(H,32,36) LYRYKHQHGYSFTP-UHFFFAOYSA-N 570973 US11440913, Example 38 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570973&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697499 473132191 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206145 Cc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C23H18F4N6O4/c1-12-16(22(36)29-8-13-6-15(2-3-17(13)24)37-23(25,26)27)7-14(9-28-12)18-4-5-20-30-19(10-33(20)32-18)31-21(35)11-34/h2-7,9-10,34H,8,11H2,1H3,(H,29,36)(H,31,35) TYLZGNSJQQKZLH-UHFFFAOYSA-N 570974 US11440913, Example 39 Receptor-interacting serine/threonine-protein kinase 1 Human 55.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570974&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697478 473132192 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206146 COc1ccc(F)c(CNC(=O)c2cc(cnc2OC)-c2ccc3nc(NC(C)=O)cn3n2)c1 InChI=1S/C23H21FN6O4/c1-13(31)27-20-12-30-21(28-20)7-6-19(29-30)15-9-17(23(34-3)26-11-15)22(32)25-10-14-8-16(33-2)4-5-18(14)24/h4-9,11-12H,10H2,1-3H3,(H,25,32)(H,27,31) IPQJGRQHPWMXJE-UHFFFAOYSA-N 570975 5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-N-[(2-fluoro-5- methoxyphenyl)methyl]-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 100::US11440913, Example 40 Receptor-interacting serine/threonine-protein kinase 1 Human 125 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570975&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074382 473132193 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206147 COc1ncc(cc1C(=O)N[C@@H](C)c1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-12(16-9-15(4-5-18(16)25)38-24(26,27)28)30-22(36)17-8-14(10-29-23(17)37-3)19-6-7-21-32-20(31-13(2)35)11-34(21)33-19/h4-12H,1-3H3,(H,30,36)(H,31,35)/t12-/m0/s1 QPWFZJRWOCUEPG-LBPRGKRZSA-N 570976 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1S)-1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl]-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 41 Receptor-interacting serine/threonine-protein kinase 1 Human 63.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570976&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437124 473132194 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206148 COc1ncc(cc1C(=O)NCc1c(F)cccc1OCC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-13(35)31-20-11-34-21(32-20)7-6-18(33-34)14-8-15(23(37-2)30-9-14)22(36)29-10-16-17(25)4-3-5-19(16)38-12-24(26,27)28/h3-9,11H,10,12H2,1-2H3,(H,29,36)(H,31,35) DOXMJMYQICODGA-UHFFFAOYSA-N 570977 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-6-(2,2,2- trifluoroethoxy)phenyl]methyl}-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 102::US11440913, Example 42 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570977&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074171 473132195 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206149 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O5/c1-15(36)32-23-13-35-24(33-23)6-5-22(34-35)16-9-20(27(38-2)31-11-16)26(37)30-12-17-8-18(28)10-21(29)25(17)40-19-4-3-7-39-14-19/h5-6,8-11,13,19H,3-4,7,12,14H2,1-2H3,(H,30,37)(H,32,36) OUXSHWXSJCGFGD-UHFFFAOYSA-N 570978 N-{[3,5-difluoro-2-(oxan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 43::US11440913, Example 46::US11440913, Example 99 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570978&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162690512 473132196 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206150 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1O[C@@H]1CCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O5/c1-14(35)31-22-12-34-23(32-22)4-3-21(33-34)15-8-19(26(37-2)30-10-15)25(36)29-11-16-7-17(27)9-20(28)24(16)39-18-5-6-38-13-18/h3-4,7-10,12,18H,5-6,11,13H2,1-2H3,(H,29,36)(H,31,35)/t18-/m1/s1 FZYLLOODESMDBI-GOSISDBHSA-N 570979 N-({3,5-difluoro-2-[(3R)-oxolan-3- yloxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 44 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570979&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437125 473132197 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206151 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1O[C@H]1CCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O5/c1-14(35)31-22-12-34-23(32-22)4-3-21(33-34)15-8-19(26(37-2)30-10-15)25(36)29-11-16-7-17(27)9-20(28)24(16)39-18-5-6-38-13-18/h3-4,7-10,12,18H,5-6,11,13H2,1-2H3,(H,29,36)(H,31,35)/t18-/m0/s1 FZYLLOODESMDBI-SFHVURJKSA-N 570980 N-({3,5-difluoro-2-[(3S)-oxolan- 3-yloxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 45 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570980&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074240 473132198 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206152 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O5/c1-15(36)32-23-13-35-24(33-23)6-5-22(34-35)16-9-20(27(38-2)31-11-16)26(37)30-12-17-8-18(28)10-21(29)25(17)40-19-4-3-7-39-14-19/h5-6,8-11,13,19H,3-4,7,12,14H2,1-2H3,(H,30,37)(H,32,36) OUXSHWXSJCGFGD-UHFFFAOYSA-N 570978 N-{[3,5-difluoro-2-(oxan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 43::US11440913, Example 46::US11440913, Example 99 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570978&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162690512 473132196 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206153 COc1ncc(cc1C(=O)N[C@H](C)c1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-12(16-9-15(4-5-18(16)25)38-24(26,27)28)30-22(36)17-8-14(10-29-23(17)37-3)19-6-7-21-32-20(31-13(2)35)11-34(21)33-19/h4-12H,1-3H3,(H,30,36)(H,31,35)/t12-/m1/s1 QPWFZJRWOCUEPG-GFCCVEGCSA-N 570982 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl]-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 109::US11440913, Example 47 Receptor-interacting serine/threonine-protein kinase 1 Human 161 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570982&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162714773 473132199 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206154 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1COC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F2N6O5/c1-13(34)30-21-10-33-22(31-21)4-3-20(32-33)14-6-18(25(36-2)29-8-14)24(35)28-9-15-5-16(26)7-19(27)23(15)38-17-11-37-12-17/h3-8,10,17H,9,11-12H2,1-2H3,(H,28,35)(H,30,34) BVIMNHKKHNWLCO-UHFFFAOYSA-N 570983 N-{[3,5-difluoro-2-(oxetan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 115::US11440913, Example 48 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570983&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074321 473132200 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206155 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O4/c1-14(35)31-22-12-34-23(32-22)6-5-21(33-34)16-8-19(26(37-2)30-10-16)25(36)29-11-17-7-18(27)9-20(28)24(17)38-13-15-3-4-15/h5-10,12,15H,3-4,11,13H2,1-2H3,(H,29,36)(H,31,35) CXQXAXGVRWRAJR-UHFFFAOYSA-N 570984 N-({2- [cyclopropyl(deutero)methoxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 121::US11440913, Example 49::US11440913, Example 55 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570984&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437126 473132201 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206156 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O5/c1-15(36)32-23-14-35-24(33-23)4-3-22(34-35)16-10-20(27(38-2)31-12-16)26(37)30-13-17-9-18(28)11-21(29)25(17)40-19-5-7-39-8-6-19/h3-4,9-12,14,19H,5-8,13H2,1-2H3,(H,30,37)(H,32,36) KEIQFMNOLQPIPY-UHFFFAOYSA-N 570985 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 129::US11440913, Example 153::US11440913, Example 50 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570985&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074097 473132202 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206157 COc1ncc(cc1C(=O)NC(C)c1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O3/c1-12(16-9-15(24(26,27)28)4-5-18(16)25)30-22(36)17-8-14(10-29-23(17)37-3)19-6-7-21-32-20(31-13(2)35)11-34(21)33-19/h4-12H,1-3H3,(H,30,36)(H,31,35) ILWDGVNDEQLXTQ-UHFFFAOYSA-N 570986 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl}-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 51::US11440913, Example 52 Receptor-interacting serine/threonine-protein kinase 1 Human 63.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570986&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437127 473132203 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206158 COc1ncc(cc1C(=O)NC(C)c1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O3/c1-12(16-9-15(24(26,27)28)4-5-18(16)25)30-22(36)17-8-14(10-29-23(17)37-3)19-6-7-21-32-20(31-13(2)35)11-34(21)33-19/h4-12H,1-3H3,(H,30,36)(H,31,35) ILWDGVNDEQLXTQ-UHFFFAOYSA-N 570986 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl}-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 51::US11440913, Example 52 Receptor-interacting serine/threonine-protein kinase 1 Human 65.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570986&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437127 473132203 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206159 COc1ncc(cc1C(=O)NCc1ccc(F)c(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O4/c1-14(35)31-21-12-34-22(32-21)8-7-20(33-34)17-9-18(26(37-2)30-11-17)25(36)29-10-16-5-6-19(27)23(28)24(16)38-13-15-3-4-15/h5-9,11-12,15H,3-4,10,13H2,1-2H3,(H,29,36)(H,31,35) CEWGKRHPOXFDTF-UHFFFAOYSA-N 570988 N-{[2-(cyclopropylmethoxy)-3,4- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 53 Receptor-interacting serine/threonine-protein kinase 1 Human 62.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570988&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437128 473132204 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206160 COc1ncc(cc1C(=O)NC(C)c1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13(16-6-4-5-7-19(16)37-24(25,26)27)29-22(35)17-10-15(11-28-23(17)36-3)18-8-9-21-31-20(30-14(2)34)12-33(21)32-18/h4-13H,1-3H3,(H,29,35)(H,30,34) OMVLHTIXQXXJID-UHFFFAOYSA-N 570989 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxy-N-{1-[2- (trifluoromethoxy)phenyl]eth- yl}pyridine-3-carboxamide::BDBM571070::US11440913, Example 54::US11440913, Example 57 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570989&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074239 473132205 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206161 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O4/c1-14(35)31-22-12-34-23(32-22)6-5-21(33-34)16-8-19(26(37-2)30-10-16)25(36)29-11-17-7-18(27)9-20(28)24(17)38-13-15-3-4-15/h5-10,12,15H,3-4,11,13H2,1-2H3,(H,29,36)(H,31,35) CXQXAXGVRWRAJR-UHFFFAOYSA-N 570984 N-({2- [cyclopropyl(deutero)methoxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 121::US11440913, Example 49::US11440913, Example 55 Receptor-interacting serine/threonine-protein kinase 1 Human 1.000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570984&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437126 473132201 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206162 COc1ncc(cc1C(=O)NCc1cc(OCC2CC2)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H25FN6O4/c1-15(34)30-23-13-33-24(31-23)8-7-22(32-33)18-10-20(26(36-2)29-12-18)25(35)28-11-17-9-19(5-6-21(17)27)37-14-16-3-4-16/h5-10,12-13,16H,3-4,11,14H2,1-2H3,(H,28,35)(H,30,34) PFUPRKBPLOLDPE-UHFFFAOYSA-N 570991 N-{[5-(cyclopropylmethoxy)-2- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyri- dazin-6-yl}-2- (D3)methoxypyridine- 3-carboxamide, TFA::US11440913, Example 149::US11440913, Example 56 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570991&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074293 473132206 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206163 COc1ncc(cc1C(=O)NC(C)c1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13(16-6-4-5-7-19(16)37-24(25,26)27)29-22(35)17-10-15(11-28-23(17)36-3)18-8-9-21-31-20(30-14(2)34)12-33(21)32-18/h4-13H,1-3H3,(H,29,35)(H,30,34) OMVLHTIXQXXJID-UHFFFAOYSA-N 570989 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxy-N-{1-[2- (trifluoromethoxy)phenyl]eth- yl}pyridine-3-carboxamide::BDBM571070::US11440913, Example 54::US11440913, Example 57 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570989&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074239 473132205 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206164 COc1ncc(cc1C(=O)NCc1c(F)cccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H18F4N6O4/c1-12(34)30-19-11-33-20(31-19)7-6-17(32-33)13-8-14(22(36-2)29-9-13)21(35)28-10-15-16(24)4-3-5-18(15)37-23(25,26)27/h3-9,11H,10H2,1-2H3,(H,28,35)(H,30,34) VWKZOHDHCHIJLS-UHFFFAOYSA-N 570993 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl]methyl}- 2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 58 Receptor-interacting serine/threonine-protein kinase 1 Human 14.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570993&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437129 473132207 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206165 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(F)c2OC2CCCOC2)c(C)nc1C InChI=1S/C28H28F2N6O4/c1-15-21(24-6-7-26-34-25(33-17(3)37)13-36(26)35-24)11-22(16(2)32-15)28(38)31-12-18-9-19(29)10-23(30)27(18)40-20-5-4-8-39-14-20/h6-7,9-11,13,20H,4-5,8,12,14H2,1-3H3,(H,31,38)(H,33,37) UXALHPARHUTVGB-UHFFFAOYSA-N 570994 N-{[3,5-difluoro-2-(oxan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2,6-dimethylpyridine-3- carboxamide::US11440913, Example 59 Receptor-interacting serine/threonine-protein kinase 1 Human 12.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570994&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074165 473132208 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206166 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(F)c2O[C@H]2CCOC2)c(C)nc1C InChI=1S/C27H26F2N6O4/c1-14-20(23-4-5-25-33-24(32-16(3)36)12-35(25)34-23)10-21(15(2)31-14)27(37)30-11-17-8-18(28)9-22(29)26(17)39-19-6-7-38-13-19/h4-5,8-10,12,19H,6-7,11,13H2,1-3H3,(H,30,37)(H,32,36)/t19-/m0/s1 KCNGMTMWDDIWCT-IBGZPJMESA-N 570995 N-({3,5-difluoro-2-[(3S)-oxolan-3- yloxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 60 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570995&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074180 473132209 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206167 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(F)c2O[C@@H]2CCOC2)c(C)nc1C InChI=1S/C27H26F2N6O4/c1-14-20(23-4-5-25-33-24(32-16(3)36)12-35(25)34-23)10-21(15(2)31-14)27(37)30-11-17-8-18(28)9-22(29)26(17)39-19-6-7-38-13-19/h4-5,8-10,12,19H,6-7,11,13H2,1-3H3,(H,30,37)(H,32,36)/t19-/m1/s1 KCNGMTMWDDIWCT-LJQANCHMSA-N 570996 N-({3,5-difluoro-2-[(3R)-oxolan-3- yloxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 61 Receptor-interacting serine/threonine-protein kinase 1 Human 33.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570996&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074216 473132210 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206168 CC1CC(CCO1)Oc1c(F)cc(F)cc1CNC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C29H30F2N6O4/c1-15-9-21(7-8-40-15)41-28-19(10-20(30)11-24(28)31)13-32-29(39)23-12-22(16(2)33-17(23)3)25-5-6-27-35-26(34-18(4)38)14-37(27)36-25/h5-6,10-12,14-15,21H,7-9,13H2,1-4H3,(H,32,39)(H,34,38) FLULSTUPQRCWIP-UHFFFAOYSA-N 570997 N-({3,5-difluoro-2-[(2-methyloxan-4- yl)oxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 62 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570997&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074148 473132211 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206169 C[C@H]1CC(C[C@@H](C)O1)Oc1c(F)cccc1CNC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C30H33FN6O4/c1-16-11-22(12-17(2)40-16)41-29-21(7-6-8-25(29)31)14-32-30(39)24-13-23(18(3)33-19(24)4)26-9-10-28-35-27(34-20(5)38)15-37(28)36-26/h6-10,13,15-17,22H,11-12,14H2,1-5H3,(H,32,39)(H,34,38)/t16-,17+,22? YFPMIRNFVFKWJG-AQKKSAQBSA-N 570998 N-[(2-{[(2R,6S)-2,6-dimethyloxan-4- yl]oxy}-3-fluorophenyl)methyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2,6-dimethylpyridine-3- carboxamide::US11440913, Example 63 Receptor-interacting serine/threonine-protein kinase 1 Human 149 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570998&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074301 473132212 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206170 CC1CC(CC(C)O1)Oc1c(F)cc(F)cc1CNC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C30H32F2N6O4/c1-15-8-22(9-16(2)41-15)42-29-20(10-21(31)11-25(29)32)13-33-30(40)24-12-23(17(3)34-18(24)4)26-6-7-28-36-27(35-19(5)39)14-38(28)37-26/h6-7,10-12,14-16,22H,8-9,13H2,1-5H3,(H,33,40)(H,35,39) VCVFWYJWLBCPSL-UHFFFAOYSA-N 570999 N-({2-[(2,6-dimethyloxan-4-yl)oxy]-3,5- difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 64 Receptor-interacting serine/threonine-protein kinase 1 Human 49.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570999&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074303 473132213 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206171 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2ncccc2OCC(F)(F)F)c(C)nc1C InChI=1S/C24H22F3N7O3/c1-13-16(18-6-7-22-32-21(31-15(3)35)11-34(22)33-18)9-17(14(2)30-13)23(36)29-10-19-20(5-4-8-28-19)37-12-24(25,26)27/h4-9,11H,10,12H2,1-3H3,(H,29,36)(H,31,35) XYHKFZXOLJTZCD-UHFFFAOYSA-N 571000 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2,6-dimethyl-N-{[3-(2,2,2- trifluoroethoxy)pyridin-2- yl]methyl}pyridine-3-carboxamide::US11440913, Example 65 Receptor-interacting serine/threonine-protein kinase 1 Human 44.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571000&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074241 473132214 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206172 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(F)c2OC2CCOCC2)c(C)nc1C InChI=1S/C28H28F2N6O4/c1-15-21(24-4-5-26-34-25(33-17(3)37)14-36(26)35-24)12-22(16(2)32-15)28(38)31-13-18-10-19(29)11-23(30)27(18)40-20-6-8-39-9-7-20/h4-5,10-12,14,20H,6-9,13H2,1-3H3,(H,31,38)(H,33,37) BXKXIZPEGRMBRV-UHFFFAOYSA-N 571001 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl](deutero)methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 66::US11440913, Example 78 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571001&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074194 473132215 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206173 CC(NC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C25H22F4N6O2/c1-12(17-9-16(25(27,28)29)5-6-20(17)26)31-24(37)19-10-18(13(2)30-14(19)3)21-7-8-23-33-22(32-15(4)36)11-35(23)34-21/h5-12H,1-4H3,(H,31,37)(H,32,36) XWRKJPHVVIEURX-UHFFFAOYSA-N 571002 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2-fluoro-5- (trifluoromethyl)phenyl](2,2,2- deutero)ethyl]-2,6-dimethylpyridine-3- carboxamide::US11440913, Example 67 Receptor-interacting serine/threonine-protein kinase 1 Human 14.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571002&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074206 473132216 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206174 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2ccccc2OCC(F)(F)F)c(C)nc1C InChI=1S/C25H23F3N6O3/c1-14-18(20-8-9-23-32-22(31-16(3)35)12-34(23)33-20)10-19(15(2)30-14)24(36)29-11-17-6-4-5-7-21(17)37-13-25(26,27)28/h4-10,12H,11,13H2,1-3H3,(H,29,36)(H,31,35) IWPHUDQKPHMVPK-UHFFFAOYSA-N 571003 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2,6-dimethyl-N-{[2-(2,2,2- trifluoroethoxy)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 68 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571003&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074110 473132217 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206175 C[C@@H](NC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C25H22F4N6O2/c1-12(17-9-16(25(27,28)29)5-6-20(17)26)31-24(37)19-10-18(13(2)30-14(19)3)21-7-8-23-33-22(32-15(4)36)11-35(23)34-21/h5-12H,1-4H3,(H,31,37)(H,32,36)/t12-/m1/s1 XWRKJPHVVIEURX-GFCCVEGCSA-N 571004 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl]-2,6- dimethylpyridine-3-carboxamide::US11440913, Example 69 Receptor-interacting serine/threonine-protein kinase 1 Human 15.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571004&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074205 473132218 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206176 CC(NC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H22F4N6O3/c1-12(17-9-16(5-6-20(17)26)38-25(27,28)29)31-24(37)19-10-18(13(2)30-14(19)3)21-7-8-23-33-22(32-15(4)36)11-35(23)34-21/h5-12H,1-4H3,(H,31,37)(H,32,36) YUBIWQAQTKPDEJ-UHFFFAOYSA-N 571005 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)phenyl](2,2,2- deutero)ethyl]-2,6-dimethylpyridine-3- carboxamide::US11440913, Example 70 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571005&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074190 473132219 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206177 C[C@@H](NC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H22F4N6O3/c1-12(17-9-16(5-6-20(17)26)38-25(27,28)29)31-24(37)19-10-18(13(2)30-14(19)3)21-7-8-23-33-22(32-15(4)36)11-35(23)34-21/h5-12H,1-4H3,(H,31,37)(H,32,36)/t12-/m1/s1 YUBIWQAQTKPDEJ-GFCCVEGCSA-N 571006 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl]-2,6- dimethylpyridine-3-carboxamide::US11440913, Example 71 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571006&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074189 473132220 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206178 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)ccc2OCC(F)(F)F)c(C)nc1C InChI=1S/C25H22F4N6O3/c1-13-18(20-5-7-23-33-22(32-15(3)36)11-35(23)34-20)9-19(14(2)31-13)24(37)30-10-16-8-17(26)4-6-21(16)38-12-25(27,28)29/h4-9,11H,10,12H2,1-3H3,(H,30,37)(H,32,36) RMHXPKYBSVLRDA-UHFFFAOYSA-N 571007 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[5-fluoro-2-(2,2,2- trifluoroethoxy)phenyl]methyl}-2,6- dimethylpyridine-3-carboxamide, TFA::US11440913, Example 72 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571007&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074191 473132221 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206179 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cccc(OCC(F)(F)F)c2)c(C)nc1C InChI=1S/C25H23F3N6O3/c1-14-19(21-7-8-23-32-22(31-16(3)35)12-34(23)33-21)10-20(15(2)30-14)24(36)29-11-17-5-4-6-18(9-17)37-13-25(26,27)28/h4-10,12H,11,13H2,1-3H3,(H,29,36)(H,31,35) DZGDSEZMBOYTCD-UHFFFAOYSA-N 571008 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2,6-dimethyl-N-{[3-(2,2,2- trifluoroethoxy)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 73 Receptor-interacting serine/threonine-protein kinase 1 Human 57.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571008&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074094 473132222 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206180 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cccc(c2)C(F)(F)F)c(C)nc1C InChI=1S/C24H21F3N6O2/c1-13-18(20-7-8-22-31-21(30-15(3)34)12-33(22)32-20)10-19(14(2)29-13)23(35)28-11-16-5-4-6-17(9-16)24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) VZFOHUDFZSYUGV-UHFFFAOYSA-N 571009 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2,6-dimethyl-N-{[3-(trifluoro- methyl)phenyl](deutero)methyl}pyridine- 3-carboxamide, TFA::US11440913, Example 74 Receptor-interacting serine/threonine-protein kinase 1 Human 63.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571009&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437130 473132223 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206181 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(ccc2F)C(F)(F)F)c(C)nc1C InChI=1S/C24H20F4N6O2/c1-12-17(20-6-7-22-32-21(31-14(3)35)11-34(22)33-20)9-18(13(2)30-12)23(36)29-10-15-8-16(24(26,27)28)4-5-19(15)25/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) NVGQPIZSMFSDGE-UHFFFAOYSA-N 571010 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5- (trifluoromethyl)phenyl](deutero)methyl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 75::US11440913, Example 80 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571010&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074269 473132224 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206182 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(OC(F)(F)F)ccc2F)c(C)nc1C InChI=1S/C24H20F4N6O3/c1-12-17(20-6-7-22-32-21(31-14(3)35)11-34(22)33-20)9-18(13(2)30-12)23(36)29-10-15-8-16(4-5-19(15)25)37-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) FCJJIJFGKWTUHG-UHFFFAOYSA-N 571011 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5-(trifluorometh- oxy)phenyl](deutero)methyl}-2,6- dimethylpyridine-3-carboxamide::US11440913, Example 76::US11440913, Example 81 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571011&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074230 473132225 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206183 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(F)c2OC2COC2)c(C)nc1C InChI=1S/C26H24F2N6O4/c1-13-19(22-4-5-24-32-23(31-15(3)35)10-34(24)33-22)8-20(14(2)30-13)26(36)29-9-16-6-17(27)7-21(28)25(16)38-18-11-37-12-18/h4-8,10,18H,9,11-12H2,1-3H3,(H,29,36)(H,31,35) VBUGZCZRGHPCHQ-UHFFFAOYSA-N 571012 N-{[3,5-difluoro-2-(oxetan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 77 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571012&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074379 473132226 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206184 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(F)c2OC2CCOCC2)c(C)nc1C InChI=1S/C28H28F2N6O4/c1-15-21(24-4-5-26-34-25(33-17(3)37)14-36(26)35-24)12-22(16(2)32-15)28(38)31-13-18-10-19(29)11-23(30)27(18)40-20-6-8-39-9-7-20/h4-5,10-12,14,20H,6-9,13H2,1-3H3,(H,31,38)(H,33,37) BXKXIZPEGRMBRV-UHFFFAOYSA-N 571001 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl](deutero)methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 66::US11440913, Example 78 Receptor-interacting serine/threonine-protein kinase 1 Human 16.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571001&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074194 473132215 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206185 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(OC(F)(F)F)c2)c(C)nc1C InChI=1S/C24H20F4N6O3/c1-12-18(20-4-5-22-32-21(31-14(3)35)11-34(22)33-20)9-19(13(2)30-12)23(36)29-10-15-6-16(25)8-17(7-15)37-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) QWZKUFKPVFLVKN-UHFFFAOYSA-N 571014 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[3-fluoro-5- (trifluoromethoxy)phenyl]methyl}-2,6- dimethylpyridine-3-carboxamide, TFA::US11440913, Example 79 Receptor-interacting serine/threonine-protein kinase 1 Human 38.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571014&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074161 473132227 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206186 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(ccc2F)C(F)(F)F)c(C)nc1C InChI=1S/C24H20F4N6O2/c1-12-17(20-6-7-22-32-21(31-14(3)35)11-34(22)33-20)9-18(13(2)30-12)23(36)29-10-15-8-16(24(26,27)28)4-5-19(15)25/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) NVGQPIZSMFSDGE-UHFFFAOYSA-N 571010 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5- (trifluoromethyl)phenyl](deutero)methyl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 75::US11440913, Example 80 Receptor-interacting serine/threonine-protein kinase 1 Human 14.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571010&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074269 473132224 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206187 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(OC(F)(F)F)ccc2F)c(C)nc1C InChI=1S/C24H20F4N6O3/c1-12-17(20-6-7-22-32-21(31-14(3)35)11-34(22)33-20)9-18(13(2)30-12)23(36)29-10-15-8-16(4-5-19(15)25)37-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) FCJJIJFGKWTUHG-UHFFFAOYSA-N 571011 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5-(trifluorometh- oxy)phenyl](deutero)methyl}-2,6- dimethylpyridine-3-carboxamide::US11440913, Example 76::US11440913, Example 81 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571011&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074230 473132225 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206188 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCC[C@H](O)c2ccc(Cl)cc2)c(C)nc1C InChI=1S/C25H25ClN6O3/c1-14-19(21-8-9-24-30-23(29-16(3)33)13-32(24)31-21)12-20(15(2)28-14)25(35)27-11-10-22(34)17-4-6-18(26)7-5-17/h4-9,12-13,22,34H,10-11H2,1-3H3,(H,27,35)(H,29,33)/t22-/m0/s1 VSXLDRQEXQTNJW-QFIPXVFZSA-N 571017 N-[(3S)-3-(4-chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 82 Receptor-interacting serine/threonine-protein kinase 1 Human 21.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571017&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074228 473132228 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206189 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2ccccc2OCC2CC2)c(C)nc1C InChI=1S/C27H28N6O3/c1-16-21(23-10-11-26-31-25(30-18(3)34)14-33(26)32-23)12-22(17(2)29-16)27(35)28-13-20-6-4-5-7-24(20)36-15-19-8-9-19/h4-7,10-12,14,19H,8-9,13,15H2,1-3H3,(H,28,35)(H,30,34) HATNEZCKYVXCAQ-UHFFFAOYSA-N 571018 N-{[2- (cyclopropylmethoxy)phenyl]methyl}-5- {2-acetamidoimidazo[1,2-b]pyridazin-6- yl}-2,6-dimethylpyridine-3-carboxamide::US11440913, Example 83 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571018&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074069 473132229 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206190 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cccnc2OCC2CCCC2)c(C)nc1C InChI=1S/C28H31N7O3/c1-17-22(24-10-11-26-33-25(32-19(3)36)15-35(26)34-24)13-23(18(2)31-17)27(37)30-14-21-9-6-12-29-28(21)38-16-20-7-4-5-8-20/h6,9-13,15,20H,4-5,7-8,14,16H2,1-3H3,(H,30,37)(H,32,36) UHUJAZYNKCOSCI-UHFFFAOYSA-N 571019 N-{[2-(cyclopentylmethoxy)pyridin-3- yl]methyl}-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-2,6-dimethylpyridine-3- carboxamide::US11440913, Example 84 Receptor-interacting serine/threonine-protein kinase 1 Human 19.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571019&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074350 473132230 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206191 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2ccccc2OCC2CCCC2)c(C)nc1C InChI=1S/C29H32N6O3/c1-18-23(25-12-13-28-33-27(32-20(3)36)16-35(28)34-25)14-24(19(2)31-18)29(37)30-15-22-10-6-7-11-26(22)38-17-21-8-4-5-9-21/h6-7,10-14,16,21H,4-5,8-9,15,17H2,1-3H3,(H,30,37)(H,32,36) DZKBRVGRGCGKJQ-UHFFFAOYSA-N 571020 N-{[2- (cyclopentylmethoxy)phenyl]methyl}-5- {2-acetamidoimidazo[1,2-b]pyridazin-6- yl}-2,6-dimethylpyridine-3-carboxamide::US11440913, Example 85 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571020&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074136 473132231 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206192 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(F)c2OCC2CC2)c(C)nc1C InChI=1S/C27H26F2N6O3/c1-14-20(23-6-7-25-33-24(32-16(3)36)12-35(25)34-23)10-21(15(2)31-14)27(37)30-11-18-8-19(28)9-22(29)26(18)38-13-17-4-5-17/h6-10,12,17H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) CTFSWJRCOGHRIX-UHFFFAOYSA-N 571021 N-{[2-(cyclopropylmethoxy)-3,5- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 87 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571021&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074068 473132232 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206193 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cccc(OC(F)(F)F)c2)c(C)nc1C InChI=1S/C24H21F3N6O3/c1-13-18(20-7-8-22-31-21(30-15(3)34)12-33(22)32-20)10-19(14(2)29-13)23(35)28-11-16-5-4-6-17(9-16)36-24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) AYROJJYEDIGLTK-UHFFFAOYSA-N 571022 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2,6-dimethyl-N-{[3-(trifluorometh- oxy)phenyl]methyl}pyridine-3- carboxamide::US11440913, Example 88 Receptor-interacting serine/threonine-protein kinase 1 Human 25.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571022&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074109 473132233 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206194 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2ccccc2OC(F)(F)F)c(C)nc1C InChI=1S/C24H21F3N6O3/c1-13-17(19-8-9-22-31-21(30-15(3)34)12-33(22)32-19)10-18(14(2)29-13)23(35)28-11-16-6-4-5-7-20(16)36-24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) KAYPCGUXDWZMPS-UHFFFAOYSA-N 571023 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2,6-dimethyl-N-{[2-(trifluoro- methoxy)phenyl]methyl}pyridine-3- carboxamide::US11440913, Example 89 Receptor-interacting serine/threonine-protein kinase 1 Human 38.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571023&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074267 473132234 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206195 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(F)cc(F)c2OCC2CCCC2)c(C)nc1C InChI=1S/C29H30F2N6O3/c1-16-22(25-8-9-27-35-26(34-18(3)38)14-37(27)36-25)12-23(17(2)33-16)29(39)32-13-20-10-21(30)11-24(31)28(20)40-15-19-6-4-5-7-19/h8-12,14,19H,4-7,13,15H2,1-3H3,(H,32,39)(H,34,38) COAHNCBMCGRURI-UHFFFAOYSA-N 571024 N-{[2-(cyclopentylmethoxy)-3,5- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 90 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571024&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074264 473132235 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206196 Cc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1O[C@H]1CCOC1)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C27H26F2N6O5/c1-14-19(22-3-4-24-32-23(11-35(24)34-22)33-25(37)12-36)9-20(15(2)31-14)27(38)30-10-16-7-17(28)8-21(29)26(16)40-18-5-6-39-13-18/h3-4,7-9,11,18,36H,5-6,10,12-13H2,1-2H3,(H,30,38)(H,33,37)/t18-/m0/s1 WPXYYMKBQOJGHY-SFHVURJKSA-N 571025 N-({3,5-difluoro-2-[(3S)-oxolan-3- yloxy]phenyl}methyl)-5-[2- (2-hydroxy- acetamido)imidazo[1,2-b]pyridazin- 6-yl]-2,6-dimethylpyridine-3- carboxamide, TFA::US11440913, Example 91 Receptor-interacting serine/threonine-protein kinase 1 Human 61.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571025&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074359 473132236 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206197 C[C@@H](NC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(=O)CO)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C25H22F4N6O3/c1-12(16-8-15(25(27,28)29)4-5-19(16)26)31-24(38)18-9-17(13(2)30-14(18)3)20-6-7-22-32-21(10-35(22)34-20)33-23(37)11-36/h4-10,12,36H,11H2,1-3H3,(H,31,38)(H,33,37)/t12-/m1/s1 GOAGXWVRJYYEDT-GFCCVEGCSA-N 571026 N-[(1R)-1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl]-5-[2- (2-hydroxyacet- amido)imidazo[1,2-b]pyridazin-6-yl]- 2,6-dimethylpyridine-3-carboxamide::US11440913, Example 92 Receptor-interacting serine/threonine-protein kinase 1 Human 48.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571026&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074287 473132237 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206198 Cc1nc(C)c(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C24H20F4N6O3/c1-12-16(19-5-6-21-31-20(10-34(21)33-19)32-22(36)11-35)8-17(13(2)30-12)23(37)29-9-14-7-15(24(26,27)28)3-4-18(14)25/h3-8,10,35H,9,11H2,1-2H3,(H,29,37)(H,32,36) PGRBXNOLGBWYNZ-UHFFFAOYSA-N 571027 N-{[2-fluoro-5-(trifluoro- methyl)phenyl](deutero)methyl}- 5-[2-(2-hydroxy- acetamido)imidazo[1,2-b]pyridazin- 6-yl]-2,6-dimethylpyridine-3- carboxamide::US11440913, Example 93::US11440913, Example 94 Receptor-interacting serine/threonine-protein kinase 1 Human 50.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571027&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074352 473132238 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206199 Cc1nc(C)c(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C24H20F4N6O3/c1-12-16(19-5-6-21-31-20(10-34(21)33-19)32-22(36)11-35)8-17(13(2)30-12)23(37)29-9-14-7-15(24(26,27)28)3-4-18(14)25/h3-8,10,35H,9,11H2,1-2H3,(H,29,37)(H,32,36) PGRBXNOLGBWYNZ-UHFFFAOYSA-N 571027 N-{[2-fluoro-5-(trifluoro- methyl)phenyl](deutero)methyl}- 5-[2-(2-hydroxy- acetamido)imidazo[1,2-b]pyridazin- 6-yl]-2,6-dimethylpyridine-3- carboxamide::US11440913, Example 93::US11440913, Example 94 Receptor-interacting serine/threonine-protein kinase 1 Human 77.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571027&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074352 473132238 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206200 C[C@@H](NC(=O)c1cc(c(C)nc1C)-c1ccc2nc(NC(=O)CO)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H22F4N6O4/c1-12(16-8-15(4-5-19(16)26)39-25(27,28)29)31-24(38)18-9-17(13(2)30-14(18)3)20-6-7-22-32-21(10-35(22)34-20)33-23(37)11-36/h4-10,12,36H,11H2,1-3H3,(H,31,38)(H,33,37)/t12-/m1/s1 ZDMAXZSSEZVCQN-GFCCVEGCSA-N 571029 N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl]- 5-[2-(2-hydroxyacet- amido)imidazo[1,2-b]pyridazin- 6-yl]-2,6-dimethylpyridine-3- carboxamide::US11440913, Example 95 Receptor-interacting serine/threonine-protein kinase 1 Human 30.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571029&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074380 473132239 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206201 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCOC(C)C1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H28F2N6O5/c1-15-8-20(6-7-40-15)41-26-18(9-19(29)11-22(26)30)13-31-27(38)21-10-17(12-32-28(21)39-3)23-4-5-25-34-24(33-16(2)37)14-36(25)35-23/h4-5,9-12,14-15,20H,6-8,13H2,1-3H3,(H,31,38)(H,33,37) MCGSNAWXBYZLHY-UHFFFAOYSA-N 571030 N-({3,5-difluoro-2-[(2-methyloxan- 4-yl)oxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 96 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571030&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074325 473132240 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206202 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-15(36)32-23-13-35-24(33-23)7-6-22(34-35)17-9-20(27(38-2)31-11-17)26(37)30-12-18-8-19(28)10-21(29)25(18)39-14-16-4-3-5-16/h6-11,13,16H,3-5,12,14H2,1-2H3,(H,30,37)(H,32,36) YCPFYKZMOVFUOT-UHFFFAOYSA-N 571031 N-{[2-(cyclobutylmethoxy)-3,5- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 97 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571031&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074305 473132241 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206203 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1O[C@H]1CCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O5/c1-14(35)31-22-12-34-23(32-22)4-3-21(33-34)15-8-19(26(37-2)30-10-15)25(36)29-11-16-7-17(27)9-20(28)24(16)39-18-5-6-38-13-18/h3-4,7-10,12,18H,5-6,11,13H2,1-2H3,(H,29,36)(H,31,35)/t18-/m0/s1 FZYLLOODESMDBI-SFHVURJKSA-N 571032 N-({3,5-difluoro-2-[(3S)-oxolan-3- yloxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 98 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571032&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074240 473132242 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206204 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O5/c1-15(36)32-23-13-35-24(33-23)6-5-22(34-35)16-9-20(27(38-2)31-11-16)26(37)30-12-17-8-18(28)10-21(29)25(17)40-19-4-3-7-39-14-19/h5-6,8-11,13,19H,3-4,7,12,14H2,1-2H3,(H,30,37)(H,32,36) OUXSHWXSJCGFGD-UHFFFAOYSA-N 570978 N-{[3,5-difluoro-2-(oxan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 43::US11440913, Example 46::US11440913, Example 99 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570978&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162690512 473132196 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206205 COc1ccc(F)c(CNC(=O)c2cc(cnc2OC)-c2ccc3nc(NC(C)=O)cn3n2)c1 InChI=1S/C23H21FN6O4/c1-13(31)27-20-12-30-21(28-20)7-6-19(29-30)15-9-17(23(34-3)26-11-15)22(32)25-10-14-8-16(33-2)4-5-18(14)24/h4-9,11-12H,10H2,1-3H3,(H,25,32)(H,27,31) IPQJGRQHPWMXJE-UHFFFAOYSA-N 570975 5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-N-[(2-fluoro-5- methoxyphenyl)methyl]-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 100::US11440913, Example 40 Receptor-interacting serine/threonine-protein kinase 1 Human 56.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570975&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074382 473132193 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206206 COc1ncc(cc1C(=O)NCc1c(F)cccc1OCC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-13(35)31-20-11-34-21(32-20)7-6-18(33-34)14-8-15(23(37-2)30-9-14)22(36)29-10-16-17(25)4-3-5-19(16)38-12-24(26,27)28/h3-9,11H,10,12H2,1-2H3,(H,29,36)(H,31,35) DOXMJMYQICODGA-UHFFFAOYSA-N 570977 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-6-(2,2,2- trifluoroethoxy)phenyl]methyl}-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 102::US11440913, Example 42 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570977&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074171 473132195 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206207 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CC(C)OC(C)C1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C29H30F2N6O5/c1-15-7-21(8-16(2)41-15)42-27-19(9-20(30)11-23(27)31)13-32-28(39)22-10-18(12-33-29(22)40-4)24-5-6-26-35-25(34-17(3)38)14-37(26)36-24/h5-6,9-12,14-16,21H,7-8,13H2,1-4H3,(H,32,39)(H,34,38) QZYVXMJSROFZTL-UHFFFAOYSA-N 571036 N-({2-[(2,6-dimethyloxan-4- yl)oxy]-3,5- difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 103 Receptor-interacting serine/threonine-protein kinase 1 Human 51.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571036&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074400 473132243 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206208 COc1ncc(cc1C(=O)N[C@H](C)c1ccccc1C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O3/c1-13(16-6-4-5-7-18(16)24(25,26)27)29-22(35)17-10-15(11-28-23(17)36-3)19-8-9-21-31-20(30-14(2)34)12-33(21)32-19/h4-13H,1-3H3,(H,29,35)(H,30,34)/t13-/m1/s1 GRNXYKACHUBWLH-CYBMUJFWSA-N 571037 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-[(1R)-1-[2- (trifluoromethyl)phenyl]ethyl]pyridine- 3-carboxamide::US11440913, Example 104 Receptor-interacting serine/threonine-protein kinase 1 Human 36.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571037&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074201 473132244 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206209 COc1ncc(cc1C(=O)NCc1cc(F)ccc1OCC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-13(35)31-20-11-34-21(32-20)6-4-18(33-34)14-8-17(23(37-2)30-9-14)22(36)29-10-15-7-16(25)3-5-19(15)38-12-24(26,27)28/h3-9,11H,10,12H2,1-2H3,(H,29,36)(H,31,35) OGMQYCRWCRUYJU-UHFFFAOYSA-N 571038 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[5-fluoro-2-(2,2,2- trifluoroethoxy)phenyl]methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 105 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571038&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074313 473132245 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206210 COc1ncc(cc1C(=O)N[C@H](C)c1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O3/c1-12(16-9-15(24(26,27)28)4-5-18(16)25)30-22(36)17-8-14(10-29-23(17)37-3)19-6-7-21-32-20(31-13(2)35)11-34(21)33-19/h4-12H,1-3H3,(H,30,36)(H,31,35)/t12-/m1/s1 ILWDGVNDEQLXTQ-GFCCVEGCSA-N 571039 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1S)-1-[2-fluoro-5- (trifluoromethyl)phenyl](2,2,2- deutero)ethyl]-2-methoxypyridine-3- carboxamide::US11440913, Example 106 Receptor-interacting serine/threonine-protein kinase 1 Human 84.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571039&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437131 473132246 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206211 COc1ncc(cc1C(=O)N[C@@H](C)c1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O3/c1-12(16-9-15(24(26,27)28)4-5-18(16)25)30-22(36)17-8-14(10-29-23(17)37-3)19-6-7-21-32-20(31-13(2)35)11-34(21)33-19/h4-12H,1-3H3,(H,30,36)(H,31,35)/t12-/m0/s1 ILWDGVNDEQLXTQ-LBPRGKRZSA-N 571040 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2-fluoro-5- (trifluoromethyl)phenyl](2,2,2- deutero)ethyl]-2-methoxypyridine-3- carboxamide::US11440913, Example 107 Receptor-interacting serine/threonine-protein kinase 1 Human 193 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571040&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437132 473132247 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206212 COc1ncc(cc1C(=O)NCc1ccccc1OCC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-14(34)30-20-12-33-21(31-20)8-7-18(32-33)16-9-17(23(36-2)29-11-16)22(35)28-10-15-5-3-4-6-19(15)37-13-24(25,26)27/h3-9,11-12H,10,13H2,1-2H3,(H,28,35)(H,30,34) UCVSKHMTJZCOLR-UHFFFAOYSA-N 571041 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-{[2-(2,2,2- trifluoroethoxy)phenyl]meth- yl}pyridine-3-carboxamide::US11440913, Example 108 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571041&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074243 473132248 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206213 COc1ncc(cc1C(=O)N[C@H](C)c1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-12(16-9-15(4-5-18(16)25)38-24(26,27)28)30-22(36)17-8-14(10-29-23(17)37-3)19-6-7-21-32-20(31-13(2)35)11-34(21)33-19/h4-12H,1-3H3,(H,30,36)(H,31,35)/t12-/m1/s1 QPWFZJRWOCUEPG-GFCCVEGCSA-N 570982 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl]-2- (D3)methoxypyridine-3- carboxamide::US11440913, Example 109::US11440913, Example 47 Receptor-interacting serine/threonine-protein kinase 1 Human 32.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570982&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162714773 473132199 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206214 COc1ncc(cc1C(=O)NCc1cccc(c1)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H19F3N6O3/c1-13(33)29-19-12-32-20(30-19)7-6-18(31-32)15-9-17(22(35-2)28-11-15)21(34)27-10-14-4-3-5-16(8-14)23(24,25)26/h3-9,11-12H,10H2,1-2H3,(H,27,34)(H,29,33) GRLJTXRIUHJDQC-UHFFFAOYSA-N 571043 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-{[3- (trifluoromethyl)phen- yl](deutero)methyl}pyridine-3- carboxamide::US11440913, Example 110 Receptor-interacting serine/threonine-protein kinase 1 Human 27.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571043&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437133 473132249 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206215 COc1ncc(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H18F4N6O3/c1-12(34)30-19-11-33-20(31-19)6-5-18(32-33)14-8-16(22(36-2)29-10-14)21(35)28-9-13-7-15(23(25,26)27)3-4-17(13)24/h3-8,10-11H,9H2,1-2H3,(H,28,35)(H,30,34) YMXYWBGJKZDGFG-UHFFFAOYSA-N 571044 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5- (trifluoromethyl)phen- yl](deutero)methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 111::US11440913, Example 146 Receptor-interacting serine/threonine-protein kinase 1 Human 19.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571044&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074218 473132250 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206216 COc1ncc(cc1C(=O)N[C@H](C)c1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13(15-5-4-6-17(9-15)37-24(25,26)27)29-22(35)18-10-16(11-28-23(18)36-3)19-7-8-21-31-20(30-14(2)34)12-33(21)32-19/h4-13H,1-3H3,(H,29,35)(H,30,34)/t13-/m1/s1 ISGBTIALGWFLEZ-CYBMUJFWSA-N 571045 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-[(1R)-1-[3- (trifluoromethoxy)phenyl](2,2,2- deutero)ethyl]pyridine-3-carboxamide::BDBM571056::US11440913, Example 112 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571045&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437134 473132251 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206217 COc1ncc(cc1C(=O)NCc1ccccc1CN1CCOCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H29N7O4/c1-18(35)30-24-17-34-25(31-24)8-7-23(32-34)21-13-22(27(37-2)29-15-21)26(36)28-14-19-5-3-4-6-20(19)16-33-9-11-38-12-10-33/h3-8,13,15,17H,9-12,14,16H2,1-2H3,(H,28,36)(H,30,35) MUCHFCHFXUJMHH-UHFFFAOYSA-N 571046 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-({2-[(morpholin- 4-yl)methyl]phenyl}methyl)pyridine- 3-carboxamide, 2 TFA::US11440913, Example 113 Receptor-interacting serine/threonine-protein kinase 1 Human 38.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571046&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074249 473132252 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206218 COc1ncc(cc1C(=O)NCc1ccccc1COC(C)C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H28N6O4/c1-16(2)36-15-19-8-6-5-7-18(19)12-27-25(34)21-11-20(13-28-26(21)35-4)22-9-10-24-30-23(29-17(3)33)14-32(24)31-22/h5-11,13-14,16H,12,15H2,1-4H3,(H,27,34)(H,29,33) DCZXDBZLURIFDM-UHFFFAOYSA-N 571047 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-({2-[(propan-2- yloxy)methyl]phenyl}meth- yl)pyridine-3-carboxamide, TFA::US11440913, Example 114 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571047&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074262 473132253 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206219 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1COC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F2N6O5/c1-13(34)30-21-10-33-22(31-21)4-3-20(32-33)14-6-18(25(36-2)29-8-14)24(35)28-9-15-5-16(26)7-19(27)23(15)38-17-11-37-12-17/h3-8,10,17H,9,11-12H2,1-2H3,(H,28,35)(H,30,34) BVIMNHKKHNWLCO-UHFFFAOYSA-N 570983 N-{[3,5-difluoro-2-(oxetan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 115::US11440913, Example 48 Receptor-interacting serine/threonine-protein kinase 1 Human 12.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570983&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074321 473132200 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206220 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC(C)C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H26F2N6O4/c1-14(2)13-38-24-17(7-18(27)9-20(24)28)11-29-25(36)19-8-16(10-30-26(19)37-4)21-5-6-23-32-22(31-15(3)35)12-34(23)33-21/h5-10,12,14H,11,13H2,1-4H3,(H,29,36)(H,31,35) GLNNWZXBAXZALR-UHFFFAOYSA-N 571049 N-{[3,5-difluoro-2-(2- methylpropoxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 116 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571049&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074302 473132254 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206221 COc1ncc(cc1C(=O)NCc1ccccc1OCC(C)C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H28N6O4/c1-16(2)15-36-22-8-6-5-7-18(22)12-27-25(34)20-11-19(13-28-26(20)35-4)21-9-10-24-30-23(29-17(3)33)14-32(24)31-21/h5-11,13-14,16H,12,15H2,1-4H3,(H,27,34)(H,29,33) LOTAJPJQFJFSIZ-UHFFFAOYSA-N 571050 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-{[2-(2-methyl- propoxy)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 117 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571050&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074372 473132255 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206222 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F2N6O4/c1-13(34)30-21-12-33-22(31-21)6-5-20(32-33)14-8-18(25(36-2)29-10-14)24(35)28-11-15-7-16(26)9-19(27)23(15)37-17-3-4-17/h5-10,12,17H,3-4,11H2,1-2H3,(H,28,35)(H,30,34) GHOGSWAHDBACDP-UHFFFAOYSA-N 571051 N-[(2-cyclopropoxy-3,5- difluorophenyl)methyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 118 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571051&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074257 473132256 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206223 COc1ncc(cc1C(=O)NCC[C@H](O)c1ccc(Cl)cc1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H23ClN6O4/c1-14(32)28-21-13-31-22(29-21)8-7-19(30-31)16-11-18(24(35-2)27-12-16)23(34)26-10-9-20(33)15-3-5-17(25)6-4-15/h3-8,11-13,20,33H,9-10H2,1-2H3,(H,26,34)(H,28,32)/t20-/m0/s1 BVBVUVCXZGLARL-FQEVSTJZSA-N 571052 N-[(3S)-3-(4-chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 119 Receptor-interacting serine/threonine-protein kinase 1 Human 116 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571052&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074126 473132257 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206224 COc1ncc(cc1C(=O)NCc1ccc(F)cc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H18F4N6O4/c1-12(34)30-19-11-33-20(31-19)6-5-17(32-33)14-7-16(22(36-2)29-10-14)21(35)28-9-13-3-4-15(24)8-18(13)37-23(25,26)27/h3-8,10-11H,9H2,1-2H3,(H,28,35)(H,30,34) VZXKKSOOTDUEHV-UHFFFAOYSA-N 571053 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[4-fluoro-2- (trifluoromethoxy)phenyl]methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 120 Receptor-interacting serine/threonine-protein kinase 1 Human 170 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571053&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074393 473132258 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206225 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O4/c1-14(35)31-22-12-34-23(32-22)6-5-21(33-34)16-8-19(26(37-2)30-10-16)25(36)29-11-17-7-18(27)9-20(28)24(17)38-13-15-3-4-15/h5-10,12,15H,3-4,11,13H2,1-2H3,(H,29,36)(H,31,35) CXQXAXGVRWRAJR-UHFFFAOYSA-N 570984 N-({2- [cyclopropyl(deutero)methoxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 121::US11440913, Example 49::US11440913, Example 55 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570984&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437126 473132201 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206226 COc1ncc(cc1C(=O)NC(C)c1c(F)cccc1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15(25-20(28)5-4-6-22(25)38-14-17-7-8-17)30-26(36)19-11-18(12-29-27(19)37-3)21-9-10-24-32-23(31-16(2)35)13-34(24)33-21/h4-6,9-13,15,17H,7-8,14H2,1-3H3,(H,30,36)(H,31,35) XOMQSZKURBYULJ-UHFFFAOYSA-N 571055 N-{1-[2-(cyclopropylmethoxy)-6- fluorophenyl]ethyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide, TFA::US11440913, Example 122::US11440913, Example 124 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571055&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074300 473132259 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206227 COc1ncc(cc1C(=O)N[C@H](C)c1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13(15-5-4-6-17(9-15)37-24(25,26)27)29-22(35)18-10-16(11-28-23(18)36-3)19-7-8-21-31-20(30-14(2)34)12-33(21)32-19/h4-13H,1-3H3,(H,29,35)(H,30,34)/t13-/m1/s1 ISGBTIALGWFLEZ-CYBMUJFWSA-N 571045 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-[(1R)-1-[3- (trifluoromethoxy)phenyl](2,2,2- deutero)ethyl]pyridine-3-carboxamide::BDBM571056::US11440913, Example 112 Receptor-interacting serine/threonine-protein kinase 1 Human 37.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571045&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437134 473132251 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206228 COc1ncc(cc1C(=O)NC(C)c1c(F)cccc1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15(25-20(28)5-4-6-22(25)38-14-17-7-8-17)30-26(36)19-11-18(12-29-27(19)37-3)21-9-10-24-32-23(31-16(2)35)13-34(24)33-21/h4-6,9-13,15,17H,7-8,14H2,1-3H3,(H,30,36)(H,31,35) XOMQSZKURBYULJ-UHFFFAOYSA-N 571055 N-{1-[2-(cyclopropylmethoxy)-6- fluorophenyl]ethyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide, TFA::US11440913, Example 122::US11440913, Example 124 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571055&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074300 473132259 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206229 COc1ncc(cc1C(=O)N[C@@H](C)c1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13(15-5-4-6-17(9-15)37-24(25,26)27)29-22(35)18-10-16(11-28-23(18)36-3)19-7-8-21-31-20(30-14(2)34)12-33(21)32-19/h4-13H,1-3H3,(H,29,35)(H,30,34)/t13-/m0/s1 ISGBTIALGWFLEZ-ZDUSSCGKSA-N 576440 US11440913, Example 125 Receptor-interacting serine/threonine-protein kinase 1 Human 34.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=576440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=576440&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 166178069 474498646 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206230 COc1ncc(cc1C(=O)NCc1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H19F3N6O4/c1-13(33)29-19-12-32-20(30-19)7-6-18(31-32)15-9-17(22(35-2)28-11-15)21(34)27-10-14-4-3-5-16(8-14)36-23(24,25)26/h3-9,11-12H,10H2,1-2H3,(H,27,34)(H,29,33) WFNXKWWWIOIDLC-UHFFFAOYSA-N 571059 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-{[3-(trifluoro- methoxy)phenyl]methyl}pyridine-3- carboxamide::US11440913, Example 126 Receptor-interacting serine/threonine-protein kinase 1 Homo sapiens 73.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571059&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074217 473132261 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5,8Z93 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 N/A A0A024QZU0 1206231 COc1ncc(cc1C(=O)NCc1c(F)ccc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O4/c1-14(35)31-22-12-34-23(32-22)8-7-21(33-34)16-9-17(26(37-2)30-10-16)25(36)29-11-18-19(27)5-6-20(28)24(18)38-13-15-3-4-15/h5-10,12,15H,3-4,11,13H2,1-2H3,(H,29,36)(H,31,35) HUIUVJULPQEKLY-UHFFFAOYSA-N 571060 N-{[2-(cyclopropylmethoxy)-3,6- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 127 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571060&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074368 473132262 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206232 COc1ncc(cc1C(=O)NCc1c(F)cccc1OC1CCOCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O5/c1-16(35)31-24-15-34-25(32-24)7-6-22(33-34)17-12-19(27(37-2)30-13-17)26(36)29-14-20-21(28)4-3-5-23(20)39-18-8-10-38-11-9-18/h3-7,12-13,15,18H,8-11,14H2,1-2H3,(H,29,36)(H,31,35) IREKEWQZJHAVIN-UHFFFAOYSA-N 571061 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-6-(oxan-4- yloxy)phenyl]methyl}-2- methoxypyridine-3-carboxamide, TFA::US11440913, Example 128 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571061&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074072 473132263 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206233 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O5/c1-15(36)32-23-14-35-24(33-23)4-3-22(34-35)16-10-20(27(38-2)31-12-16)26(37)30-13-17-9-18(28)11-21(29)25(17)40-19-5-7-39-8-6-19/h3-4,9-12,14,19H,5-8,13H2,1-2H3,(H,30,37)(H,32,36) KEIQFMNOLQPIPY-UHFFFAOYSA-N 570985 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 129::US11440913, Example 153::US11440913, Example 50 Receptor-interacting serine/threonine-protein kinase 1 Human 1.000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570985&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074097 473132202 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206234 COc1ncc(cc1C(=O)NC(C)c1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14(19-9-18(28)10-21(29)25(19)39-13-16-4-5-16)31-26(37)20-8-17(11-30-27(20)38-3)22-6-7-24-33-23(32-15(2)36)12-35(24)34-22/h6-12,14,16H,4-5,13H2,1-3H3,(H,31,37)(H,32,36) QDXVERMDLRFDTI-UHFFFAOYSA-N 571063 N-{1-[2-(cyclopropylmethoxy)-3,5- difluorophenyl]ethyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 130::US11440913, Example 133 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571063&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074172 473132264 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206235 COc1ncc(cc1C(=O)NCc1ccc(F)c(F)c1OC(C)C1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14(16-4-5-16)39-25-17(6-7-20(28)24(25)29)11-30-26(37)19-10-18(12-31-27(19)38-3)21-8-9-23-33-22(32-15(2)36)13-35(23)34-21/h6-10,12-14,16H,4-5,11H2,1-3H3,(H,30,37)(H,32,36) UWTKGQXESQHYNR-UHFFFAOYSA-N 571064 N-{[2-(1-cyclopropylethoxy)-3,4- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 131::US11440913, Example 132 Receptor-interacting serine/threonine-protein kinase 1 Human 79.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571064&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074263 473132265 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206236 COc1ncc(cc1C(=O)NCc1ccc(F)c(F)c1OC(C)C1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14(16-4-5-16)39-25-17(6-7-20(28)24(25)29)11-30-26(37)19-10-18(12-31-27(19)38-3)21-8-9-23-33-22(32-15(2)36)13-35(23)34-21/h6-10,12-14,16H,4-5,11H2,1-3H3,(H,30,37)(H,32,36) UWTKGQXESQHYNR-UHFFFAOYSA-N 571064 N-{[2-(1-cyclopropylethoxy)-3,4- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 131::US11440913, Example 132 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571064&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074263 473132265 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206237 COc1ncc(cc1C(=O)NC(C)c1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14(19-9-18(28)10-21(29)25(19)39-13-16-4-5-16)31-26(37)20-8-17(11-30-27(20)38-3)22-6-7-24-33-23(32-15(2)36)12-35(24)34-22/h6-12,14,16H,4-5,13H2,1-3H3,(H,31,37)(H,32,36) QDXVERMDLRFDTI-UHFFFAOYSA-N 571063 N-{1-[2-(cyclopropylmethoxy)-3,5- difluorophenyl]ethyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 130::US11440913, Example 133 Receptor-interacting serine/threonine-protein kinase 1 Human 23.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571063&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074172 473132264 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206238 COc1ncc(cc1C(=O)NCc1cccc(F)c1OC(C)C1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15(17-7-8-17)38-25-18(5-4-6-21(25)28)12-29-26(36)20-11-19(13-30-27(20)37-3)22-9-10-24-32-23(31-16(2)35)14-34(24)33-22/h4-6,9-11,13-15,17H,7-8,12H2,1-3H3,(H,29,36)(H,31,35) ZASXMYMDOKNCMC-UHFFFAOYSA-N 571067 N-{[2-(1-cyclopropylethoxy)-3- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 134::US11440913, Example 135::US11440913, Example 144::US11440913, Example 148 Receptor-interacting serine/threonine-protein kinase 1 Human 18.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571067&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074203 473132266 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206239 COc1ncc(cc1C(=O)NCc1cccc(F)c1OC(C)C1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15(17-7-8-17)38-25-18(5-4-6-21(25)28)12-29-26(36)20-11-19(13-30-27(20)37-3)22-9-10-24-32-23(31-16(2)35)14-34(24)33-22/h4-6,9-11,13-15,17H,7-8,12H2,1-3H3,(H,29,36)(H,31,35) ZASXMYMDOKNCMC-UHFFFAOYSA-N 571067 N-{[2-(1-cyclopropylethoxy)-3- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 134::US11440913, Example 135::US11440913, Example 144::US11440913, Example 148 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571067&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074203 473132266 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206240 COc1ncc(cc1C(=O)NCc1ncccc1OC(C)C1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H27N7O4/c1-15(17-6-7-17)37-22-5-4-10-27-21(22)13-28-25(35)19-11-18(12-29-26(19)36-3)20-8-9-24-31-23(30-16(2)34)14-33(24)32-20/h4-5,8-12,14-15,17H,6-7,13H2,1-3H3,(H,28,35)(H,30,34) BXKUNYQDSZVCKQ-UHFFFAOYSA-N 571069 N-{[3-(1-cyclopropylethoxy)pyridin-2- yl]methyl}-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-2-methoxypyridine- 3-carboxamide::US11440913, Example 136 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571069&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074137 473132267 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206241 COc1ncc(cc1C(=O)NC(C)c1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13(16-6-4-5-7-19(16)37-24(25,26)27)29-22(35)17-10-15(11-28-23(17)36-3)18-8-9-21-31-20(30-14(2)34)12-33(21)32-18/h4-13H,1-3H3,(H,29,35)(H,30,34) OMVLHTIXQXXJID-UHFFFAOYSA-N 570989 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxy-N-{1-[2- (trifluoromethoxy)phenyl]eth- yl}pyridine-3-carboxamide::BDBM571070::US11440913, Example 54::US11440913, Example 57 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570989&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074239 473132205 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206242 COc1ncc(cc1C(=O)NCc1cc(F)cc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H18F4N6O4/c1-12(34)30-19-11-33-20(31-19)4-3-18(32-33)14-7-17(22(36-2)29-10-14)21(35)28-9-13-5-15(24)8-16(6-13)37-23(25,26)27/h3-8,10-11H,9H2,1-2H3,(H,28,35)(H,30,34) QJCRSDDWOFJLAV-UHFFFAOYSA-N 571071 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[3-fluoro-5- (trifluoromethoxy)phenyl]methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 138 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571071&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074156 473132269 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206243 COc1ncc(cc1C(=O)NC(C)c1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13(16-6-4-5-7-19(16)37-24(25,26)27)29-22(35)17-10-15(11-28-23(17)36-3)18-8-9-21-31-20(30-14(2)34)12-33(21)32-18/h4-13H,1-3H3,(H,29,35)(H,30,34) OMVLHTIXQXXJID-UHFFFAOYSA-N 570989 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxy-N-{1-[2- (trifluoromethoxy)phenyl]eth- yl}pyridine-3-carboxamide::BDBM571070::US11440913, Example 54::US11440913, Example 57 Receptor-interacting serine/threonine-protein kinase 1 Human 15.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570989&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074239 473132205 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206244 COc1ncc(cc1C(=O)NCc1cc(F)cc(OCC2CC2)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H25FN6O4/c1-15(34)30-23-13-33-24(31-23)6-5-22(32-33)18-9-21(26(36-2)29-12-18)25(35)28-11-17-7-19(27)10-20(8-17)37-14-16-3-4-16/h5-10,12-13,16H,3-4,11,14H2,1-2H3,(H,28,35)(H,30,34) SQRUNTXEAPTDDV-UHFFFAOYSA-N 571073 N-{[3-(cyclopropylmethoxy)-5- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 140 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571073&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074175 473132270 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206245 COc1ncc(cc1C(=O)NCc1c(F)ccc(F)c1OC)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H20F2N6O4/c1-12(32)28-19-11-31-20(29-19)7-6-18(30-31)13-8-14(23(35-3)27-9-13)22(33)26-10-15-16(24)4-5-17(25)21(15)34-2/h4-9,11H,10H2,1-3H3,(H,26,33)(H,28,32) KUVJMYINFFODPB-UHFFFAOYSA-N 571074 N-[(3,6-difluoro-2- methoxyphenyl)methyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 141 Receptor-interacting serine/threonine-protein kinase 1 Human 97.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571074&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074200 473132271 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206246 COc1ncc(cc1C(=O)NCc1ccc(F)c(OCC2CC2)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H25FN6O4/c1-15(34)30-23-13-33-24(31-23)8-7-21(32-33)18-10-19(26(36-2)29-12-18)25(35)28-11-17-5-6-20(27)22(9-17)37-14-16-3-4-16/h5-10,12-13,16H,3-4,11,14H2,1-2H3,(H,28,35)(H,30,34) PBEHHYHUPRJMLQ-UHFFFAOYSA-N 571075 N-{[3-(cyclopropylmethoxy)-4- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 142 Receptor-interacting serine/threonine-protein kinase 1 Human 29.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571075&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074378 473132272 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206247 COc1ncc(cc1C(=O)N(C)Cc1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-14(34)29-20-13-33-21(30-20)8-7-19(31-33)16-10-18(22(36-3)28-11-16)23(35)32(2)12-15-5-4-6-17(9-15)37-24(25,26)27/h4-11,13H,12H2,1-3H3,(H,29,34) TVILPIHGNMKMGV-UHFFFAOYSA-N 571076 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-methyl-N-{[3- (trifluoromethoxy)phenyl]meth- yl}pyridine-3-carboxamide::US11440913, Example 143 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571076&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074075 473132273 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206248 COc1ncc(cc1C(=O)NCc1cccc(F)c1OC(C)C1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15(17-7-8-17)38-25-18(5-4-6-21(25)28)12-29-26(36)20-11-19(13-30-27(20)37-3)22-9-10-24-32-23(31-16(2)35)14-34(24)33-22/h4-6,9-11,13-15,17H,7-8,12H2,1-3H3,(H,29,36)(H,31,35) ZASXMYMDOKNCMC-UHFFFAOYSA-N 571067 N-{[2-(1-cyclopropylethoxy)-3- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 134::US11440913, Example 135::US11440913, Example 144::US11440913, Example 148 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571067&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074203 473132266 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206249 COc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H18F4N6O4/c1-12(34)30-19-11-33-20(31-19)6-5-18(32-33)14-8-16(22(36-2)29-10-14)21(35)28-9-13-7-15(3-4-17(13)24)37-23(25,26)27/h3-8,10-11H,9H2,1-2H3,(H,28,35)(H,30,34) WUODHJTYHZBCCM-UHFFFAOYSA-N 571078 BDBM571087::5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5-(trifluoro- methoxy)phenyl](deutero)methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 145 Receptor-interacting serine/threonine-protein kinase 1 Homo sapiens 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571078&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074212 473132274 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5,8Z93 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 N/A A0A024QZU0 1206250 COc1ncc(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H18F4N6O3/c1-12(34)30-19-11-33-20(31-19)6-5-18(32-33)14-8-16(22(36-2)29-10-14)21(35)28-9-13-7-15(23(25,26)27)3-4-17(13)24/h3-8,10-11H,9H2,1-2H3,(H,28,35)(H,30,34) YMXYWBGJKZDGFG-UHFFFAOYSA-N 571044 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5- (trifluoromethyl)phen- yl](deutero)methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 111::US11440913, Example 146 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571044&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074218 473132250 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206251 COc1ncc(cc1C(=O)NCc1cc(ccc1Cl)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H18ClF3N6O3/c1-12(34)30-19-11-33-20(31-19)6-5-18(32-33)14-8-16(22(36-2)29-10-14)21(35)28-9-13-7-15(23(25,26)27)3-4-17(13)24/h3-8,10-11H,9H2,1-2H3,(H,28,35)(H,30,34) WHEGJKHOOKPGPH-UHFFFAOYSA-N 571080 N-{[2-chloro-5- (trifluoromethyl)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 147 Receptor-interacting serine/threonine-protein kinase 1 Human 95.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571080&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074225 473132275 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206252 COc1ncc(cc1C(=O)NCc1cccc(F)c1OC(C)C1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15(17-7-8-17)38-25-18(5-4-6-21(25)28)12-29-26(36)20-11-19(13-30-27(20)37-3)22-9-10-24-32-23(31-16(2)35)14-34(24)33-22/h4-6,9-11,13-15,17H,7-8,12H2,1-3H3,(H,29,36)(H,31,35) ZASXMYMDOKNCMC-UHFFFAOYSA-N 571067 N-{[2-(1-cyclopropylethoxy)-3- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 134::US11440913, Example 135::US11440913, Example 144::US11440913, Example 148 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571067&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074203 473132266 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206253 COc1ncc(cc1C(=O)NCc1cc(OCC2CC2)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H25FN6O4/c1-15(34)30-23-13-33-24(31-23)8-7-22(32-33)18-10-20(26(36-2)29-12-18)25(35)28-11-17-9-19(5-6-21(17)27)37-14-16-3-4-16/h5-10,12-13,16H,3-4,11,14H2,1-2H3,(H,28,35)(H,30,34) PFUPRKBPLOLDPE-UHFFFAOYSA-N 570991 N-{[5-(cyclopropylmethoxy)-2- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyri- dazin-6-yl}-2- (D3)methoxypyridine- 3-carboxamide, TFA::US11440913, Example 149::US11440913, Example 56 Receptor-interacting serine/threonine-protein kinase 1 Human 16.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570991&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074293 473132206 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206254 COc1ncc(cc1C(=O)NCc1c(F)cc(F)cc1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24F2N6O4/c1-14(35)31-23-12-34-24(32-23)6-5-21(33-34)16-7-18(26(37-2)30-10-16)25(36)29-11-19-20(28)8-17(27)9-22(19)38-13-15-3-4-15/h5-10,12,15H,3-4,11,13H2,1-2H3,(H,29,36)(H,31,35) RMDJOBPALLCQHU-UHFFFAOYSA-N 571083 N-{[2-(cyclopropylmethoxy)-4,6- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 150 Receptor-interacting serine/threonine-protein kinase 1 Human 18.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571083&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074150 473132276 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206255 COc1ncc(cc1C(=O)NCc1cccc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H25FN6O4/c1-15(34)30-22-13-33-23(31-22)9-8-21(32-33)18-10-19(26(36-2)29-12-18)25(35)28-11-17-4-3-5-20(27)24(17)37-14-16-6-7-16/h3-5,8-10,12-13,16H,6-7,11,14H2,1-2H3,(H,28,35)(H,30,34) XNQJWAXGOSIPGJ-UHFFFAOYSA-N 571084 N-{[2-(cyclopropylmethoxy)-3- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3- carboxamide, TFA::US11440913, Example 151 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571084&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074204 473132277 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206256 COc1ncc(cc1C(=O)NCc1ccc(F)cc1OC1CCOCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O5/c1-16(35)31-24-15-34-25(32-24)6-5-22(33-34)18-11-21(27(37-2)30-14-18)26(36)29-13-17-3-4-19(28)12-23(17)39-20-7-9-38-10-8-20/h3-6,11-12,14-15,20H,7-10,13H2,1-2H3,(H,29,36)(H,31,35) ZUZRZYZDYRQIOK-UHFFFAOYSA-N 571085 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[4-fluoro-2-(oxan-4- yloxy)phenyl]methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 152 Receptor-interacting serine/threonine-protein kinase 1 Human 49.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571085&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074183 473132278 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206257 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O5/c1-15(36)32-23-14-35-24(33-23)4-3-22(34-35)16-10-20(27(38-2)31-12-16)26(37)30-13-17-9-18(28)11-21(29)25(17)40-19-5-7-39-8-6-19/h3-4,9-12,14,19H,5-8,13H2,1-2H3,(H,30,37)(H,32,36) KEIQFMNOLQPIPY-UHFFFAOYSA-N 570985 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(D3)methoxypyridine- 3-carboxamide::US11440913, Example 129::US11440913, Example 153::US11440913, Example 50 Receptor-interacting serine/threonine-protein kinase 1 Human 1.000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570985&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074097 473132202 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206258 COc1ncc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H18F4N6O4/c1-12(34)30-19-11-33-20(31-19)6-5-18(32-33)14-8-16(22(36-2)29-10-14)21(35)28-9-13-7-15(3-4-17(13)24)37-23(25,26)27/h3-8,10-11H,9H2,1-2H3,(H,28,35)(H,30,34) WUODHJTYHZBCCM-UHFFFAOYSA-N 571078 BDBM571087::5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5-(trifluoro- methoxy)phenyl](deutero)methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 145 Receptor-interacting serine/threonine-protein kinase 1 Homo sapiens 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571078&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074212 473132274 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5,8Z93 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 N/A A0A024QZU0 1206259 COc1ncc(cc1C(=O)NCc1ccccc1OCC1CCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H28N6O4/c1-17(34)30-24-15-33-25(31-24)11-10-22(32-33)20-12-21(27(36-2)29-14-20)26(35)28-13-19-8-3-4-9-23(19)37-16-18-6-5-7-18/h3-4,8-12,14-15,18H,5-7,13,16H2,1-2H3,(H,28,35)(H,30,34) MSTGCINGCSESNI-UHFFFAOYSA-N 571088 N-{[2- (cyclobutylmethoxy)phenyl]methyl}-5- {2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 155 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571088&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074260 473132280 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206260 COc1ncc(cc1C(=O)NCc1c(F)cccc1OC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-16(35)31-24-15-34-25(32-24)11-10-22(33-34)17-12-19(27(37-2)30-13-17)26(36)29-14-20-21(28)8-5-9-23(20)38-18-6-3-4-7-18/h5,8-13,15,18H,3-4,6-7,14H2,1-2H3,(H,29,36)(H,31,35) MSYLNOCOZOATQD-UHFFFAOYSA-N 571089 N-{[2-(cyclopentyloxy)-6- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 156 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571089&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074389 473132281 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206261 COc1ncc(cc1C(=O)NCc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C23H19F3N6O4/c1-13(33)29-19-12-32-20(30-19)8-7-17(31-32)15-9-16(22(35-2)28-11-15)21(34)27-10-14-5-3-4-6-18(14)36-23(24,25)26/h3-9,11-12H,10H2,1-2H3,(H,27,34)(H,29,33) PJKATLLHXWKCPC-UHFFFAOYSA-N 570949 BDBM571090::US11440913, Example 14 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570949&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581016 473132167 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206262 COc1ncc(cc1C(=O)NCc1ccccc1S(=O)(=O)C1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H24N6O5S/c1-15(32)28-22-14-31-23(29-22)10-9-20(30-31)17-11-19(25(36-2)27-13-17)24(33)26-12-16-5-3-4-6-21(16)37(34,35)18-7-8-18/h3-6,9-11,13-14,18H,7-8,12H2,1-2H3,(H,26,33)(H,28,32) SEMUVBOQQIYPHI-UHFFFAOYSA-N 571091 N-{[2- (cyclopropanesulfonyl)phenyl]methyl}- 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 158 Receptor-interacting serine/threonine-protein kinase 1 Human 31.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571091&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074146 473132283 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206263 COc1ncc(cc1C(=O)NCc1ccccc1OC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H28N6O4/c1-17(34)30-24-16-33-25(31-24)12-11-22(32-33)19-13-21(27(36-2)29-15-19)26(35)28-14-18-7-3-6-10-23(18)37-20-8-4-5-9-20/h3,6-7,10-13,15-16,20H,4-5,8-9,14H2,1-2H3,(H,28,35)(H,30,34) TVPBFLXRFXEGOM-UHFFFAOYSA-N 571092 N-{[2- (cyclopentyloxy)phenyl]methyl}- 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 159 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571092&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074394 473132284 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206264 COc1ncc(cc1C(=O)NCc1ccccc1-n1cccc1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H23N7O3/c1-17(34)29-23-16-33-24(30-23)10-9-21(31-33)19-13-20(26(36-2)28-15-19)25(35)27-14-18-7-3-4-8-22(18)32-11-5-6-12-32/h3-13,15-16H,14H2,1-2H3,(H,27,35)(H,29,34) ZCMNJIMIOYJXNM-UHFFFAOYSA-N 571093 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-{[2-(1H-pyrrol-1- yl)phenyl]methyl}pyridine-3- carboxamide::US11440913, Example 160 Receptor-interacting serine/threonine-protein kinase 1 Human 489 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571093&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074067 473132285 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206265 COc1ncc(cc1C(=O)NC[C@H]1C[C@@H]1c1ccc(F)cc1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23FN6O3/c1-14(33)29-22-13-32-23(30-22)8-7-21(31-32)17-10-20(25(35-2)28-12-17)24(34)27-11-16-9-19(16)15-3-5-18(26)6-4-15/h3-8,10,12-13,16,19H,9,11H2,1-2H3,(H,27,34)(H,29,33)/t16-,19-/m1/s1 JNHUGOVUTJWMHW-VQIMIIECSA-N 571094 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[(1S,2S)-2-(4- fluorophenyl)cyclopropyl]methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 161 Receptor-interacting serine/threonine-protein kinase 1 Human 145 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571094&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074070 473132286 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206266 COc1ncc(cc1C(=O)NCc1ccccc1N1CCOCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H27N7O4/c1-17(34)29-23-16-33-24(30-23)8-7-21(31-33)19-13-20(26(36-2)28-15-19)25(35)27-14-18-5-3-4-6-22(18)32-9-11-37-12-10-32/h3-8,13,15-16H,9-12,14H2,1-2H3,(H,27,35)(H,29,34) DFWDXQYRGFSNKN-UHFFFAOYSA-N 571095 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-{[2-(morpholin-4- yl)phenyl]methyl}pyridine-3- carboxamide::US11440913, Example 162 Receptor-interacting serine/threonine-protein kinase 1 Human 64.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571095&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074384 473132287 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206267 COc1ncc(cc1C(=O)NCc1ncccc1OC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H27N7O4/c1-16(34)30-23-15-33-24(31-23)10-9-20(32-33)17-12-19(26(36-2)29-13-17)25(35)28-14-21-22(8-5-11-27-21)37-18-6-3-4-7-18/h5,8-13,15,18H,3-4,6-7,14H2,1-2H3,(H,28,35)(H,30,34) XSYUTOGXUOCCEM-UHFFFAOYSA-N 571096 N-{[3-(cyclopentyloxy)pyridin-2- yl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 163 Receptor-interacting serine/threonine-protein kinase 1 Human 12.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571096&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074255 473132288 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206268 COc1ncc(cc1C(=O)NCc1ccccc1OCC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H30N6O4/c1-18(35)31-25-16-34-26(32-25)12-11-23(33-34)21-13-22(28(37-2)30-15-21)27(36)29-14-20-9-5-6-10-24(20)38-17-19-7-3-4-8-19/h5-6,9-13,15-16,19H,3-4,7-8,14,17H2,1-2H3,(H,29,36)(H,31,35) LCXYVRSATMMMFR-UHFFFAOYSA-N 571097 N-{[2- (cyclopentylmethoxy)phenyl]methyl}- 5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 164 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571097&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074134 473132289 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206269 COc1ncc(cc1C(=O)NCc1ccccc1OC(C)C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H26N6O4/c1-15(2)35-21-8-6-5-7-17(21)12-26-24(33)19-11-18(13-27-25(19)34-4)20-9-10-23-29-22(28-16(3)32)14-31(23)30-20/h5-11,13-15H,12H2,1-4H3,(H,26,33)(H,28,32) UJUBCZPFJGBJDF-UHFFFAOYSA-N 571098 5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N-{[2-(propan-2- yloxy)phenyl]methyl}pyridine-3- carboxamide::US11440913, Example 165 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571098&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074234 473132290 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206270 COc1ncc(cc1C(=O)NCc1cc(F)ccc1OC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-16(35)31-24-15-34-25(32-24)10-8-22(33-34)17-12-21(27(37-2)30-13-17)26(36)29-14-18-11-19(28)7-9-23(18)38-20-5-3-4-6-20/h7-13,15,20H,3-6,14H2,1-2H3,(H,29,36)(H,31,35) RTABTZBIKOIHBU-UHFFFAOYSA-N 571099 N-{[2-(cyclopentyloxy)-5- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxypyridine-3-carboxamide::US11440913, Example 166 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571099&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074343 473132291 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206271 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1OC1CC(C)OC(C)C1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C30H32F2N6O5/c1-15-8-21(9-16(2)42-15)43-28-19(10-20(31)11-24(28)32)13-33-29(40)23-12-22(17(3)34-30(23)41-5)25-6-7-27-36-26(35-18(4)39)14-38(27)37-25/h6-7,10-12,14-16,21H,8-9,13H2,1-5H3,(H,33,40)(H,35,39) MWOGFSOWYFZRBI-UHFFFAOYSA-N 571100 N-({2-[(2,6-dimethyloxan-4-yl)oxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 167 Receptor-interacting serine/threonine-protein kinase 1 Human 18.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571100&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437135 473132292 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206272 COc1nc(C)c(cc1C(=O)NCc1cccc(F)c1OC1C[C@H](C)O[C@H](C)C1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C30H33FN6O5/c1-16-11-21(12-17(2)41-16)42-28-20(7-6-8-24(28)31)14-32-29(39)23-13-22(18(3)33-30(23)40-5)25-9-10-27-35-26(34-19(4)38)15-37(27)36-25/h6-10,13,15-17,21H,11-12,14H2,1-5H3,(H,32,39)(H,34,38)/t16-,17+,21? PKYTVQHORNLDON-QRTHJKPMSA-N 571101 N-[(2-{[(2R,6S)-2,6-dimethyloxan-4- yl]oxy}-3-fluorophenyl)methyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy- 6-methylpyridine-3-carboxamide::US11440913, Example 168 Receptor-interacting serine/threonine-protein kinase 1 Human 21.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571101&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437136 473132293 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206273 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1O[C@@H]1CCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O5/c1-14-19(22-4-5-24-33-23(32-15(2)36)12-35(24)34-22)10-20(27(31-14)38-3)26(37)30-11-16-8-17(28)9-21(29)25(16)40-18-6-7-39-13-18/h4-5,8-10,12,18H,6-7,11,13H2,1-3H3,(H,30,37)(H,32,36)/t18-/m1/s1 XBMIPBTUWPJSGA-GOSISDBHSA-N 571102 N-({3,5-difluoro-2-[(3R)-oxolan-3- yloxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 169 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571102&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437137 473132294 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206274 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H28F2N6O5/c1-15-20(23-6-7-25-34-24(33-16(2)37)13-36(25)35-23)11-21(28(32-15)39-3)27(38)31-12-17-9-18(29)10-22(30)26(17)41-19-5-4-8-40-14-19/h6-7,9-11,13,19H,4-5,8,12,14H2,1-3H3,(H,31,38)(H,33,37) VOZFDZLMNYZLDE-UHFFFAOYSA-N 571103 N-{[3,5-difluoro-2-(oxan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 170 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571103&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437138 473132295 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206275 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1O[C@H]1CCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O5/c1-14-19(22-4-5-24-33-23(32-15(2)36)12-35(24)34-22)10-20(27(31-14)38-3)26(37)30-11-16-8-17(28)9-21(29)25(16)40-18-6-7-39-13-18/h4-5,8-10,12,18H,6-7,11,13H2,1-3H3,(H,30,37)(H,32,36)/t18-/m0/s1 XBMIPBTUWPJSGA-SFHVURJKSA-N 571104 N-({3,5-difluoro-2-[(3S)-oxolan-3- yloxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 171 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571104&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437139 473132296 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206276 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCOC(C)C1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C29H30F2N6O5/c1-15-9-20(7-8-41-15)42-27-18(10-19(30)11-23(27)31)13-32-28(39)22-12-21(16(2)33-29(22)40-4)24-5-6-26-35-25(34-17(3)38)14-37(26)36-24/h5-6,10-12,14-15,20H,7-9,13H2,1-4H3,(H,32,39)(H,34,38) RXZGVOOQQCWBKK-UHFFFAOYSA-N 571105 N-({3,5-difluoro-2-[(2-methyloxan-4- yl)oxy]phenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 172 Receptor-interacting serine/threonine-protein kinase 1 Human 15.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571105&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437140 473132297 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206277 COc1nc(C)c(cc1C(=O)NCc1c(F)cccc1OCC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F4N6O4/c1-13-15(19-7-8-22-33-21(32-14(2)36)11-35(22)34-19)9-16(24(31-13)38-3)23(37)30-10-17-18(26)5-4-6-20(17)39-12-25(27,28)29/h4-9,11H,10,12H2,1-3H3,(H,30,37)(H,32,36) SFGNIAAXIUKCQJ-UHFFFAOYSA-N 571106 5-{2-acetemidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro-6-(2,2,2- trifluoroethoxy)phenyl]methyl}-2- (deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 173 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571106&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437141 473132298 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206278 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14-19(22-6-7-24-33-23(32-15(2)36)12-35(24)34-22)10-20(27(31-14)38-3)26(37)30-11-17-8-18(28)9-21(29)25(17)39-13-16-4-5-16/h6-10,12,16H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) OWVAXLZIOWYFGP-UHFFFAOYSA-N 571107 N-({2-[cyclopropyl(deutero)methoxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 174::US11440913, Example 177::US11440913, Example 287::US11440913, Example 300 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571107&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074401 473132299 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206279 COc1nc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-12-16(19-6-7-21-32-20(31-13(2)35)11-34(21)33-19)9-17(23(30-12)37-3)22(36)29-10-14-8-15(4-5-18(14)25)38-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) QNNGKHDFSWSUBF-UHFFFAOYSA-N 571108 BDBM571112::5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl](deutero) methyl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 175 Receptor-interacting serine/threonine-protein kinase 1 Homo sapiens 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571108&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074284 473132300 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5,8Z93 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 N/A A0A024QZU0 1206280 COc1nc(C)c(cc1C(=O)NCc1ccc(F)c(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14-18(21-8-9-23-33-22(32-15(2)36)12-35(23)34-21)10-19(27(31-14)38-3)26(37)30-11-17-6-7-20(28)24(29)25(17)39-13-16-4-5-16/h6-10,12,16H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) YCSRVTAEAHWFKO-UHFFFAOYSA-N 571109 N-{[2-(cyclopropylmethoxy)-3,4- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy- 6-methylpyridine-3-carboxamide::US11440913, Example 176::US11440913, Example 286 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571109&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074397 473132301 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206281 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14-19(22-6-7-24-33-23(32-15(2)36)12-35(24)34-22)10-20(27(31-14)38-3)26(37)30-11-17-8-18(28)9-21(29)25(17)39-13-16-4-5-16/h6-10,12,16H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) OWVAXLZIOWYFGP-UHFFFAOYSA-N 571107 N-({2-[cyclopropyl(deutero)methoxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 174::US11440913, Example 177::US11440913, Example 287::US11440913, Example 300 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571107&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074401 473132299 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206282 COc1nc(C)c(cc1C(=O)NCc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13-16(18-8-9-21-31-20(30-14(2)34)12-33(21)32-18)10-17(23(29-13)36-3)22(35)28-11-15-6-4-5-7-19(15)37-24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) FGHDUBUMNALLNW-UHFFFAOYSA-N 570954 BDBM571228::US11440913, Example 178::US11440913, Example 19 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570954&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580816 473132172 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206283 COc1nc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-12-16(19-6-7-21-32-20(31-13(2)35)11-34(21)33-19)9-17(23(30-12)37-3)22(36)29-10-14-8-15(4-5-18(14)25)38-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) QNNGKHDFSWSUBF-UHFFFAOYSA-N 571108 BDBM571112::5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl](deutero) methyl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 175 Receptor-interacting serine/threonine-protein kinase 1 Homo sapiens 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571108&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074284 473132300 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5,8Z93 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 N/A A0A024QZU0 1206284 COc1nc(C)c(cc1C(=O)NCc1cc(OCC2CC2)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15-20(23-8-9-25-32-24(31-16(2)35)13-34(25)33-23)11-21(27(30-15)37-3)26(36)29-12-18-10-19(6-7-22(18)28)38-14-17-4-5-17/h6-11,13,17H,4-5,12,14H2,1-3H3,(H,29,36)(H,31,35) BLZGRMHGRNGVKQ-UHFFFAOYSA-N 571113 N-{[5-(cyclopropyhnethoxy)-2- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 180::US11440913, Example 297 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571113&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074299 473132303 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206285 C[C@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CO)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O4/c1-12-17(23(37)30-13(2)16-8-15(3-4-18(16)25)38-24(26,27)28)7-14(9-29-12)19-5-6-21-31-20(10-34(21)33-19)32-22(36)11-35/h3-10,13,35H,11H2,1-2H3,(H,30,37)(H,32,36)/t13-/m0/s1 RREJSMUUFSWOAZ-ZDUSSCGKSA-N 571114 N-[(1S)-1-[2-fluoro-5- (trifluoromethoxy)phenyl] ethyl]-5-[2-(2-hydroxyacetamido) imidazo[1,2-b]pyridazin-6-yl]- 2-methylpyridine-3- carboxamide::US11440913, Example 181 Receptor-interacting serine/threonine-protein kinase 1 Human 103 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571114&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074266 473132304 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206286 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CO)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C24H20F4N6O3/c1-12-17(23(37)30-13(2)16-8-15(24(26,27)28)3-4-18(16)25)7-14(9-29-12)19-5-6-21-31-20(10-34(21)33-19)32-22(36)11-35/h3-10,13,35H,11H2,1-2H3,(H,30,37)(H,32,36)/t13-/m1/s1 DYLFSABZZXLVFE-CYBMUJFWSA-N 571115 N-[(1R)-1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl]- 5-[2-(2-hydroxyacetamido)imidazo [1,2-b]pyridazin-6-yl]- 2-methylpyridine-3- carboxamide, TFA::US11440913, Example 182 Receptor-interacting serine/threonine-protein kinase 1 Human 272 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571115&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074127 473132305 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206287 Cc1ncc(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C23H18F4N6O3/c1-12-16(22(36)29-8-13-6-15(23(25,26)27)2-3-17(13)24)7-14(9-28-12)18-4-5-20-30-19(10-33(20)32-18)31-21(35)11-34/h2-7,9-10,34H,8,11H2,1H3,(H,29,36)(H,31,35) YDRIHNSVCNTWBA-UHFFFAOYSA-N 571116 N-{[2-fluoro-5- (trifluoromethyl)phenyl]methyl}- 5-[2-(2-hydroxyacetamido)imidazo [1,2-b]pyridazin-6-yl]- 2-methylpyridine-3-carboxamide::US11440913, Example 183 Receptor-interacting serine/threonine-protein kinase 1 Human 166 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571116&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074346 473132306 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206288 Cc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C27H26F2N6O5/c1-15-20(9-16(11-30-15)22-2-3-24-32-23(13-35(24)34-22)33-25(37)14-36)27(38)31-12-17-8-18(28)10-21(29)26(17)40-19-4-6-39-7-5-19/h2-3,8-11,13,19,36H,4-7,12,14H2,1H3,(H,31,38)(H,33,37) LFORRQCDWWBURV-UHFFFAOYSA-N 571117 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl](deutero)methyl}- 5-[2-(2-hydroxyacetamido)imidazo [1,2-b]pyridazin-6-yl]- 2-methylpyridine-3-carboxamide::US11440913, Example 184 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571117&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437142 473132307 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206289 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CO)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O4/c1-12-17(23(37)30-13(2)16-8-15(3-4-18(16)25)38-24(26,27)28)7-14(9-29-12)19-5-6-21-31-20(10-34(21)33-19)32-22(36)11-35/h3-10,13,35H,11H2,1-2H3,(H,30,37)(H,32,36)/t13-/m1/s1 RREJSMUUFSWOAZ-CYBMUJFWSA-N 571118 N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl]- 5-[2-(2-hydroxyacetamido)imidazo [1,2-b]pyridazin-6-yl]- 2-methylpyridine-3-carboxamide::US11440913, Example 185 Receptor-interacting serine/threonine-protein kinase 1 Human 30.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571118&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074235 473132308 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206290 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)cc(F)c1OC1CCCOC1 InChI=1S/C27H26F2N6O4/c1-15-21(9-17(11-30-15)23-5-6-25-33-24(32-16(2)36)13-35(25)34-23)27(37)31-12-18-8-19(28)10-22(29)26(18)39-20-4-3-7-38-14-20/h5-6,8-11,13,20H,3-4,7,12,14H2,1-2H3,(H,31,37)(H,32,36) XDCFOBCBIZDTJQ-UHFFFAOYSA-N 571119 N-{[3,5-difluoro-2-(oxan-3- yloxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine-3- carboxamide::US11440913, Example 186 Receptor-interacting serine/threonine-protein kinase 1 Human 15.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571119&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074093 473132309 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206291 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)cc(F)c1O[C@H]1CCOC1 InChI=1S/C26H24F2N6O4/c1-14-20(8-16(10-29-14)22-3-4-24-32-23(31-15(2)35)12-34(24)33-22)26(36)30-11-17-7-18(27)9-21(28)25(17)38-19-5-6-37-13-19/h3-4,7-10,12,19H,5-6,11,13H2,1-2H3,(H,30,36)(H,31,35)/t19-/m0/s1 NZPJAQBDZXDQRT-IBGZPJMESA-N 571120 N-({3,5-difluoro-2-[(3S)- oxolan-3-yloxy]phenyl} methyl)- 5-{2-acetamidoimidazo [1,2-b]pyridazin-6-yl}-2- methylpyridine- 3-carboxamide::US11440913, Example 187 Receptor-interacting serine/threonine-protein kinase 1 Human 18.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571120&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074104 473132310 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206292 CC1CC(CCO1)Oc1c(F)cc(F)cc1CNC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H28F2N6O4/c1-15-8-21(6-7-39-15)40-27-19(9-20(29)11-23(27)30)13-32-28(38)22-10-18(12-31-16(22)2)24-4-5-26-34-25(33-17(3)37)14-36(26)35-24/h4-5,9-12,14-15,21H,6-8,13H2,1-3H3,(H,32,38)(H,33,37) LYRUIDRYFGLZED-UHFFFAOYSA-N 571121 N-({3,5-difluoro-2-[(2- methyloxan-4-yl)oxy]phenyl} methyl)- 5-{2-acetamidoimidazo [1,2-b]pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 188 Receptor-interacting serine/threonine-protein kinase 1 Human 22.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571121&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074291 473132311 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206293 CC1CC(CC(C)O1)Oc1c(F)cc(F)cc1CNC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C29H30F2N6O4/c1-15-7-22(8-16(2)40-15)41-28-20(9-21(30)11-24(28)31)13-33-29(39)23-10-19(12-32-17(23)3)25-5-6-27-35-26(34-18(4)38)14-37(27)36-25/h5-6,9-12,14-16,22H,7-8,13H2,1-4H3,(H,33,39)(H,34,38) ORMWDKPMYFDUIC-UHFFFAOYSA-N 571122 N-({2-[(2,6- dimethyloxan-4-yl) oxy]-3,5-difluorophenyl} methyl)- 5-{2-acetamidoimidazo [1,2-b]pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 189 Receptor-interacting serine/threonine-protein kinase 1 Human 91.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571122&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074220 473132312 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206294 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1c(F)cccc1OCC(F)(F)F InChI=1S/C24H20F4N6O3/c1-13-16(23(36)30-10-17-18(25)4-3-5-20(17)37-12-24(26,27)28)8-15(9-29-13)19-6-7-22-32-21(31-14(2)35)11-34(22)33-19/h3-9,11H,10,12H2,1-2H3,(H,30,36)(H,31,35) BQYYCZMXRQSBRY-UHFFFAOYSA-N 571123 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro- 6-(2,2,2-trifluoroethoxy) phenyl]methyl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 190 Receptor-interacting serine/threonine-protein kinase 1 Human 23.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571123&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074099 473132313 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206295 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(ccn1)C(F)(F)F InChI=1S/C22H18F3N7O2/c1-12-17(21(34)28-10-16-8-15(5-6-26-16)22(23,24)25)7-14(9-27-12)18-3-4-20-30-19(29-13(2)33)11-32(20)31-18/h3-9,11H,10H2,1-2H3,(H,28,34)(H,29,33) RJYAQMHJPWLGDN-UHFFFAOYSA-N 571124 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2-methyl- N-{[4-(trifluoromethyl)pyridin- 2-yl]methyl}pyridine- 3-carboxamide::US11440913, Example 191 Receptor-interacting serine/threonine-protein kinase 1 Human 938 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571124&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074138 473132314 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206296 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1 InChI=1S/C27H26F2N6O4/c1-15-21(10-17(12-30-15)23-3-4-25-33-24(32-16(2)36)14-35(25)34-23)27(37)31-13-18-9-19(28)11-22(29)26(18)39-20-5-7-38-8-6-20/h3-4,9-12,14,20H,5-8,13H2,1-2H3,(H,31,37)(H,32,36) XGPSBTHUXSDDCB-UHFFFAOYSA-N 571125 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl](deutero)methyl}- 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 192::US11440913, Example 201 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571125&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074294 473132315 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206297 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1ccccc1OCC(F)(F)F InChI=1S/C24H21F3N6O3/c1-14-18(23(35)29-10-16-5-3-4-6-20(16)36-13-24(25,26)27)9-17(11-28-14)19-7-8-22-31-21(30-15(2)34)12-33(22)32-19/h3-9,11-12H,10,13H2,1-2H3,(H,29,35)(H,30,34) CDCUWYIBBLSZQW-UHFFFAOYSA-N 571126 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2-methyl- N-{[2-(2,2,2- trifluoroethoxy)phenyl] methyl}pyridine- 3-carboxamide::US11440913, Example 193 Receptor-interacting serine/threonine-protein kinase 1 Human 56.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571126&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074076 473132316 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206298 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cccc(OCC(F)(F)F)c1 InChI=1S/C24H21F3N6O3/c1-14-19(23(35)29-10-16-4-3-5-18(8-16)36-13-24(25,26)27)9-17(11-28-14)20-6-7-22-31-21(30-15(2)34)12-33(22)32-20/h3-9,11-12H,10,13H2,1-2H3,(H,29,35)(H,30,34) PEKXSGLBZNZXGD-UHFFFAOYSA-N 571127 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2-methyl- N-{[3-(2,2,2-trifluoroethoxy) phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 194 Receptor-interacting serine/threonine-protein kinase 1 Human 100.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571127&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074170 473132317 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206299 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)ccc1OCC(F)(F)F InChI=1S/C24H20F4N6O3/c1-13-18(23(36)30-10-16-7-17(25)3-5-20(16)37-12-24(26,27)28)8-15(9-29-13)19-4-6-22-32-21(31-14(2)35)11-34(22)33-19/h3-9,11H,10,12H2,1-2H3,(H,30,36)(H,31,35) XCSSMNQQBWWIOB-UHFFFAOYSA-N 571128 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[5-fluoro- 2-(2,2,2-trifluoroethoxy) phenyl]methyl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 195 Receptor-interacting serine/threonine-protein kinase 1 Human 43.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571128&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074377 473132318 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206300 C[C@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C24H20F4N6O2/c1-12-18(23(36)30-13(2)17-9-16(24(26,27)28)4-5-19(17)25)8-15(10-29-12)20-6-7-22-32-21(31-14(3)35)11-34(22)33-20/h4-11,13H,1-3H3,(H,30,36)(H,31,35)/t13-/m0/s1 VDJDGOUZNYXMIK-ZDUSSCGKSA-N 571129 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-[(1S)- 1-[2-fluoro-5-(trifluoromethyl) phenyl](2,2,2-deutero)ethyl]-2- methylpyridine-3-carboxamide::US11440913, Example 196 Receptor-interacting serine/threonine-protein kinase 1 Human 45.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571129&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437143 473132319 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206301 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C24H20F4N6O2/c1-12-18(23(36)30-13(2)17-9-16(24(26,27)28)4-5-19(17)25)8-15(10-29-12)20-6-7-22-32-21(31-14(3)35)11-34(22)33-20/h4-11,13H,1-3H3,(H,30,36)(H,31,35)/t13-/m1/s1 VDJDGOUZNYXMIK-CYBMUJFWSA-N 571130 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-[(1R)- 1-[2-fluoro-5-(trifluoromethyl) phenyl](2,2,2-deutero)ethyl]- 2-methylpyridine- 3-carboxamide::US11440913, Example 197 Receptor-interacting serine/threonine-protein kinase 1 Human 72.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571130&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437144 473132320 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206302 C[C@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O3/c1-12-18(23(36)30-13(2)17-9-16(4-5-19(17)25)37-24(26,27)28)8-15(10-29-12)20-6-7-22-32-21(31-14(3)35)11-34(22)33-20/h4-11,13H,1-3H3,(H,30,36)(H,31,35)/t13-/m0/s1 HBLIJLAULCIWLO-ZDUSSCGKSA-N 570942 US11440913, Example 198::US11440913, Example 9-1 Receptor-interacting serine/threonine-protein kinase 1 Human 16.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570942&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437121 473132160 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206303 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O3/c1-12-18(23(36)30-13(2)17-9-16(4-5-19(17)25)37-24(26,27)28)8-15(10-29-12)20-6-7-22-32-21(31-14(3)35)11-34(22)33-20/h4-11,13H,1-3H3,(H,30,36)(H,31,35)/t13-/m1/s1 HBLIJLAULCIWLO-CYBMUJFWSA-N 570943 US11440913, Example 199::US11440913, Example 9-2 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570943&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697465 473132161 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206304 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(ccc1F)C(F)(F)F InChI=1S/C23H18F4N6O2/c1-12-17(22(35)29-9-14-7-16(23(25,26)27)3-4-18(14)24)8-15(10-28-12)19-5-6-21-31-20(30-13(2)34)11-33(21)32-19/h3-8,10-11H,9H2,1-2H3,(H,29,35)(H,30,34) OFOUPNZBHNVKRZ-UHFFFAOYSA-N 571133 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro- 5-(trifluoromethyl)phenyl] (deutero)methyl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 200::US11440913, Example 206 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571133&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074088 473132321 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206305 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1 InChI=1S/C27H26F2N6O4/c1-15-21(10-17(12-30-15)23-3-4-25-33-24(32-16(2)36)14-35(25)34-23)27(37)31-13-18-9-19(28)11-22(29)26(18)39-20-5-7-38-8-6-20/h3-4,9-12,14,20H,5-8,13H2,1-2H3,(H,31,37)(H,32,36) XGPSBTHUXSDDCB-UHFFFAOYSA-N 571125 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl](deutero)methyl}- 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 192::US11440913, Example 201 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571125&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074294 473132315 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206306 CC(NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1ccccc1OC(F)(F)F InChI=1S/C24H21F3N6O3/c1-13-18(23(35)29-14(2)17-6-4-5-7-20(17)36-24(25,26)27)10-16(11-28-13)19-8-9-22-31-21(30-15(3)34)12-33(22)32-19/h4-12,14H,1-3H3,(H,29,35)(H,30,34) VMRWQSZMDFZHGM-UHFFFAOYSA-N 571135 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2-methyl- N-{1-[2-(trifluoromethoxy) phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 202::US11440913, Example 203 Receptor-interacting serine/threonine-protein kinase 1 Human 32.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571135&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074320 473132322 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206307 CC(NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1ccccc1OC(F)(F)F InChI=1S/C24H21F3N6O3/c1-13-18(23(35)29-14(2)17-6-4-5-7-20(17)36-24(25,26)27)10-16(11-28-13)19-8-9-22-31-21(30-15(3)34)12-33(22)32-19/h4-12,14H,1-3H3,(H,29,35)(H,30,34) VMRWQSZMDFZHGM-UHFFFAOYSA-N 571135 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2-methyl- N-{1-[2-(trifluoromethoxy) phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 202::US11440913, Example 203 Receptor-interacting serine/threonine-protein kinase 1 Human >5000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571135&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074320 473132322 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206308 CC(NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C24H20F4N6O2/c1-12-18(23(36)30-13(2)17-9-16(24(26,27)28)4-5-19(17)25)8-15(10-29-12)20-6-7-22-32-21(31-14(3)35)11-34(22)33-20/h4-11,13H,1-3H3,(H,30,36)(H,31,35) VDJDGOUZNYXMIK-UHFFFAOYSA-N 571137 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{1-[2-fluoro- 5-(trifluoromethyl)phenyl] ethyl}-2-methylpyridine- 3-carboxamide::US11440913, Example 204::US11440913, Example 205 Receptor-interacting serine/threonine-protein kinase 1 Human 122 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571137&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074275 473132323 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206309 CC(NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C24H20F4N6O2/c1-12-18(23(36)30-13(2)17-9-16(24(26,27)28)4-5-19(17)25)8-15(10-29-12)20-6-7-22-32-21(31-14(3)35)11-34(22)33-20/h4-11,13H,1-3H3,(H,30,36)(H,31,35) VDJDGOUZNYXMIK-UHFFFAOYSA-N 571137 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{1-[2-fluoro- 5-(trifluoromethyl)phenyl] ethyl}-2-methylpyridine- 3-carboxamide::US11440913, Example 204::US11440913, Example 205 Receptor-interacting serine/threonine-protein kinase 1 Human 27.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571137&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074275 473132323 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206310 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(ccc1F)C(F)(F)F InChI=1S/C23H18F4N6O2/c1-12-17(22(35)29-9-14-7-16(23(25,26)27)3-4-18(14)24)8-15(10-28-12)19-5-6-21-31-20(30-13(2)34)11-33(21)32-19/h3-8,10-11H,9H2,1-2H3,(H,29,35)(H,30,34) OFOUPNZBHNVKRZ-UHFFFAOYSA-N 571133 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro- 5-(trifluoromethyl)phenyl] (deutero)methyl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 200::US11440913, Example 206 Receptor-interacting serine/threonine-protein kinase 1 Human 12.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571133&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074088 473132321 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206311 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)cc(OC(F)(F)F)c1 InChI=1S/C23H18F4N6O3/c1-12-18(22(35)29-9-14-5-16(24)8-17(6-14)36-23(25,26)27)7-15(10-28-12)19-3-4-21-31-20(30-13(2)34)11-33(21)32-19/h3-8,10-11H,9H2,1-2H3,(H,29,35)(H,30,34) JEICNSGGVZBSQX-UHFFFAOYSA-N 571140 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[3-fluoro-5- (trifluoromethoxy)phenyl] methyl}-2-methylpyridine- 3-carboxamide, TFA::US11440913, Example 207 Receptor-interacting serine/threonine-protein kinase 1 Human 29.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571140&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074381 473132324 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206312 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C23H18F4N6O3/c1-12-17(22(35)29-9-14-7-16(3-4-18(14)24)36-23(25,26)27)8-15(10-28-12)19-5-6-21-31-20(30-13(2)34)11-33(21)32-19/h3-8,10-11H,9H2,1-2H3,(H,29,35)(H,30,34) LXWMSZGNIYMMBU-UHFFFAOYSA-N 571141 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}- N-{[2-fluoro-5- (trifluoromethoxy)phenyl] (deutero)methyl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 208::US11440913, Example 213 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571141&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581037 473132325 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206313 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1ccc(F)c(F)c1OCC1CC1 InChI=1S/C26H24F2N6O3/c1-14-19(26(36)30-10-17-5-6-20(27)24(28)25(17)37-13-16-3-4-16)9-18(11-29-14)21-7-8-23-32-22(31-15(2)35)12-34(23)33-21/h5-9,11-12,16H,3-4,10,13H2,1-2H3,(H,30,36)(H,31,35) AXFNTHXGJDVUGX-UHFFFAOYSA-N 571142 N-{[2-(cyclopropylmethoxy)- 3,4-difluorophenyl]methyl}- 5-{2-acetamidoimidazo [1,2-b]pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 209 Receptor-interacting serine/threonine-protein kinase 1 Human 133 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571142&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074195 473132326 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206314 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)cc(F)c1OCC1CCC1 InChI=1S/C27H26F2N6O3/c1-15-21(9-18(11-30-15)23-6-7-25-33-24(32-16(2)36)13-35(25)34-23)27(37)31-12-19-8-20(28)10-22(29)26(19)38-14-17-4-3-5-17/h6-11,13,17H,3-5,12,14H2,1-2H3,(H,31,37)(H,32,36) TWNOCTRIUBPYCP-UHFFFAOYSA-N 571143 N-{[2-(cyclobutylmethoxy)-3,5- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide, TFA::US11440913, Example 210 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571143&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074123 473132327 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206315 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCC[C@@H](O)c1ccc(Cl)cc1 InChI=1S/C24H23ClN6O3/c1-14-19(24(34)26-10-9-21(33)16-3-5-18(25)6-4-16)11-17(12-27-14)20-7-8-23-29-22(28-15(2)32)13-31(23)30-20/h3-8,11-13,21,33H,9-10H2,1-2H3,(H,26,34)(H,28,32)/t21-/m1/s1 KALGXOYBHUNCPS-OAQYLSRUSA-N 571144 N-[(3R)-3-(4-chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 211 Receptor-interacting serine/threonine-protein kinase 1 Human 62.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571144&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074311 473132328 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206316 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cccc(F)c1OCC1CC1 InChI=1S/C26H25FN6O3/c1-15-20(26(35)29-11-18-4-3-5-21(27)25(18)36-14-17-6-7-17)10-19(12-28-15)22-8-9-24-31-23(30-16(2)34)13-33(24)32-22/h3-5,8-10,12-13,17H,6-7,11,14H2,1-2H3,(H,29,35)(H,30,34) CONAHTIQCVOWLK-UHFFFAOYSA-N 571145 N-{[2-(cyclopropylmethoxy)- 3-fluorophenyl]methyl}- 5-{2-acetamidoimidazo [1,2-b]pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 212 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571145&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074288 473132329 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206317 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C23H18F4N6O3/c1-12-17(22(35)29-9-14-7-16(3-4-18(14)24)36-23(25,26)27)8-15(10-28-12)19-5-6-21-31-20(30-13(2)34)11-33(21)32-19/h3-8,10-11H,9H2,1-2H3,(H,29,35)(H,30,34) LXWMSZGNIYMMBU-UHFFFAOYSA-N 571141 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}- N-{[2-fluoro-5- (trifluoromethoxy)phenyl] (deutero)methyl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 208::US11440913, Example 213 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571141&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581037 473132325 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206318 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)cc(F)c1OCC1CC1 InChI=1S/C26H24F2N6O3/c1-14-20(26(36)30-11-18-7-19(27)9-21(28)25(18)37-13-16-3-4-16)8-17(10-29-14)22-5-6-24-32-23(31-15(2)35)12-34(24)33-22/h5-10,12,16H,3-4,11,13H2,1-2H3,(H,30,36)(H,31,35) PJLUPVRPPPUFDN-UHFFFAOYSA-N 571147 N-{[2-(cyclopropylmethoxy)- 3,5-difluorophenyl]methyl}- 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 214 Receptor-interacting serine/threonine-protein kinase 1 Human 1.000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571147&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074178 473132330 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206319 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(OCC2CC2)ccc1F InChI=1S/C26H25FN6O3/c1-15-21(26(35)29-11-18-9-20(5-6-22(18)27)36-14-17-3-4-17)10-19(12-28-15)23-7-8-25-31-24(30-16(2)34)13-33(25)32-23/h5-10,12-13,17H,3-4,11,14H2,1-2H3,(H,29,35)(H,30,34) IMYWDCJRCGAHKN-UHFFFAOYSA-N 571148 N-{[5-(cyclopropylmethoxy)-2- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 215 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571148&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074117 473132331 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206320 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCC[C@H](O)c1ccc(Cl)cc1 InChI=1S/C24H23ClN6O3/c1-14-19(24(34)26-10-9-21(33)16-3-5-18(25)6-4-16)11-17(12-27-14)20-7-8-23-29-22(28-15(2)32)13-31(23)30-20/h3-8,11-13,21,33H,9-10H2,1-2H3,(H,26,34)(H,28,32)/t21-/m0/s1 KALGXOYBHUNCPS-NRFANRHFSA-N 571149 N-[(3S)-3-(4-chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 216 Receptor-interacting serine/threonine-protein kinase 1 Human 66.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571149&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074105 473132332 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206321 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cccnc1OCC1CCCC1 InChI=1S/C27H29N7O3/c1-17-22(26(36)30-13-20-8-5-11-28-27(20)37-16-19-6-3-4-7-19)12-21(14-29-17)23-9-10-25-32-24(31-18(2)35)15-34(25)33-23/h5,8-12,14-15,19H,3-4,6-7,13,16H2,1-2H3,(H,30,36)(H,31,35) HINFKZLCUCHAPG-UHFFFAOYSA-N 571150 N-{[2-(cyclopentylmethoxy) pyridin-3-yl]methyl}- 5-{2-acetamidoimidazo [1,2-b]pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 217 Receptor-interacting serine/threonine-protein kinase 1 Human 54.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571150&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074367 473132333 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206322 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)ccc1OCC1CCCC1 InChI=1S/C28H29FN6O3/c1-17-23(12-20(13-30-17)24-8-10-27-33-26(32-18(2)36)15-35(27)34-24)28(37)31-14-21-11-22(29)7-9-25(21)38-16-19-5-3-4-6-19/h7-13,15,19H,3-6,14,16H2,1-2H3,(H,31,37)(H,32,36) OYHLEIJSYDMZJL-UHFFFAOYSA-N 571151 N-{[2-(cyclopentylmethoxy)-5- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 218 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571151&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074333 473132334 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206323 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1c(F)cccc1OCC1CCC1 InChI=1S/C27H27FN6O3/c1-16-20(27(36)30-13-21-22(28)7-4-8-24(21)37-15-18-5-3-6-18)11-19(12-29-16)23-9-10-26-32-25(31-17(2)35)14-34(26)33-23/h4,7-12,14,18H,3,5-6,13,15H2,1-2H3,(H,30,36)(H,31,35) GFJLBJVVCLKWJI-UHFFFAOYSA-N 571152 N-{[2-(cyclobutylmethoxy)-6- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 219 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571152&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074080 473132335 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206324 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1ccccc1OC(F)(F)F InChI=1S/C23H19F3N6O3/c1-13-17(22(34)28-10-15-5-3-4-6-19(15)35-23(24,25)26)9-16(11-27-13)18-7-8-21-30-20(29-14(2)33)12-32(21)31-18/h3-9,11-12H,10H2,1-2H3,(H,28,34)(H,29,33) ODQHJJRRVHGFEN-UHFFFAOYSA-N 571153 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2-methyl- N-{[2-(trifluoromethoxy) phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 220 Receptor-interacting serine/threonine-protein kinase 1 Human 202 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571153&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074121 473132336 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206325 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cccc(OC(F)(F)F)c1 InChI=1S/C23H19F3N6O3/c1-13-18(22(34)28-10-15-4-3-5-17(8-15)35-23(24,25)26)9-16(11-27-13)19-6-7-21-30-20(29-14(2)33)12-32(21)31-19/h3-9,11-12H,10H2,1-2H3,(H,28,34)(H,29,33) GRXATLDJJRESAB-UHFFFAOYSA-N 571154 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2-methyl- N-{[3-(trifluoromethoxy) phenyl]methyl}pyridine- 3-carboxamide, TFA::US11440913, Example 221 Receptor-interacting serine/threonine-protein kinase 1 Human 49.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571154&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074357 473132337 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206326 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1cc(F)ccc1OC1CCCC1 InChI=1S/C27H27FN6O3/c1-16-22(27(36)30-14-19-11-20(28)7-9-24(19)37-21-5-3-4-6-21)12-18(13-29-16)23-8-10-26-32-25(31-17(2)35)15-34(26)33-23/h7-13,15,21H,3-6,14H2,1-2H3,(H,30,36)(H,31,35) RMPNLBFGSQHBGB-UHFFFAOYSA-N 571155 N-{[2-(cyclopentyloxy)-5- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 222 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571155&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074079 473132338 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206327 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1c(F)cccc1OC1CCCC1 InChI=1S/C27H27FN6O3/c1-16-20(27(36)30-14-21-22(28)8-5-9-24(21)37-19-6-3-4-7-19)12-18(13-29-16)23-10-11-26-32-25(31-17(2)35)15-34(26)33-23/h5,8-13,15,19H,3-4,6-7,14H2,1-2H3,(H,30,36)(H,31,35) MFBROSZXZNFDDQ-UHFFFAOYSA-N 571156 N-{[2-(cyclopentyloxy)-6- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}-2- methylpyridine- 3-carboxamide::US11440913, Example 223 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571156&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074344 473132339 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206328 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1ccccc1OC1CCOC1 InChI=1S/C26H26N6O4/c1-16-21(26(34)28-12-18-5-3-4-6-23(18)36-20-9-10-35-15-20)11-19(13-27-16)22-7-8-25-30-24(29-17(2)33)14-32(25)31-22/h3-8,11,13-14,20H,9-10,12,15H2,1-2H3,(H,28,34)(H,29,33) AFYMXTAFAGBCKD-UHFFFAOYSA-N 571157 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2-methyl-N- {[2-(oxolan-3-yloxy) phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 224 Receptor-interacting serine/threonine-protein kinase 1 Human 157 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571157&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074272 473132340 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206329 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1ccccc1OC1CCCC1 InChI=1S/C27H28N6O3/c1-17-22(27(35)29-14-19-7-3-6-10-24(19)36-21-8-4-5-9-21)13-20(15-28-17)23-11-12-26-31-25(30-18(2)34)16-33(26)32-23/h3,6-7,10-13,15-16,21H,4-5,8-9,14H2,1-2H3,(H,29,35)(H,30,34) CRNMBMNUZJCZDD-UHFFFAOYSA-N 571158 N-{[2-(cyclopentyloxy) phenyl]methyl}-5- {2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-2- methylpyridine- 3-carboxamide::US11440913, Example 225 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571158&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074211 473132341 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206330 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1c(F)cccc1OCC1CC1 InChI=1S/C26H25FN6O3/c1-15-19(26(35)29-12-20-21(27)4-3-5-23(20)36-14-17-6-7-17)10-18(11-28-15)22-8-9-25-31-24(30-16(2)34)13-33(25)32-22/h3-5,8-11,13,17H,6-7,12,14H2,1-2H3,(H,29,35)(H,30,34) CJMHVQFBBXRVRC-UHFFFAOYSA-N 571159 N-{[2-(cyclopropylmethoxy)-6- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6-yl}- 2-methylpyridine- 3-carboxamide::US11440913, Example 226 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571159&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074285 473132342 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206331 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCc1ccccc1OCC1CC1 InChI=1S/C26H26N6O3/c1-16-21(26(34)28-12-19-5-3-4-6-23(19)35-15-18-7-8-18)11-20(13-27-16)22-9-10-25-30-24(29-17(2)33)14-32(25)31-22/h3-6,9-11,13-14,18H,7-8,12,15H2,1-2H3,(H,28,34)(H,29,33) XMGTTZQCPRDZMS-UHFFFAOYSA-N 571160 N-{[2-(cyclopropylmethoxy) phenyl]methyl}-5- {2-acetamidoimidazo [1,2-b]pyridazin-6- yl}-2-methylpyridine- 3-carboxamide::US11440913, Example 227 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571160&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074399 473132343 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206332 C[C@H](NC(=O)c1cnc(C)c(c1)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O3/c1-12-18(20-6-7-22-32-21(31-14(3)35)11-34(22)33-20)8-15(10-29-12)23(36)30-13(2)17-9-16(4-5-19(17)25)37-24(26,27)28/h4-11,13H,1-3H3,(H,30,36)(H,31,35)/t13-/m0/s1 WFMGZWHHYWLITJ-ZDUSSCGKSA-N 571161 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1S)-1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl]-6- methylpyridine-3-carboxamide::US11440913, Example 228 Receptor-interacting serine/threonine-protein kinase 1 Human 16.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571161&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074270 473132344 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206333 C[C@@H](NC(=O)c1cnc(C)c(c1)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O3/c1-12-18(20-6-7-22-32-21(31-14(3)35)11-34(22)33-20)8-15(10-29-12)23(36)30-13(2)17-9-16(4-5-19(17)25)37-24(26,27)28/h4-11,13H,1-3H3,(H,30,36)(H,31,35)/t13-/m1/s1 WFMGZWHHYWLITJ-CYBMUJFWSA-N 571162 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)phenyl] (2,2,2- deutero)ethyl]-6-methylpyridine-3- carboxamide::US11440913, Example 229 Receptor-interacting serine/threonine-protein kinase 1 Human 134 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571162&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437145 473132345 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206334 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(cnc1C)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C23H18F4N6O3/c1-12-17(19-5-6-21-31-20(30-13(2)34)11-33(21)32-19)8-15(10-28-12)22(35)29-9-14-7-16(3-4-18(14)24)36-23(25,26)27/h3-8,10-11H,9H2,1-2H3,(H,29,35)(H,30,34) SSSLWIJRSHGTIY-UHFFFAOYSA-N 571163 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl](deutero)methy 1}-6-methylpyridine-3-carboxamide::US11440913, Example 230::US11440913, Example 234 Receptor-interacting serine/threonine-protein kinase 1 Human 19.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571163&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074247 473132346 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206335 CC(CCNC(=O)c1cnc(C)c(c1)-c1ccc2nc(NC(C)=O)cn2n1)c1ccccc1 InChI=1S/C25H26N6O2/c1-16(19-7-5-4-6-8-19)11-12-26-25(33)20-13-21(17(2)27-14-20)22-9-10-24-29-23(28-18(3)32)15-31(24)30-22/h4-10,13-16H,11-12H2,1-3H3,(H,26,33)(H,28,32) MHPBAWPUNVAINP-UHFFFAOYSA-N 571164 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-6-methyl-N-(3- phenylbutyl)pyridine-3-carboxamide::US11440913, Example 231 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571164&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074192 473132347 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206336 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(cnc1C)C(=O)NCc1cccc(F)c1OCC1CC1 InChI=1S/C26H25FN6O3/c1-15-20(22-8-9-24-31-23(30-16(2)34)13-33(24)32-22)10-19(12-28-15)26(35)29-11-18-4-3-5-21(27)25(18)36-14-17-6-7-17/h3-5,8-10,12-13,17H,6-7,11,14H2,1-2H3,(H,29,35)(H,30,34) KXHGKTZDUXSICN-UHFFFAOYSA-N 571165 N-{[2-(cyclopropylmethoxy)-3- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 6-methylpyridine-3-carboxamide::US11440913, Example 232 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571165&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074111 473132348 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206337 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(cnc1C)C(=O)NCc1ccccc1OC(F)(F)F InChI=1S/C23H19F3N6O3/c1-13-17(18-7-8-21-30-20(29-14(2)33)12-32(21)31-18)9-16(11-27-13)22(34)28-10-15-5-3-4-6-19(15)35-23(24,25)26/h3-9,11-12H,10H2,1-2H3,(H,28,34)(H,29,33) GQNNAQVABFWQGE-UHFFFAOYSA-N 571166 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-6-methyl-N-{[2- (trifluoromethoxy)phenyl]methyl}pyridin e-3-carboxamide::US11440913, Example 233 Receptor-interacting serine/threonine-protein kinase 1 Human 38.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571166&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074403 473132349 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206338 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(cnc1C)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C23H18F4N6O3/c1-12-17(19-5-6-21-31-20(30-13(2)34)11-33(21)32-19)8-15(10-28-12)22(35)29-9-14-7-16(3-4-18(14)24)36-23(25,26)27/h3-8,10-11H,9H2,1-2H3,(H,29,35)(H,30,34) SSSLWIJRSHGTIY-UHFFFAOYSA-N 571163 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl](deutero)methy 1}-6-methylpyridine-3-carboxamide::US11440913, Example 230::US11440913, Example 234 Receptor-interacting serine/threonine-protein kinase 1 Human 46.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571163&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074247 473132346 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206339 C[C@@H](NC(=O)c1cncc(c1)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C23H18F4N6O3/c1-12(17-8-16(3-4-18(17)24)36-23(25,26)27)29-22(35)15-7-14(9-28-10-15)19-5-6-21-31-20(30-13(2)34)11-33(21)32-19/h3-12H,1-2H3,(H,29,35)(H,30,34)/t12-/m1/s1 SVPPPSRVXDYGNL-GFCCVEGCSA-N 571168 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-[(1R)-1- [2-fluoro-5-(trifluoromethoxy)phenyl] ethyl]pyridine-3-carboxamide::US11440913, Example 235 Receptor-interacting serine/threonine-protein kinase 1 Human 345 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571168&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074142 473132350 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206340 CC(=O)Nc1cn2nc(ccc2n1)-c1cncc(c1)C(=O)NCc1cc(OCC2CC2)ccc1F InChI=1S/C25H23FN6O3/c1-15(33)29-23-13-32-24(30-23)7-6-22(31-32)18-8-19(11-27-10-18)25(34)28-12-17-9-20(4-5-21(17)26)35-14-16-2-3-16/h4-11,13,16H,2-3,12,14H2,1H3,(H,28,34)(H,29,33) BGZMEWDVTXBBLV-UHFFFAOYSA-N 571169 N-{[5-(cyclopropylmethoxy)-2- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 236 Receptor-interacting serine/threonine-protein kinase 1 Human 95.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571169&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074158 473132351 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206341 CC(=O)Nc1cn2nc(ccc2n1)-c1cncc(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C22H16F4N6O3/c1-12(33)29-19-11-32-20(30-19)5-4-18(31-32)14-6-15(9-27-8-14)21(34)28-10-13-7-16(2-3-17(13)23)35-22(24,25)26/h2-9,11H,10H2,1H3,(H,28,34)(H,29,33) VXDZUZFQAKNYFR-UHFFFAOYSA-N 571170 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl]methyl} pyridine-3-carboxamide::US11440913, Example 237 Receptor-interacting serine/threonine-protein kinase 1 Human 45.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571170&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074169 473132352 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206342 CC(CCNC(=O)c1cncc(c1)-c1ccc2nc(NC(C)=O)cn2n1)c1ccccc1 InChI=1S/C24H24N6O2/c1-16(18-6-4-3-5-7-18)10-11-26-24(32)20-12-19(13-25-14-20)21-8-9-23-28-22(27-17(2)31)15-30(23)29-21/h3-9,12-16H,10-11H2,1-2H3,(H,26,32)(H,27,31) RBHTVXVLVZUGFC-UHFFFAOYSA-N 571171 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-(3-phenylbutyl) pyridine-3-carboxamide::US11440913, Example 238 Receptor-interacting serine/threonine-protein kinase 1 Human 41.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571171&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074286 473132353 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206343 CC(=O)Nc1cn2nc(ccc2n1)-c1cncc(c1)C(=O)NCc1ccccc1OCC1CC1 InChI=1S/C25H24N6O3/c1-16(32)28-23-14-31-24(29-23)9-8-21(30-31)19-10-20(12-26-11-19)25(33)27-13-18-4-2-3-5-22(18)34-15-17-6-7-17/h2-5,8-12,14,17H,6-7,13,15H2,1H3,(H,27,33)(H,28,32) SDUBZDVBOIBEAM-UHFFFAOYSA-N 571172 N-{[2-(cyclopropylmethoxy)phenyl] methyl}-5-{2-acetamidoimidazo [1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 239 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571172&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074256 473132354 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206344 CC(=O)Nc1cn2nc(ccc2n1)-c1cncc(c1)C(=O)NCc1c(F)cccc1OC1CCCC1 InChI=1S/C26H25FN6O3/c1-16(34)30-24-15-33-25(31-24)10-9-22(32-33)17-11-18(13-28-12-17)26(35)29-14-20-21(27)7-4-8-23(20)36-19-5-2-3-6-19/h4,7-13,15,19H,2-3,5-6,14H2,1H3,(H,29,35)(H,30,34) RIUCEPLMZGWQJN-UHFFFAOYSA-N 571173 N-{[2-(cyclopentyloxy)-6- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 240 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571173&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074221 473132355 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206345 CC(=O)Nc1cn2nc(ccc2n1)-c1cncc(c1)C(=O)NCc1ncccc1OC1CCCC1 InChI=1S/C25H25N7O3/c1-16(33)29-23-15-32-24(30-23)9-8-20(31-32)17-11-18(13-26-12-17)25(34)28-14-21-22(7-4-10-27-21)35-19-5-2-3-6-19/h4,7-13,15,19H,2-3,5-6,14H2,1H3,(H,28,34)(H,29,33) DVYKFJFEYMXAAW-UHFFFAOYSA-N 571174 N-{[3-(cyclopentyloxy)pyridin-2- yl]methyl}-5-{2-acetamidoimidazo [1,2-b]pyridazin-6-yl}pyridine- 3-carboxamide::US11440913, Example 241 Receptor-interacting serine/threonine-protein kinase 1 Human 35.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571174&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074396 473132356 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206346 CC(=O)Nc1cn2nc(ccc2n1)-c1cncc(c1)C(=O)NCc1cc(F)ccc1OC1CCCC1 InChI=1S/C26H25FN6O3/c1-16(34)30-24-15-33-25(31-24)9-7-22(32-33)17-10-19(13-28-12-17)26(35)29-14-18-11-20(27)6-8-23(18)36-21-4-2-3-5-21/h6-13,15,21H,2-5,14H2,1H3,(H,29,35)(H,30,34) QWRUVZBFEBJRDN-UHFFFAOYSA-N 571175 N-{[2-(cyclopentyloxy)-5- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 242 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571175&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074278 473132357 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206347 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(F)cc(F)c1OCC1CC1 InChI=1S/C27H26F2N6O4/c1-3-24(36)33-22-13-35-23(32-22)7-6-21(34-35)16-9-19(27(38-2)31-11-16)26(37)30-12-17-8-18(28)10-20(29)25(17)39-14-15-4-5-15/h6-11,13,15H,3-5,12,14H2,1-2H3,(H,30,37)(H,33,36) WGGCMJCNPCVDNE-UHFFFAOYSA-N 570937 US11440913, Example 243::US11440913, Example 4 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570937&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697491 473132155 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206348 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O4/c1-3-21(35)32-19-12-34-20(31-19)7-6-18(33-34)14-9-16(23(37-2)30-11-14)22(36)29-10-13-8-15(4-5-17(13)25)38-24(26,27)28/h4-9,11-12H,3,10H2,1-2H3,(H,29,36)(H,32,35) JCVYLVCNYQQYOG-UHFFFAOYSA-N 570944 US11440913, Example 10::US11440913, Example 244 Receptor-interacting serine/threonine-protein kinase 1 Human 257 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570944&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697489 473132162 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206349 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)N[C@H](C)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H22F4N6O4/c1-4-22(36)33-20-12-35-21(32-20)8-7-19(34-35)14-9-17(24(38-3)30-11-14)23(37)31-13(2)16-10-15(5-6-18(16)26)39-25(27,28)29/h5-13H,4H2,1-3H3,(H,31,37)(H,33,36)/t13-/m1/s1 MAAKFUPWHFCZFJ-CYBMUJFWSA-N 571178 N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl]-2- methoxy-5-{2-propanamidoimidazo[1,2- b]pyridazin-6-yl}pyridine-3-carboxamide::US11440913, Example 245 Receptor-interacting serine/threonine-protein kinase 1 Human 486 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571178&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074328 473132358 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206350 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCC[C@H](O)c1ccc(Cl)cc1 InChI=1S/C25H25ClN6O4/c1-3-23(34)30-21-14-32-22(29-21)9-8-19(31-32)16-12-18(25(36-2)28-13-16)24(35)27-11-10-20(33)15-4-6-17(26)7-5-15/h4-9,12-14,20,33H,3,10-11H2,1-2H3,(H,27,35)(H,30,34)/t20-/m0/s1 DNAGCOVYVJFBDJ-FQEVSTJZSA-N 571179 N-[(3S)-3-(4-chlorophenyl)-3- hydroxypropyl]-2-methoxy-5-{2- propanamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 246 Receptor-interacting serine/threonine-protein kinase 1 Human 92.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571179&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074145 473132359 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206351 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1 InChI=1S/C28H28F2N6O5/c1-3-25(37)34-23-15-36-24(33-23)5-4-22(35-36)16-11-20(28(39-2)32-13-16)27(38)31-14-17-10-18(29)12-21(30)26(17)41-19-6-8-40-9-7-19/h4-5,10-13,15,19H,3,6-9,14H2,1-2H3,(H,31,38)(H,34,37) PAKIRGPIHULWLE-UHFFFAOYSA-N 571180 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl]methyl}-2-methoxy-5-{2- propanamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 247 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571180&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074338 473132360 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206352 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1ccccc1OC(F)(F)F InChI=1S/C24H21F3N6O4/c1-3-21(34)31-19-13-33-20(30-19)9-8-17(32-33)15-10-16(23(36-2)29-12-15)22(35)28-11-14-6-4-5-7-18(14)37-24(25,26)27/h4-10,12-13H,3,11H2,1-2H3,(H,28,35)(H,31,34) WICBZVLVMOWJIT-UHFFFAOYSA-N 571181 2-methoxy-5-{2- propanamidoimidazo[1,2-b]pyridazin-6- yl}-N-{[2- (trifluoromethoxy)phenyl]methyl}pyridine- 3-carboxamide, TFA::US11440913, Example 248 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571181&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074373 473132361 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206353 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1ccc(F)c(F)c1OCC1CC1 InChI=1S/C27H26F2N6O4/c1-3-23(36)33-21-13-35-22(32-21)9-8-20(34-35)17-10-18(27(38-2)31-12-17)26(37)30-11-16-6-7-19(28)24(29)25(16)39-14-15-4-5-15/h6-10,12-13,15H,3-5,11,14H2,1-2H3,(H,30,37)(H,33,36) JVUKTXFGXBSDSF-UHFFFAOYSA-N 571182 N-{[2-(cyclopropylmethoxy)-3,4- difluorophenyl]methyl}-2-methoxy-5-{2- propanamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 249 Receptor-interacting serine/threonine-protein kinase 1 Human 29.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571182&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074182 473132362 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206354 CCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(OCC2CC2)ccc1F InChI=1S/C27H27FN6O4/c1-3-25(35)32-23-14-34-24(31-23)9-8-22(33-34)18-11-20(27(37-2)30-13-18)26(36)29-12-17-10-19(6-7-21(17)28)38-15-16-4-5-16/h6-11,13-14,16H,3-5,12,15H2,1-2H3,(H,29,36)(H,32,35) NMMYHUQETTWFTE-UHFFFAOYSA-N 571183 N-{[5-(cyclopropylmethoxy)-2- fluorophenyl]methyl}-2-methoxy-5-{2- propanamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 250 Receptor-interacting serine/threonine-protein kinase 1 Human 18.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571183&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074296 473132363 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206355 CC(=O)Nc1nc2ccc(nn2c1C)-c1cnc(C)c(c1)C(=O)NCc1cccc(OC(F)(F)F)c1 InChI=1S/C24H21F3N6O3/c1-13-19(23(35)29-11-16-5-4-6-18(9-16)36-24(25,26)27)10-17(12-28-13)20-7-8-21-31-22(30-15(3)34)14(2)33(21)32-20/h4-10,12H,11H2,1-3H3,(H,29,35)(H,30,34) UAOUKGGJSOXGNE-UHFFFAOYSA-N 571184 5-{2-acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-2-methyl-N-{[3- (trifluoromethoxy)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 251 Receptor-interacting serine/threonine-protein kinase 1 Human 53.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571184&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074376 473132364 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206356 CC(=O)Nc1nc2ccc(nn2c1C)-c1cnc(C)c(c1)C(=O)NCc1cc(ccc1F)C(F)(F)F InChI=1S/C24H20F4N6O2/c1-12-18(23(36)30-10-15-8-17(24(26,27)28)4-5-19(15)25)9-16(11-29-12)20-6-7-21-32-22(31-14(3)35)13(2)34(21)33-20/h4-9,11H,10H2,1-3H3,(H,30,36)(H,31,35) IPKANJIGOHYTMC-UHFFFAOYSA-N 571185 5-{2-acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethyl)phenyl]methyl}-2- methylpyridine-3-carboxamide::US11440913, Example 252 Receptor-interacting serine/threonine-protein kinase 1 Human 27.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571185&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074086 473132365 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206357 CC(=O)Nc1nc2ccc(nn2c1C)-c1cnc(C)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O3/c1-12-18(23(36)30-10-15-8-17(4-5-19(15)25)37-24(26,27)28)9-16(11-29-12)20-6-7-21-32-22(31-14(3)35)13(2)34(21)33-20/h4-9,11H,10H2,1-3H3,(H,30,36)(H,31,35) OBWFSRXMMADAEK-UHFFFAOYSA-N 571186 5-{2-acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl]methyl}-2- methylpyridine-3-carboxamide::US11440913, Example 253 Receptor-interacting serine/threonine-protein kinase 1 Human 14.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571186&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074245 473132366 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206358 COc1ncc(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)c(C)n2n1 InChI=1S/C24H20F4N6O3/c1-12-21(31-13(2)35)32-20-7-6-19(33-34(12)20)15-9-17(23(37-3)30-11-15)22(36)29-10-14-8-16(24(26,27)28)4-5-18(14)25/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) IYFHYZCKQVIPFF-UHFFFAOYSA-N 571187 5-{2-acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethyl)phenyl]methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 254 Receptor-interacting serine/threonine-protein kinase 1 Human 101 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571187&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074238 473132367 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206359 COc1ncc(cc1C(=O)NCc1ccc(F)c(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)c(C)n2n1 InChI=1S/C24H20F4N6O4/c1-12-21(31-13(2)35)32-20-7-6-18(33-34(12)20)15-9-16(23(37-3)30-11-15)22(36)29-10-14-4-5-17(25)19(8-14)38-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) ZDCIXMKUKPETCI-UHFFFAOYSA-N 571188 5-{2-acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-N-{[4-fluoro-3- (trifluoromethoxy)phenyl]methyl}-2- methoxypyridine-3-carboxamide::US11440913, Example 255 Receptor-interacting serine/threonine-protein kinase 1 Human 87.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571188&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074108 473132368 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206360 COc1ncc(cc1C(=O)NCCC(C)c1ccccc1)-c1ccc2nc(NC(C)=O)c(C)n2n1 InChI=1S/C26H28N6O3/c1-16(19-8-6-5-7-9-19)12-13-27-25(34)21-14-20(15-28-26(21)35-4)22-10-11-23-30-24(29-18(3)33)17(2)32(23)31-22/h5-11,14-16H,12-13H2,1-4H3,(H,27,34)(H,29,33) XVJMULGNJSWESB-UHFFFAOYSA-N 571189 5-{2-acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-2-methoxy-N-(3- phenylbutyl)pyridine-3-carboxamide, TFA::US11440913, Example 256 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571189&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074149 473132369 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206361 COc1ncc(cc1C(=O)NCc1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)c(C)n2n1 InChI=1S/C24H21F3N6O4/c1-13-21(30-14(2)34)31-20-8-7-19(32-33(13)20)16-10-18(23(36-3)29-12-16)22(35)28-11-15-5-4-6-17(9-15)37-24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) GMSZTRAFGDBCRK-UHFFFAOYSA-N 571190 5-{2-acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-2-methoxy-N-{[3- (trifluoromethoxy)phenyl]methyl}pyridine- 3-carboxamide, TFA::US11440913, Example 257 Receptor-interacting serine/threonine-protein kinase 1 Human 61.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571190&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074366 473132370 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206362 COc1ncc(cc1C(=O)NCc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)c(C)n2n1 InChI=1S/C24H21F3N6O4/c1-13-21(30-14(2)34)31-20-9-8-18(32-33(13)20)16-10-17(23(36-3)29-12-16)22(35)28-11-15-6-4-5-7-19(15)37-24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) ZQRICYYGVMRNPN-UHFFFAOYSA-N 571191 5-{2-acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-2-methoxy-N-{[2- (trifluoromethoxy)phenyl]methyl}pyridine- 3-carboxamide, TFA::US11440913, Example 258 Receptor-interacting serine/threonine-protein kinase 1 Human 72.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571191&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074360 473132371 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206363 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)c(C)n2n1 InChI=1S/C27H26F2N6O4/c1-14-25(32-15(2)36)33-23-7-6-22(34-35(14)23)17-9-20(27(38-3)31-11-17)26(37)30-12-18-8-19(28)10-21(29)24(18)39-13-16-4-5-16/h6-11,16H,4-5,12-13H2,1-3H3,(H,30,37)(H,32,36) NKMGHZQIYYQPPY-UHFFFAOYSA-N 571192 N-({2-[cyclopropyl(deutero)methoxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamido-3-methylimidazo[1,2- b]pyridazin-6-yl}-2-methoxypyridine-3- carboxamide::US11440913, Example 259 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571192&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437146 473132372 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206364 COCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(OCC2CC2)ccc1F InChI=1S/C27H27FN6O5/c1-37-15-25(35)32-23-13-34-24(31-23)8-7-22(33-34)18-10-20(27(38-2)30-12-18)26(36)29-11-17-9-19(5-6-21(17)28)39-14-16-3-4-16/h5-10,12-13,16H,3-4,11,14-15H2,1-2H3,(H,29,36)(H,32,35) WFBGMQSUTZWYIR-UHFFFAOYSA-N 571193 N-{[5-(cyclopropylmethoxy)-2- fluorophenyl]methyl}-2-methoxy- 5-[2- (2-methoxyacetamido)imidazo[1,2- b]pyridazin-6-yl]pyridine- 3-carboxamide::US11440913, Example 260 Receptor-interacting serine/threonine-protein kinase 1 Human 18.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571193&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074199 473132373 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206365 COCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(F)cc(F)c1OCC1CC1 InChI=1S/C27H26F2N6O5/c1-38-14-24(36)33-22-12-35-23(32-22)6-5-21(34-35)16-8-19(27(39-2)31-10-16)26(37)30-11-17-7-18(28)9-20(29)25(17)40-13-15-3-4-15/h5-10,12,15H,3-4,11,13-14H2,1-2H3,(H,30,37)(H,33,36) QJISXUCSJCOLEN-UHFFFAOYSA-N 571194 N-{[2-(cyclopropylmethoxy)-3,5- difluorophenyl]methyl}-2 -methoxy-5-[2- (2-methoxyacetamido)imidazo[1,2- b]pyridazin-6-yl]pyridine-3- carboxamide, TFA::US11440913, Example 261 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571194&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074144 473132374 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206366 COCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(OC)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C24H20F4N6O5/c1-37-12-21(35)32-19-11-34-20(31-19)6-5-18(33-34)14-8-16(23(38-2)30-10-14)22(36)29-9-13-7-15(3-4-17(13)25)39-24(26,27)28/h3-8,10-11H,9,12H2,1-2H3,(H,29,36)(H,32,35) GVHGMSUBIDKOFJ-UHFFFAOYSA-N 571195 N-{[2-fluoro-5- (trifluoromethoxy)phenyl]methyl}- 2-methoxy-5-[2-(2- methoxyacetamido)imidazo[1,2- b]pyridazin-6-yl]pyridine- 3-carboxamide::US11440913, Example 262 Receptor-interacting serine/threonine-protein kinase 1 Human 39.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571195&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074258 473132375 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206367 COc1ncc(cc1C(=O)NCc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(=O)C(C)C)cn2n1 InChI=1S/C25H23F3N6O4/c1-14(2)22(35)32-20-13-34-21(31-20)9-8-18(33-34)16-10-17(24(37-3)30-12-16)23(36)29-11-15-6-4-5-7-19(15)38-25(26,27)28/h4-10,12-14H,11H2,1-3H3,(H,29,36)(H,32,35) HEQOZPOBLOOTIK-UHFFFAOYSA-N 571196 2-methoxy-5-[2-(2- methylpropanamido)imidazo[1,2- b]pyridazin-6-yl]-N-{[2- (trifluoromethoxy)phenyl]- methyl}pyridine- 3-carboxamide::US11440913, Example 263 Receptor-interacting serine/threonine-protein kinase 1 Human 107 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571196&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074290 473132376 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206368 COc1ncc(cc1C(=O)NCc1ccc(F)c(F)c1OCC1CC1)-c1ccc2nc(NC(=O)C(C)C)cn2n1 InChI=1S/C28H28F2N6O4/c1-15(2)26(37)34-22-13-36-23(33-22)9-8-21(35-36)18-10-19(28(39-3)32-12-18)27(38)31-11-17-6-7-20(29)24(30)25(17)40-14-16-4-5-16/h6-10,12-13,15-16H,4-5,11,14H2,1-3H3,(H,31,38)(H,34,37) KEDXXDPLTFIBPV-UHFFFAOYSA-N 571197 N-{[2-(cyclopropylmethoxy)-3,4- difluorophenyl]methyl}-2-methoxy-5-[2- (2-methylpropanamido)imidazo[1,2- b]pyridazin-6-yl]pyridine-3- carboxamide, TFA::US11440913, Example 264 Receptor-interacting serine/threonine-protein kinase 1 Human 55.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571197&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074209 473132377 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206369 COc1ncc(cc1C(=O)NCc1cc(F)cc(F)c1OC1CCOCC1)-c1ccc2nc(NC(=O)C(C)C)cn2n1 InChI=1S/C29H30F2N6O5/c1-16(2)27(38)35-24-15-37-25(34-24)5-4-23(36-37)17-11-21(29(40-3)33-13-17)28(39)32-14-18-10-19(30)12-22(31)26(18)42-20-6-8-41-9-7-20/h4-5,10-13,15-16,20H,6-9,14H2,1-3H3,(H,32,39)(H,35,38) QGHKWSCDNVOJBY-UHFFFAOYSA-N 571198 N-{[3,5-difluoro-2-(oxan-4- yloxy)phenyl]methyl}-2-methoxy-5-[2- (2-methylpropanamido)imidazo[1,2- b]pyridazin-6-yl]pyridine-3- carboxamide::US11440913, Example 265 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571198&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074364 473132378 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206370 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(Cl)c(c1)C(=O)NCc1cc(F)cc(F)c1OCC1CC1 InChI=1S/C25H21ClF2N6O3/c1-13(35)31-21-11-34-22(32-21)5-4-20(33-34)15-7-18(24(26)29-9-15)25(36)30-10-16-6-17(27)8-19(28)23(16)37-12-14-2-3-14/h4-9,11,14H,2-3,10,12H2,1H3,(H,30,36)(H,31,35) DEAUYZXLPQVIRI-UHFFFAOYSA-N 571199 2-chloro-N-({2- [cyclopropyl(deutero)methoxy]-3,5- difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide, TFA::US11440913, Example 266 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571199&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437147 473132379 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206371 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(Cl)c(c1)C(=O)NCC[C@H](O)c1ccc(Cl)cc1 InChI=1S/C23H20Cl2N6O3/c1-13(32)28-20-12-31-21(29-20)7-6-18(30-31)15-10-17(22(25)27-11-15)23(34)26-9-8-19(33)14-2-4-16(24)5-3-14/h2-7,10-12,19,33H,8-9H2,1H3,(H,26,34)(H,28,32)/t19-/m0/s1 DQYSAQGQKKVUST-IBGZPJMESA-N 571200 2-chloro-N-[(3S)-3-(4-chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide::US11440913, Example 267 Receptor-interacting serine/threonine-protein kinase 1 Human 81.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571200&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074362 473132380 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206372 CC(NC(=O)c1cc(cnc1Cl)-c1ccc2nc(NC(C)=O)cn2n1)c1ccccc1OC(F)(F)F InChI=1S/C23H18ClF3N6O3/c1-12(15-5-3-4-6-18(15)36-23(25,26)27)29-22(35)16-9-14(10-28-21(16)24)17-7-8-20-31-19(30-13(2)34)11-33(20)32-17/h3-12H,1-2H3,(H,29,35)(H,30,34) OAFPPXJBGOCBFJ-UHFFFAOYSA-N 571201 2-chloro-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-N-{1-[2- (trifluoromethoxy)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 268::US11440913, Example 271 Receptor-interacting serine/threonine-protein kinase 1 Human 46.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571201&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074342 473132381 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206373 CC(NC(=O)c1cc(cnc1Cl)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C23H17ClF4N6O2/c1-11(15-8-14(23(26,27)28)3-4-17(15)25)30-22(36)16-7-13(9-29-21(16)24)18-5-6-20-32-19(31-12(2)35)10-34(20)33-18/h3-11H,1-2H3,(H,30,36)(H,31,35) GYKLZIYAECFALP-UHFFFAOYSA-N 571202 2-chloro-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-N-{1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 269::US11440913, Example 270 Receptor-interacting serine/threonine-protein kinase 1 Human 55.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571202&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074114 473132382 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206374 CC(NC(=O)c1cc(cnc1Cl)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C23H17ClF4N6O2/c1-11(15-8-14(23(26,27)28)3-4-17(15)25)30-22(36)16-7-13(9-29-21(16)24)18-5-6-20-32-19(31-12(2)35)10-34(20)33-18/h3-11H,1-2H3,(H,30,36)(H,31,35) GYKLZIYAECFALP-UHFFFAOYSA-N 571202 2-chloro-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-N-{1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 269::US11440913, Example 270 Receptor-interacting serine/threonine-protein kinase 1 Human 23.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571202&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074114 473132382 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206375 CC(NC(=O)c1cc(cnc1Cl)-c1ccc2nc(NC(C)=O)cn2n1)c1ccccc1OC(F)(F)F InChI=1S/C23H18ClF3N6O3/c1-12(15-5-3-4-6-18(15)36-23(25,26)27)29-22(35)16-9-14(10-28-21(16)24)17-7-8-20-31-19(30-13(2)34)11-33(20)32-17/h3-12H,1-2H3,(H,29,35)(H,30,34) OAFPPXJBGOCBFJ-UHFFFAOYSA-N 571201 2-chloro-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-N-{1-[2- (trifluoromethoxy)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 268::US11440913, Example 271 Receptor-interacting serine/threonine-protein kinase 1 Human 49.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571201&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074342 473132381 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206376 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(Cl)c(c1)C(=O)NCc1cccc(OC(F)(F)F)c1 InChI=1S/C22H16ClF3N6O3/c1-12(33)29-18-11-32-19(30-18)6-5-17(31-32)14-8-16(20(23)27-10-14)21(34)28-9-13-3-2-4-15(7-13)35-22(24,25)26/h2-8,10-11H,9H2,1H3,(H,28,34)(H,29,33) SLKKPVBZZWNJPO-UHFFFAOYSA-N 571205 2-chloro-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-N-{[3- (trifluoromethoxy)phenyl]methyl}pyridine- 3-carboxamide, TFA::US11440913, Example 272 Receptor-interacting serine/threonine-protein kinase 1 Human 26.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571205&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074246 473132383 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206377 CC(Oc1c(F)cc(F)cc1CNC(=O)c1cc(cnc1Cl)-c1ccc2nc(NC(C)=O)cn2n1)C1CCC1 InChI=1S/C27H25ClF2N6O3/c1-14(16-4-3-5-16)39-25-18(8-19(29)10-21(25)30)12-32-27(38)20-9-17(11-31-26(20)28)22-6-7-24-34-23(33-15(2)37)13-36(24)35-22/h6-11,13-14,16H,3-5,12H2,1-2H3,(H,32,38)(H,33,37) UWFXLHQOXKERJW-UHFFFAOYSA-N 571206 2-chloro-N-{[2-(1-cyclobutylethoxy)- 3,5-difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide, TFA::US11440913, Example 273 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571206&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074081 473132384 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206378 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(Cl)c(c1)C(=O)NCc1cc(ccc1Cl)C(F)(F)F InChI=1S/C22H15Cl2F3N6O2/c1-11(34)30-18-10-33-19(31-18)5-4-17(32-33)13-7-15(20(24)28-9-13)21(35)29-8-12-6-14(22(25,26)27)2-3-16(12)23/h2-7,9-10H,8H2,1H3,(H,29,35)(H,30,34) NLCOEJJBIRNATL-UHFFFAOYSA-N 571207 2-chloro-N-{[2-chloro-5- (trifluoromethyl)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6- yl}pyridine-3-carboxamide, TFA::US11440913, Example 274 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571207&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074226 473132385 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206379 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(Cl)c(c1)C(=O)NCc1cc(ccc1F)C(F)(F)F InChI=1S/C22H15ClF4N6O2/c1-11(34)30-18-10-33-19(31-18)5-4-17(32-33)13-7-15(20(23)28-9-13)21(35)29-8-12-6-14(22(25,26)27)2-3-16(12)24/h2-7,9-10H,8H2,1H3,(H,29,35)(H,30,34) WOBIJHRMWKFSKX-UHFFFAOYSA-N 571208 2-chloro-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethyl)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 275 Receptor-interacting serine/threonine-protein kinase 1 Human 32.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571208&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074365 473132386 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206380 COc1nc(C)c(cc1C(=O)NC(C)c1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F4N6O3/c1-12(16-9-15(25(27,28)29)5-6-19(16)26)30-23(37)18-10-17(13(2)31-24(18)38-4)20-7-8-22-33-21(32-14(3)36)11-35(22)34-20/h5-12H,1-4H3,(H,30,37)(H,32,36) KTAAKTIJJSSIEI-UHFFFAOYSA-N 571209 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl}-2- methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 276::US11440913, Example 277 Receptor-interacting serine/threonine-protein kinase 1 Human 28.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571209&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074309 473132387 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206381 COc1nc(C)c(cc1C(=O)NC(C)c1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F4N6O3/c1-12(16-9-15(25(27,28)29)5-6-19(16)26)30-23(37)18-10-17(13(2)31-24(18)38-4)20-7-8-22-33-21(32-14(3)36)11-35(22)34-20/h5-12H,1-4H3,(H,30,37)(H,32,36) KTAAKTIJJSSIEI-UHFFFAOYSA-N 571209 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{1-[2-fluoro-5- (trifluoromethyl)phenyl]ethyl}-2- methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 276::US11440913, Example 277 Receptor-interacting serine/threonine-protein kinase 1 Human 107 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571209&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074309 473132387 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206382 COc1nc(C)c(cc1C(=O)NC(C)c1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F4N6O4/c1-12(16-9-15(5-6-19(16)26)39-25(27,28)29)30-23(37)18-10-17(13(2)31-24(18)38-4)20-7-8-22-33-21(32-14(3)36)11-35(22)34-20/h5-12H,1-4H3,(H,30,37)(H,32,36) JENJKXDDENQRMK-UHFFFAOYSA-N 571211 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl}-2- methoxy-6-methylpyridine-3- carboxamide, TFA::US11440913, Example 278::US11440913, Example 279 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571211&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074100 473132388 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206383 COc1nc(C)c(cc1C(=O)NC(C)c1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F4N6O4/c1-12(16-9-15(5-6-19(16)26)39-25(27,28)29)30-23(37)18-10-17(13(2)31-24(18)38-4)20-7-8-22-33-21(32-14(3)36)11-35(22)34-20/h5-12H,1-4H3,(H,30,37)(H,32,36) JENJKXDDENQRMK-UHFFFAOYSA-N 571211 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{1-[2-fluoro-5- (trifluoromethoxy)phenyl]ethyl}-2- methoxy-6-methylpyridine-3- carboxamide, TFA::US11440913, Example 278::US11440913, Example 279 Receptor-interacting serine/threonine-protein kinase 1 Human 47.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571211&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074100 473132388 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206384 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-12-17(19-4-5-21-32-20(31-13(2)35)11-34(21)33-19)9-18(23(30-12)37-3)22(36)29-10-14-6-15(25)8-16(7-14)38-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) MFQTYPWBECAJML-UHFFFAOYSA-N 571213 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[3-fluoro-5- (trifluoromethoxy)phenyl]methyl}-2- methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 280 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571213&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074248 473132389 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206385 COc1nc(C)c(cc1C(=O)N(C)Cc1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-14-18(20-8-9-22-31-21(30-15(2)35)13-34(22)32-20)11-19(23(29-14)37-4)24(36)33(3)12-16-6-5-7-17(10-16)38-25(26,27)28/h5-11,13H,12H2,1-4H3,(H,30,35) FYENAYGJJMOSOT-UHFFFAOYSA-N 571214 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N,6-dimethyl-N-{[3- (trifluoromethoxy)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 281 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571214&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074119 473132390 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206386 COc1nc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-12-16(19-6-7-21-32-20(31-13(2)35)11-34(21)33-19)9-17(23(30-12)37-3)22(36)29-10-14-8-15(4-5-18(14)25)38-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) QNNGKHDFSWSUBF-UHFFFAOYSA-N 571108 BDBM571112::5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl](deutero) methyl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 175 Receptor-interacting serine/threonine-protein kinase 1 Homo sapiens 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571108&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074284 473132300 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5,8Z93 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 N/A A0A024QZU0 1206387 COc1nc(C)c(cc1C(=O)N(C)Cc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-14-17(19-9-10-22-31-21(30-15(2)35)13-34(22)32-19)11-18(23(29-14)37-4)24(36)33(3)12-16-7-5-6-8-20(16)38-25(26,27)28/h5-11,13H,12H2,1-4H3,(H,30,35) XBMRSFBYJUQCQF-UHFFFAOYSA-N 571216 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-N,6-dimethyl-N-{[2- (trifluoromethoxy)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 283 Receptor-interacting serine/threonine-protein kinase 1 Human 16.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571216&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074159 473132391 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206388 COc1nc(C)c(cc1C(=O)NCc1cc(F)c(F)cc1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14-18(22-6-7-25-33-24(32-15(2)36)12-35(25)34-22)9-19(27(31-14)38-3)26(37)30-11-17-8-20(28)21(29)10-23(17)39-13-16-4-5-16/h6-10,12,16H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) NHKWKRONWMDHRV-UHFFFAOYSA-N 571217 N-{[2-(cyclopropylmethoxy)-4,5- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 284 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571217&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074141 473132392 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206389 COc1nc(C)c(cc1C(=O)NCc1c(F)ccc(F)c1OC)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H22F2N6O4/c1-12-14(19-7-8-21-30-20(29-13(2)33)11-32(21)31-19)9-15(24(28-12)36-4)23(34)27-10-16-17(25)5-6-18(26)22(16)35-3/h5-9,11H,10H2,1-4H3,(H,27,34)(H,29,33) USRGSCMLXWAAMH-UHFFFAOYSA-N 571218 N-[(3,6-difluoro-2- methoxyphenyl)methyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 285 Receptor-interacting serine/threonine-protein kinase 1 Human 17.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571218&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074339 473132393 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206390 COc1nc(C)c(cc1C(=O)NCc1ccc(F)c(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14-18(21-8-9-23-33-22(32-15(2)36)12-35(23)34-21)10-19(27(31-14)38-3)26(37)30-11-17-6-7-20(28)24(29)25(17)39-13-16-4-5-16/h6-10,12,16H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) YCSRVTAEAHWFKO-UHFFFAOYSA-N 571109 N-{[2-(cyclopropylmethoxy)-3,4- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy- 6-methylpyridine-3-carboxamide::US11440913, Example 176::US11440913, Example 286 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571109&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074397 473132301 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206391 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14-19(22-6-7-24-33-23(32-15(2)36)12-35(24)34-22)10-20(27(31-14)38-3)26(37)30-11-17-8-18(28)9-21(29)25(17)39-13-16-4-5-16/h6-10,12,16H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) OWVAXLZIOWYFGP-UHFFFAOYSA-N 571107 N-({2-[cyclopropyl(deutero)methoxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 174::US11440913, Example 177::US11440913, Example 287::US11440913, Example 300 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571107&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074401 473132299 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206392 COc1nc(C)c(cc1C(=O)NCc1cccc(F)c1OCC1CCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H29FN6O4/c1-16-20(23-10-11-25-33-24(32-17(2)36)14-35(25)34-23)12-21(28(31-16)38-3)27(37)30-13-19-8-5-9-22(29)26(19)39-15-18-6-4-7-18/h5,8-12,14,18H,4,6-7,13,15H2,1-3H3,(H,30,37)(H,32,36) WUPGVEJRDJGUDX-UHFFFAOYSA-N 571221 N-{[2-(cyclobutylmethoxy)-3- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 288 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571221&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074370 473132394 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206393 COc1nc(C)c(cc1C(=O)NC(C)c1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-13(16-6-5-7-17(10-16)38-25(26,27)28)29-23(36)19-11-18(14(2)30-24(19)37-4)20-8-9-22-32-21(31-15(3)35)12-34(22)33-20/h5-13H,1-4H3,(H,29,36)(H,31,35) MHMGCOGZLRIKSJ-UHFFFAOYSA-N 571222 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{1-[3- (trifluoromethoxy)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 289::US11440913, Example 292 Receptor-interacting serine/threonine-protein kinase 1 Human 16.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571222&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074168 473132395 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206394 COc1nc(C)c(cc1C(=O)NC(C)c1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-13(16-7-5-6-8-20(16)38-25(26,27)28)29-23(36)18-11-17(14(2)30-24(18)37-4)19-9-10-22-32-21(31-15(3)35)12-34(22)33-19/h5-13H,1-4H3,(H,29,36)(H,31,35) CXYFKSXFYQFGMV-UHFFFAOYSA-N 571223 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{1-[2- (trifluoromethoxy)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 290::US11440913, Example 291 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571223&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074118 473132396 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206395 COc1nc(C)c(cc1C(=O)NC(C)c1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-13(16-7-5-6-8-20(16)38-25(26,27)28)29-23(36)18-11-17(14(2)30-24(18)37-4)19-9-10-22-32-21(31-15(3)35)12-34(22)33-19/h5-13H,1-4H3,(H,29,36)(H,31,35) CXYFKSXFYQFGMV-UHFFFAOYSA-N 571223 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{1-[2- (trifluoromethoxy)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 290::US11440913, Example 291 Receptor-interacting serine/threonine-protein kinase 1 Human >5000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571223&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074118 473132396 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206396 COc1nc(C)c(cc1C(=O)NC(C)c1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-13(16-6-5-7-17(10-16)38-25(26,27)28)29-23(36)19-11-18(14(2)30-24(19)37-4)20-8-9-22-32-21(31-15(3)35)12-34(22)33-20/h5-13H,1-4H3,(H,29,36)(H,31,35) MHMGCOGZLRIKSJ-UHFFFAOYSA-N 571222 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{1-[3- (trifluoromethoxy)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 289::US11440913, Example 292 Receptor-interacting serine/threonine-protein kinase 1 Human 24.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571222&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074168 473132395 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206397 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(c1)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O3/c1-12-17(19-4-5-21-32-20(31-13(2)35)11-34(21)33-19)9-18(23(30-12)37-3)22(36)29-10-14-6-15(24(26,27)28)8-16(25)7-14/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) QOTDIEWHGIFMAM-UHFFFAOYSA-N 571226 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[3-fluoro-5- (trifluoromethyl)phenyl]methyl}-2- methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 293 Receptor-interacting serine/threonine-protein kinase 1 Human 33.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571226&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074102 473132397 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206398 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H28F2N6O4/c1-15-20(23-7-8-25-34-24(33-16(2)37)13-36(25)35-23)11-21(28(32-15)39-3)27(38)31-12-18-9-19(29)10-22(30)26(18)40-14-17-5-4-6-17/h7-11,13,17H,4-6,12,14H2,1-3H3,(H,31,38)(H,33,37) YBMDOTZPTGTFNJ-UHFFFAOYSA-N 571227 N-{[2-(cyclobutylmethoxy)-3,5- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 294 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571227&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074112 473132398 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206399 COc1nc(C)c(cc1C(=O)NCc1ccccc1OC(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13-16(18-8-9-21-31-20(30-14(2)34)12-33(21)32-18)10-17(23(29-13)36-3)22(35)28-11-15-6-4-5-7-19(15)37-24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) FGHDUBUMNALLNW-UHFFFAOYSA-N 570954 BDBM571228::US11440913, Example 178::US11440913, Example 19 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=570954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=570954&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580816 473132172 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206400 COc1nc(C)c(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O3/c1-12-16(19-6-7-21-32-20(31-13(2)35)11-34(21)33-19)9-17(23(30-12)37-3)22(36)29-10-14-8-15(24(26,27)28)4-5-18(14)25/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) UVDMXDDHLLDWCE-UHFFFAOYSA-N 571229 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-N-{[2-fluoro-5- (trifluoromethyl)phenyl]methyl}-2- methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 296 Receptor-interacting serine/threonine-protein kinase 1 Human 10.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571229&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074351 473132400 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206401 COc1nc(C)c(cc1C(=O)NCc1cc(OCC2CC2)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15-20(23-8-9-25-32-24(31-16(2)35)13-34(25)33-23)11-21(27(30-15)37-3)26(36)29-12-18-10-19(6-7-22(18)28)38-14-17-4-5-17/h6-11,13,17H,4-5,12,14H2,1-3H3,(H,29,36)(H,31,35) BLZGRMHGRNGVKQ-UHFFFAOYSA-N 571113 N-{[5-(cyclopropyhnethoxy)-2- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 180::US11440913, Example 297 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571113&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074299 473132303 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206402 COc1nc(C)c(cc1C(=O)NCc1c(F)cc(F)cc1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14-18(22-6-7-25-33-24(32-15(2)36)12-35(25)34-22)10-19(27(31-14)38-3)26(37)30-11-20-21(29)8-17(28)9-23(20)39-13-16-4-5-16/h6-10,12,16H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) ZWSILDWWAYSANI-UHFFFAOYSA-N 571231 N-{[2-(cyclopropylmethoxy)-4,6- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 298 Receptor-interacting serine/threonine-protein kinase 1 Human 43.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571231&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074139 473132401 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206403 COc1nc(C)c(cc1C(=O)NCc1cccc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15-19(22-9-10-24-32-23(31-16(2)35)13-34(24)33-22)11-20(27(30-15)37-3)26(36)29-12-18-5-4-6-21(28)25(18)38-14-17-7-8-17/h4-6,9-11,13,17H,7-8,12,14H2,1-3H3,(H,29,36)(H,31,35) YUDOTAOAEDCGJP-UHFFFAOYSA-N 571232 N-{[2-(cyclopropylmethoxy)-3- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 299 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571232&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074244 473132402 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206404 COc1nc(C)c(cc1C(=O)NCc1cc(F)cc(F)c1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H26F2N6O4/c1-14-19(22-6-7-24-33-23(32-15(2)36)12-35(24)34-22)10-20(27(31-14)38-3)26(37)30-11-17-8-18(28)9-21(29)25(17)39-13-16-4-5-16/h6-10,12,16H,4-5,11,13H2,1-3H3,(H,30,37)(H,32,36) OWVAXLZIOWYFGP-UHFFFAOYSA-N 571107 N-({2-[cyclopropyl(deutero)methoxy]- 3,5-difluorophenyl}methyl)-5-{2- acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 174::US11440913, Example 177::US11440913, Example 287::US11440913, Example 300 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571107&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074401 473132299 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206405 COc1nc(C)c(cc1C(=O)NCC[C@H](O)c1ccc(Cl)cc1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H25ClN6O4/c1-14-18(20-8-9-23-30-22(29-15(2)33)13-32(23)31-20)12-19(25(28-14)36-3)24(35)27-11-10-21(34)16-4-6-17(26)7-5-16/h4-9,12-13,21,34H,10-11H2,1-3H3,(H,27,35)(H,29,33)/t21-/m0/s1 RJXXADXXOGBJPH-NRFANRHFSA-N 571234 N-[(3S)-3-(4-chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 301 Receptor-interacting serine/threonine-protein kinase 1 Human 25.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571234&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074273 473132403 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206406 COc1nc(C)c(cc1C(=O)NCc1ccccc1OC(C)C1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C30H34N6O4/c1-18-23(25-13-14-28-34-27(33-20(3)37)17-36(28)35-25)15-24(30(32-18)39-4)29(38)31-16-22-11-7-8-12-26(22)40-19(2)21-9-5-6-10-21/h7-8,11-15,17,19,21H,5-6,9-10,16H2,1-4H3,(H,31,38)(H,33,37) QNGRZTWTIAECIB-UHFFFAOYSA-N 571235 N-{[2-(1- cyclopentylethoxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 302::US11440913, Example 303 Receptor-interacting serine/threonine-protein kinase 1 Human 25.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571235&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074196 473132404 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206407 COc1nc(C)c(cc1C(=O)NCc1ccccc1OC(C)C1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C30H34N6O4/c1-18-23(25-13-14-28-34-27(33-20(3)37)17-36(28)35-25)15-24(30(32-18)39-4)29(38)31-16-22-11-7-8-12-26(22)40-19(2)21-9-5-6-10-21/h7-8,11-15,17,19,21H,5-6,9-10,16H2,1-4H3,(H,31,38)(H,33,37) QNGRZTWTIAECIB-UHFFFAOYSA-N 571235 N-{[2-(1- cyclopentylethoxy)phenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 302::US11440913, Example 303 Receptor-interacting serine/threonine-protein kinase 1 Human 22.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571235&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074196 473132404 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206408 COc1nc(C)c(cc1C(=O)NCCc1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23F3N6O4/c1-14-18(20-7-8-22-32-21(31-15(2)35)13-34(22)33-20)12-19(24(30-14)37-3)23(36)29-10-9-16-5-4-6-17(11-16)38-25(26,27)28/h4-8,11-13H,9-10H2,1-3H3,(H,29,36)(H,31,35) OCOSNDOAABGAFU-UHFFFAOYSA-N 571237 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{2-[3- (trifluoromethoxy)phenyl]ethyl}pyridine- 3-carboxamide::US11440913, Example 304 Receptor-interacting serine/threonine-protein kinase 1 Human 206 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571237&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074306 473132405 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206409 COc1nc(C)c(cc1C(=O)NCc1cccc(c1)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O3/c1-13-17(19-7-8-21-31-20(30-14(2)34)12-33(21)32-19)10-18(23(29-13)36-3)22(35)28-11-15-5-4-6-16(9-15)24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) UMCHQPZEWMMSRA-UHFFFAOYSA-N 571238 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{[3- (trifluoromethyl)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 305 Receptor-interacting serine/threonine-protein kinase 1 Human 41.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571238&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074349 473132406 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206410 COc1nc(C)c(cc1C(=O)NCc1ccccc1OC1CCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H28N6O5/c1-16-20(22-8-9-25-31-24(30-17(2)34)14-33(25)32-22)12-21(27(29-16)36-3)26(35)28-13-18-6-4-5-7-23(18)38-19-10-11-37-15-19/h4-9,12,14,19H,10-11,13,15H2,1-3H3,(H,28,35)(H,30,34) GYZJCPRVCXKLGD-UHFFFAOYSA-N 571239 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{[2- (oxolan-3- yloxy)phenyl]methyl}pyridine-3- carboxamide::US11440913, Example 306::US11440913, Example 307 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571239&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074116 473132407 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206411 COc1nc(C)c(cc1C(=O)NCc1ccccc1OC1CCOC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H28N6O5/c1-16-20(22-8-9-25-31-24(30-17(2)34)14-33(25)32-22)12-21(27(29-16)36-3)26(35)28-13-18-6-4-5-7-23(18)38-19-10-11-37-15-19/h4-9,12,14,19H,10-11,13,15H2,1-3H3,(H,28,35)(H,30,34) GYZJCPRVCXKLGD-UHFFFAOYSA-N 571239 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{[2- (oxolan-3- yloxy)phenyl]methyl}pyridine-3- carboxamide::US11440913, Example 306::US11440913, Example 307 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571239&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074116 473132407 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206412 COc1nc(C)c(cc1C(=O)NCc1c(F)cc(F)cc1OCC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C29H30F2N6O4/c1-16-20(24-8-9-27-35-26(34-17(2)38)14-37(27)36-24)12-21(29(33-16)40-3)28(39)32-13-22-23(31)10-19(30)11-25(22)41-15-18-6-4-5-7-18/h8-12,14,18H,4-7,13,15H2,1-3H3,(H,32,39)(H,34,38) PHGYKXMMMOLINY-UHFFFAOYSA-N 571241 N-{[2-(cyclopentylmethoxy)-4,6- difluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 308 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571241&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074326 473132408 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206413 COc1nc(C)c(cc1C(=O)NCc1cccc(OCC2CC2)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H28N6O4/c1-16-21(23-9-10-25-31-24(30-17(2)34)14-33(25)32-23)12-22(27(29-16)36-3)26(35)28-13-19-5-4-6-20(11-19)37-15-18-7-8-18/h4-6,9-12,14,18H,7-8,13,15H2,1-3H3,(H,28,35)(H,30,34) GSCWCTCZPUWOCJ-UHFFFAOYSA-N 571242 N-{[3- (cyclopropylmethoxy)phenyl]methyl}-5- {2-acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 309 Receptor-interacting serine/threonine-protein kinase 1 Human 19.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571242&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074073 473132409 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206414 COc1nc(C)c(cc1C(=O)NCc1ccccc1OCC1CCC(F)(F)CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C30H32F2N6O4/c1-18-22(24-8-9-27-36-26(35-19(2)39)16-38(27)37-24)14-23(29(34-18)41-3)28(40)33-15-21-6-4-5-7-25(21)42-17-20-10-12-30(31,32)13-11-20/h4-9,14,16,20H,10-13,15,17H2,1-3H3,(H,33,40)(H,35,39) BSORVSQKVNGBNI-UHFFFAOYSA-N 571243 N-({2-[(4,4- difluorocyclohexyl)methoxy]phenyl}methyl)- 5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-2-methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 310 Receptor-interacting serine/threonine-protein kinase 1 Human 21.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571243&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074277 473132410 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206415 COc1nc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O4/c1-12-16(19-6-7-21-32-20(31-13(2)35)11-34(21)33-19)9-17(23(30-12)37-3)22(36)29-10-14-8-15(4-5-18(14)25)38-24(26,27)28/h4-9,11H,10H2,1-3H3,(H,29,36)(H,31,35) QNNGKHDFSWSUBF-UHFFFAOYSA-N 571108 BDBM571112::5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{[2-fluoro-5- (trifluoromethoxy)phenyl](deutero) methyl}-2-(deutero)methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 175 Receptor-interacting serine/threonine-protein kinase 1 Homo sapiens 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571108&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074284 473132300 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5,8Z93 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 N/A A0A024QZU0 1206416 COc1nc(C)c(cc1C(=O)NCc1ncccc1OCC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H31N7O4/c1-17-20(22-10-11-26-33-25(32-18(2)36)15-35(26)34-22)13-21(28(31-17)38-3)27(37)30-14-23-24(9-6-12-29-23)39-16-19-7-4-5-8-19/h6,9-13,15,19H,4-5,7-8,14,16H2,1-3H3,(H,30,37)(H,32,36) WCJKFZSLEAZILK-UHFFFAOYSA-N 571245 N-{[3-(cyclopentylmethoxy)pyridin-2- yl]methyl}-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-2-methoxy-6- methylpyridine-3-carboxamide, 2 TFA::US11440913, Example 312 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571245&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074298 473132411 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206417 COc1nc(C)c(cc1C(=O)NCc1cccnc1OCC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H31N7O4/c1-17-21(23-10-11-25-33-24(32-18(2)36)15-35(25)34-23)13-22(28(31-17)38-3)26(37)30-14-20-9-6-12-29-27(20)39-16-19-7-4-5-8-19/h6,9-13,15,19H,4-5,7-8,14,16H2,1-3H3,(H,30,37)(H,32,36) HDXOAUTZLJKKRS-UHFFFAOYSA-N 571246 N-{[2-(cyclopentylmethoxy)pyridin-3- yl]methyl}-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-2-methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 313 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571246&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074193 473132412 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206418 COc1nc(C)c(cc1C(=O)NCc1cccnc1OCC1CCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H29N7O4/c1-16-20(22-9-10-24-32-23(31-17(2)35)14-34(24)33-22)12-21(27(30-16)37-3)25(36)29-13-19-8-5-11-28-26(19)38-15-18-6-4-7-18/h5,8-12,14,18H,4,6-7,13,15H2,1-3H3,(H,29,36)(H,31,35) JUBSGHQJGLYUHX-UHFFFAOYSA-N 571247 N-{[2-(cyclobutylmethoxy)pyridin-3- yl]methyl}-5-{2-acetamidoimidazo[1,2- b]pyridazin-6-yl}-2-methoxy-6- methylpyridine-3-carboxamide::US11440913, Example 314 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571247&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074184 473132413 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206419 COc1nc(C)c(cc1C(=O)NCc1cc(F)ccc1OCC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C29H31FN6O4/c1-17-22(24-9-11-27-34-26(33-18(2)37)15-36(27)35-24)13-23(29(32-17)39-3)28(38)31-14-20-12-21(30)8-10-25(20)40-16-19-6-4-5-7-19/h8-13,15,19H,4-7,14,16H2,1-3H3,(H,31,38)(H,33,37) FOBWMSCNWRJIJB-UHFFFAOYSA-N 571248 N-{[2-(cyclopentylmethoxy)-5- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 315 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571248&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074327 473132414 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206420 COc1nc(C)c(cc1C(=O)NCc1ccccc1OCC1CCCC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C29H32N6O4/c1-18-22(24-12-13-27-33-26(32-19(2)36)16-35(27)34-24)14-23(29(31-18)38-3)28(37)30-15-21-10-6-7-11-25(21)39-17-20-8-4-5-9-20/h6-7,10-14,16,20H,4-5,8-9,15,17H2,1-3H3,(H,30,37)(H,32,36) JBMONVNKRNIRHO-UHFFFAOYSA-N 571249 N-{[2- (cyclopentylmethoxy)phenyl]methyl}-5- {2-acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 316 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571249&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074331 473132415 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206421 COc1nc(C)c(cc1C(=O)NCc1ccc(F)cc1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H27FN6O4/c1-15-20(22-8-9-25-32-24(31-16(2)35)13-34(25)33-22)11-21(27(30-15)37-3)26(36)29-12-18-6-7-19(28)10-23(18)38-14-17-4-5-17/h6-11,13,17H,4-5,12,14H2,1-3H3,(H,29,36)(H,31,35) RXWTVBKXLBDRMR-UHFFFAOYSA-N 571250 N-{[2-(cyclopropylmethoxy)-4- fluorophenyl]methyl}-5-{2- acetamidoimidazo[1,2-b]pyridazin-6-yl}- 2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 317 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571250&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074254 473132416 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206422 COc1nc(C)c(cc1C(=O)NCc1ccccc1OCC1CC1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C27H28N6O4/c1-16-20(22-10-11-25-31-24(30-17(2)34)14-33(25)32-22)12-21(27(29-16)36-3)26(35)28-13-19-6-4-5-7-23(19)37-15-18-8-9-18/h4-7,10-12,14,18H,8-9,13,15H2,1-3H3,(H,28,35)(H,30,34) NXZYQIAKXWLNKU-UHFFFAOYSA-N 571251 N-{[2- (cyclopropylmethoxy)phenyl]methyl}-5- {2-acetamidoimidazo[1,2-b]pyridazin-6- yl}-2-methoxy-6-methylpyridine-3- carboxamide::US11440913, Example 318 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571251&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074227 473132417 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206423 COc1nc(C)c(cc1C(=O)NCc1cccc(OC(F)(F)F)c1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F3N6O4/c1-13-17(19-7-8-21-31-20(30-14(2)34)12-33(21)32-19)10-18(23(29-13)36-3)22(35)28-11-15-5-4-6-16(9-15)37-24(25,26)27/h4-10,12H,11H2,1-3H3,(H,28,35)(H,30,34) CITAPNZWVYMBRR-UHFFFAOYSA-N 571252 5-{2-acetamidoimidazo[1,2-b]pyridazin- 6-yl}-2-methoxy-6-methyl-N-{[3- (trifluoromethoxy)phenyl]methyl}pyridine- 3-carboxamide::US11440913, Example 319 Receptor-interacting serine/threonine-protein kinase 1 Human 15.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571252&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074390 473132418 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206424 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(cnc1Cl)C(=O)NCc1cc(F)ccc1OC(F)(F)F InChI=1S/C22H15ClF4N6O3/c1-11(34)30-18-10-33-19(31-18)5-3-16(32-33)15-7-13(9-28-20(15)23)21(35)29-8-12-6-14(24)2-4-17(12)36-22(25,26)27/h2-7,9-10H,8H2,1H3,(H,29,35)(H,30,34) RYZZHBDTVXNQOP-UHFFFAOYSA-N 571253 US11440913, Example 321 Receptor-interacting serine/threonine-protein kinase 1 Human 44.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571253&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697480 473132419 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206425 COc1nc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)COC(C)=O)cn2n1 InChI=1S/C26H22F4N6O6/c1-13-17(20-6-7-22-33-21(11-36(22)35-20)34-23(38)12-41-14(2)37)9-18(25(32-13)40-3)24(39)31-10-15-8-16(4-5-19(15)27)42-26(28,29)30/h4-9,11H,10,12H2,1-3H3,(H,31,39)(H,34,38) UCONXPVQZPXXBB-UHFFFAOYSA-N 571254 US11440913, Example 322 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571254&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437148 473132420 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206426 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2c(F)cccc2OCC(F)(F)F)c(C)nc1C InChI=1S/C25H22F4N6O3/c1-13-16(20-7-8-23-33-22(32-15(3)36)11-35(23)34-20)9-17(14(2)31-13)24(37)30-10-18-19(26)5-4-6-21(18)38-12-25(27,28)29/h4-9,11H,10,12H2,1-3H3,(H,30,37)(H,32,36) ORIMICCIUFLHIF-UHFFFAOYSA-N 571255 US11440913, Example 325 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571255&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580829 473132421 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206427 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(OCC3CC3)ccc2F)c(C)nc1C InChI=1S/C27H27FN6O3/c1-15-21(24-8-9-26-32-25(31-17(3)35)13-34(26)33-24)11-22(16(2)30-15)27(36)29-12-19-10-20(6-7-23(19)28)37-14-18-4-5-18/h6-11,13,18H,4-5,12,14H2,1-3H3,(H,29,36)(H,31,35) UKUHQONJUQSDKK-UHFFFAOYSA-N 571256 US11440913, Example 326 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571256&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580972 473132422 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206428 CC(=O)OCC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(OC(F)(F)F)ccc2F)c(C)nc1C InChI=1S/C26H22F4N6O5/c1-13-18(21-6-7-23-33-22(11-36(23)35-21)34-24(38)12-40-15(3)37)9-19(14(2)32-13)25(39)31-10-16-8-17(4-5-20(16)27)41-26(28,29)30/h4-9,11H,10,12H2,1-3H3,(H,31,39)(H,34,38) QRERVUJUPAKVCW-UHFFFAOYSA-N 571257 US11440913, Example 327 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571257&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580860 473132423 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206429 CCc1ncc(cc1C(=O)N[C@H](C)c1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H22F4N6O3/c1-4-20-18(24(37)31-13(2)17-10-16(5-6-19(17)26)38-25(27,28)29)9-15(11-30-20)21-7-8-23-33-22(32-14(3)36)12-35(23)34-21/h5-13H,4H2,1-3H3,(H,31,37)(H,32,36)/t13-/m1/s1 IKCYZPXSSYJYBT-CYBMUJFWSA-N 571258 US11440913, Example 328 Receptor-interacting serine/threonine-protein kinase 1 Human 36.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571258&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697479 473132424 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206430 CCc1ncc(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F4N6O2/c1-3-19-17(23(36)30-10-14-8-16(24(26,27)28)4-5-18(14)25)9-15(11-29-19)20-6-7-22-32-21(31-13(2)35)12-34(22)33-20/h4-9,11-12H,3,10H2,1-2H3,(H,30,36)(H,31,35) RCUXZLQNFXUWIL-UHFFFAOYSA-N 571259 US11440913, Example 329 Receptor-interacting serine/threonine-protein kinase 1 Human 53.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571259&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580933 473132425 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206431 C[C@@H](N(C)C(=O)c1cc(cnc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H22F4N6O3/c1-13-18(24(37)34(4)14(2)19-10-17(5-6-20(19)26)38-25(27,28)29)9-16(11-30-13)21-7-8-23-32-22(31-15(3)36)12-35(23)33-21/h5-12,14H,1-4H3,(H,31,36)/t14-/m1/s1 NKIMGBGTGCHWBU-CQSZACIVSA-N 571260 US11440913, Example 330 Receptor-interacting serine/threonine-protein kinase 1 Human 46.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571260&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697492 473132426 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206432 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CN3CCC(CC3)C(F)(F)F)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C30H28F7N7O2/c1-16-22(28(46)39-17(2)21-12-20(30(35,36)37)3-4-23(21)31)11-18(13-38-16)24-5-6-26-40-25(14-44(26)42-24)41-27(45)15-43-9-7-19(8-10-43)29(32,33)34/h3-6,11-14,17,19H,7-10,15H2,1-2H3,(H,39,46)(H,41,45)/t17-/m1/s1 UMJLELRLAHJBCU-QGZVFWFLSA-N 571261 N-[(1R)-1-[2-fluoro-5- (trifluoromethyl)- phenyl]ethyl]-2- methyl-5-(2-{2-[4- (trifluoromethyl)piperidin-1- yl]acetamido}imidazo[1,2- b]pyridazin-6-yl)pyridine-3- carboxamide::US11440913, Example 331 Receptor-interacting serine/threonine-protein kinase 1 Human 42.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571261&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074318 473132427 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206433 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CN3CCN(C)CC3)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C29H30F4N8O2/c1-17-22(28(43)35-18(2)21-13-20(29(31,32)33)4-5-23(21)30)12-19(14-34-17)24-6-7-26-36-25(15-41(26)38-24)37-27(42)16-40-10-8-39(3)9-11-40/h4-7,12-15,18H,8-11,16H2,1-3H3,(H,35,43)(H,37,42)/t18-/m1/s1 QAGJJLZUVNTSOM-GOSISDBHSA-N 571262 N-[(1R)-1-[2-fluoro-5- (trifluoromethyl)- phenyl]ethyl]-2- methyl-5-{2-[2-(4- methylpiperazin-1- yl)acetamido]imidazo[1,2- b]pyridazin-6-yl}pyridine-3- carboxamide::US11440913, Example 332 Receptor-interacting serine/threonine-protein kinase 1 Human 308 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571262&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074208 473132428 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206434 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CN3CCCC3)cn2n1)c1cc(ccc1F)C(F)(F)F InChI=1S/C28H27F4N7O2/c1-16-21(27(41)34-17(2)20-12-19(28(30,31)32)5-6-22(20)29)11-18(13-33-16)23-7-8-25-35-24(14-39(25)37-23)36-26(40)15-38-9-3-4-10-38/h5-8,11-14,17H,3-4,9-10,15H2,1-2H3,(H,34,41)(H,36,40)/t17-/m1/s1 YFEOWSCXHYVSIQ-QGZVFWFLSA-N 571263 N-[(1R)-1-[2-fluoro-5- (trifluoromethyl)- phenyl]ethyl]-2- methyl-5-{2-[2-(pynolidin-1- yl)acetamido]imidazo[1,2- b]pyridazin-6-yl}pyridine-3- carboxamide::US11440913, Example 333 Receptor-interacting serine/threonine-protein kinase 1 Human 91.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571263&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162690518 473132429 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206435 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CN3CCC(F)(F)CC3)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C29H27F6N7O3/c1-16-21(27(44)37-17(2)20-12-19(3-4-22(20)30)45-29(33,34)35)11-18(13-36-16)23-5-6-25-38-24(14-42(25)40-23)39-26(43)15-41-9-7-28(31,32)8-10-41/h3-6,11-14,17H,7-10,15H2,1-2H3,(H,37,44)(H,39,43)/t17-/m1/s1 SDRZUDFCUDXQSL-QGZVFWFLSA-N 571264 5-{2-[2-(4,4-difluoropiperidin-1- yl)acetamido]- imidazo[1,2-b]pyridazin- 6-yl}-N-[(1R)-1-[2- fluoro-5- (trifluoromethoxy)- phenyl]ethyl]- 2-methylpyridine-3- carboxamide::US11440913, Example 334 Receptor-interacting serine/threonine-protein kinase 1 Human 15.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571264&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074128 473132430 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206436 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CN3CC(F)(F)C3)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C27H23F6N7O3/c1-14-19(25(42)35-15(2)18-8-17(3-4-20(18)28)43-27(31,32)33)7-16(9-34-14)21-5-6-23-36-22(10-40(23)38-21)37-24(41)11-39-12-26(29,30)13-39/h3-10,15H,11-13H2,1-2H3,(H,35,42)(H,37,41)/t15-/m1/s1 RDBKPPGVAXCKDX-OAHLLOKOSA-N 571265 5-{2-[2-(3,3-difluoroazetidin-1- yl)acetamido]- imidazo[1,2- b]pyridazin-6-yl}- N-[(1R)-1-[2- fluoro-5- (trifluoromethoxy)- phenyl]ethyl]- 2-methylpyridine- 3-carboxamide::US11440913, Example 335 Receptor-interacting serine/threonine-protein kinase 1 Human 28.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571265&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074322 473132431 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206437 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CN3CCN(C)CC3)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C29H30F4N8O3/c1-17-22(28(43)35-18(2)21-13-20(4-5-23(21)30)44-29(31,32)33)12-19(14-34-17)24-6-7-26-36-25(15-41(26)38-24)37-27(42)16-40-10-8-39(3)9-11-40/h4-7,12-15,18H,8-11,16H2,1-3H3,(H,35,43)(H,37,42)/t18-/m1/s1 VLDJSABXSJNUFK-GOSISDBHSA-N 571266 N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)- phenyl]ethyl]- 2-methyl-5-{2-[2-(4- methylpiperazin-1- yl)acetamido]imidazo[1,2- b]pyridazin-6-yl}pyridine-3- carboxamide::US11440913, Example 336 Receptor-interacting serine/threonine-protein kinase 1 Human 19.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571266&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074358 473132432 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206438 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CN(C)C)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C26H25F4N7O3/c1-14-19(25(39)32-15(2)18-10-17(5-6-20(18)27)40-26(28,29)30)9-16(11-31-14)21-7-8-23-33-22(12-37(23)35-21)34-24(38)13-36(3)4/h5-12,15H,13H2,1-4H3,(H,32,39)(H,34,38)/t15-/m1/s1 DBTVAAHFJJMYDC-OAHLLOKOSA-N 571267 5-{2-[2- (dimethylamino)- acetamido]- imidazo[1, 2-b]pyridazin-6- yl}-N-[(1R)- 1-[2-fluoro-5-::US11440913, Example 338 Receptor-interacting serine/threonine-protein kinase 1 Human 21.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571267&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162690516 473132433 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206439 C[C@H](O)C(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)N[C@H](C)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H22F4N6O4/c1-12-18(24(38)31-13(2)17-9-16(4-5-19(17)26)39-25(27,28)29)8-15(10-30-12)20-6-7-22-32-21(11-35(22)34-20)33-23(37)14(3)36/h4-11,13-14,36H,1-3H3,(H,31,38)(H,33,37)/t13-,14+/m1/s1 ONCAYAZWAFZLDN-KGLIPLIRSA-N 571268 N-((R)-1-(2-fluoro-5- (trifluoromethoxy)- phenyl)ethyl)- 5-(2-((S)-2- hydroxypropanamido)- imidazo[1,2- b]pyridazin-6-yl)-2-::US11440913, Example 339 Receptor-interacting serine/threonine-protein kinase 1 Human 48.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571268&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162690515 473132434 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206440 CNCC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)N[C@H](C)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H23F4N7O3/c1-13-18(24(38)32-14(2)17-9-16(4-5-19(17)26)39-25(27,28)29)8-15(10-31-13)20-6-7-22-33-21(12-36(22)35-20)34-23(37)11-30-3/h4-10,12,14,30H,11H2,1-3H3,(H,32,38)(H,34,37)/t14-/m1/s1 LTMITRONVOGFBM-CQSZACIVSA-N 571269 N-[(1R)-1-[2-fluoro-5- (trifluoromethoxy)- phenyl]ethyl]- 2-methyl-5-{2-[2- (methylamino)- acetamido]imidazo [1,2-b]pyridazin-::US11440913, Example 340 Receptor-interacting serine/threonine-protein kinase 1 Human 67.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571269&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162617758 473132435 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206441 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)CN)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H21F4N7O3/c1-12-17(23(37)31-13(2)16-8-15(3-4-18(16)25)38-24(26,27)28)7-14(10-30-12)19-5-6-21-32-20(11-35(21)34-19)33-22(36)9-29/h3-8,10-11,13H,9,29H2,1-2H3,(H,31,37)(H,33,36)/t13-/m1/s1 YKMAKQIUVPIYFL-CYBMUJFWSA-N 571270 5-[2-(2- aminoacetamido)- imidazo[1,2- b]pyridazin-6-yl]- N-[(1R)-1-[2- fluoro-5- (trifluoromethoxy)-::US11440913, Example 341 Receptor-interacting serine/threonine-protein kinase 1 Human 91.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571270&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162690513 473132436 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206442 C[C@@H](NC(=O)c1cc(cnc1C)-c1ccc2nc(NC(=O)COC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C26H22F4N6O5/c1-13-19(25(39)32-14(2)18-9-17(4-5-20(18)27)41-26(28,29)30)8-16(10-31-13)21-6-7-23-33-22(11-36(23)35-21)34-24(38)12-40-15(3)37/h4-11,14H,12H2,1-3H3,(H,32,39)(H,34,38)/t14-/m1/s1 ZKVGMFXRKWKUQC-CQSZACIVSA-N 571271 US11440913, Example 342::{[6-(5-{[(1R)-1-[2-fluoro-5- (trifluoromethoxy)- phenyl]ethyl]- carbamoyl}-6- methylpyridin-3- yl)imidazo[1,2- b]pyridazin-2- yl]carbamoyl}- methyl acetate Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571271&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074251 473132437 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206443 Cc1ncc(cc1C(=O)NCC[C@@H](O)c1ccc(Cl)cc1)-c1ccc2nc(NC(=O)CN3CCC(F)(F)CC3)cn2n1 InChI=1S/C29H30ClF2N7O3/c1-18-22(28(42)33-11-8-24(40)19-2-4-21(30)5-3-19)14-20(15-34-18)23-6-7-26-35-25(16-39(26)37-23)36-27(41)17-38-12-9-29(31,32)10-13-38/h2-7,14-16,24,40H,8-13,17H2,1H3,(H,33,42)(H,36,41)/t24-/m1/s1 OYYWCSJEBVGYMV-XMMPIXPASA-N 571272 N-[(3R)-3-(4- chlorophenyl)-3- hydroxypropyl]-5- {2-[2-(4,4- difluoropiperidin-1- yl)acetamido]imidazo[1,2- b]pyridazin-6-yl}-2- methylpyridine-3- carboxamide::US11440913, Example 343 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571272&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074280 473132438 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206444 Cc1ncc(cc1C(=O)NCC[C@@H](O)c1ccc(Cl)cc1)-c1ccc2nc(NC(=O)CN3CC(F)(F)C3)cn2n1 InChI=1S/C27H26ClF2N7O3/c1-16-20(26(40)31-9-8-22(38)17-2-4-19(28)5-3-17)10-18(11-32-16)21-6-7-24-33-23(12-37(24)35-21)34-25(39)13-36-14-27(29,30)15-36/h2-7,10-12,22,38H,8-9,13-15H2,1H3,(H,31,40)(H,34,39)/t22-/m1/s1 QHXPQRIUXPVCCT-JOCHJYFZSA-N 571273 N-[(3R)-3-(4- chlorophenyl)-3- hydroxypropyl]-5- {2-[2-(3,3- difluoroazetidin-1- yl)acetamido]imidazo[1,2- b]pyridazin-6-yl}-2- methylpyridine-3- carboxamide::US11440913, Example 344 Receptor-interacting serine/threonine-protein kinase 1 Human 266 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571273&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074197 473132439 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206445 CN(C)CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCC[C@H](O)c1ccc(Cl)cc1 InChI=1S/C26H28ClN7O3/c1-16-20(26(37)28-11-10-22(35)17-4-6-19(27)7-5-17)12-18(13-29-16)21-8-9-24-30-23(14-34(24)32-21)31-25(36)15-33(2)3/h4-9,12-14,22,35H,10-11,15H2,1-3H3,(H,28,37)(H,31,36)/t22-/m0/s1 DTDSAJSXFYFTGL-QFIPXVFZSA-N 571274 N-[(3S)-3-(4- chlorophenyl)-3- hydroxypropyl]-5-{2-[2- (dimethylamino)- acetamido]- imidazo[1,2-b]pyridazin- 6-yl}-2-::US11440913, Example 347 Receptor-interacting serine/threonine-protein kinase 1 Human 44.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571274&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 162690517 473132440 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206446 CC(c1ccc(F)cc1)n1cc(NC(=O)c2cc(cnc2C)-c2ccc3nc(NC(C)=O)cn3n2)cn1 InChI=1S/C26H23FN8O2/c1-15-22(26(37)31-21-12-29-34(13-21)16(2)18-4-6-20(27)7-5-18)10-19(11-28-15)23-8-9-25-32-24(30-17(3)36)14-35(25)33-23/h4-14,16H,1-3H3,(H,30,36)(H,31,37) FSQFUXOPQZXZMZ-UHFFFAOYSA-N 571275 US11440913, Example 348 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571275&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697487 473132441 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206447 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)Nc1cn(Cc2ccc(Cl)cc2)cn1 InChI=1S/C25H21ClN8O2/c1-15-20(25(36)31-22-12-33(14-28-22)11-17-3-5-19(26)6-4-17)9-18(10-27-15)21-7-8-24-30-23(29-16(2)35)13-34(24)32-21/h3-10,12-14H,11H2,1-2H3,(H,29,35)(H,31,36) IOLVLPOURDTQIW-UHFFFAOYSA-N 571276 N-{1-[(4-chlorophenyl) methyl]-1H-imidazol- 4-yl}-5-{2- acetamidoimidazo[1,2-b] pyridazin-6- yl}-2-methylpyridine-3- carboxamide::US11440913, Example 349 Receptor-interacting serine/threonine-protein kinase 1 Human 51.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571276&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074207 473132442 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206448 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)Nc1cn(Cc2ccc(F)cc2)cn1 InChI=1S/C25H21FN8O2/c1-15-20(25(36)31-22-12-33(14-28-22)11-17-3-5-19(26)6-4-17)9-18(10-27-15)21-7-8-24-30-23(29-16(2)35)13-34(24)32-21/h3-10,12-14H,11H2,1-2H3,(H,29,35)(H,31,36) YBYXLAHIWSAKPC-UHFFFAOYSA-N 571277 5-{2-acetamidoimidazo[1,2-b] pyridazin-6-yl}-N-{1-[(4- fluorophenyl)methyl]- 1H-imidazol-4-yl}-2- methylpyridine-3- carboxamide::US11440913, Example 350 Receptor-interacting serine/threonine-protein kinase 1 Human 27.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571277&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074122 473132443 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206449 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)Nc1cn(Cc2ccccc2)cn1 InChI=1S/C25H22N8O2/c1-16-20(25(35)30-22-13-32(15-27-22)12-18-6-4-3-5-7-18)10-19(11-26-16)21-8-9-24-29-23(28-17(2)34)14-33(24)31-21/h3-11,13-15H,12H2,1-2H3,(H,28,34)(H,30,35) AHJWFAGDUANYCZ-UHFFFAOYSA-N 571278 N-(1-benzyl-1H-imidazol- 4-yl)-5-{2-acetamidoimidazo [1,2-b]pyridazin-6-yl}-2- methylpyridine-3-carboxamide::US11440913, Example 351 Receptor-interacting serine/threonine-protein kinase 1 Human 28.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571278&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074232 473132444 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206450 CN\C=C(/C=N)c1ccc(F)c(CNC(=O)c2cc(cnc2C)-c2ccc3nc(NC(C)=O)cn3n2)c1 InChI=1S/C26H25FN8O2/c1-15-21(26(37)31-12-18-8-17(4-5-22(18)27)20(10-28)11-29-3)9-19(13-30-15)23-6-7-25-33-24(32-16(2)36)14-35(25)34-23/h4-11,13-14,28-29H,12H2,1-3H3,(H,31,37)(H,32,36)/b20-11+,28-10? ATZUSLHUIZSRJZ-DKAPALTKSA-N 571279 US11440913, Example 352 Receptor-interacting serine/threonine-protein kinase 1 Human 125 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571279&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580924 473132445 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206451 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)N1CCCC(C1)C(O)c1ccc(F)cc1 InChI=1S/C27H27FN6O3/c1-16-22(27(37)33-11-3-4-19(14-33)26(36)18-5-7-21(28)8-6-18)12-20(13-29-16)23-9-10-25-31-24(30-17(2)35)15-34(25)32-23/h5-10,12-13,15,19,26,36H,3-4,11,14H2,1-2H3,(H,30,35) ISKARULSHNQEEJ-UHFFFAOYSA-N 571280 N-[6-(5-{3-[(4-fluorophenyl)(hydroxy)methyl]piperidine-1-carbonyl}-6-methylpyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide and N-[6-(5-{3-[(4-fluorophenyl)(hydroxy)methyl]piperidine-1-carbonyl}-6-methylpyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl] acetamide::US11440913, Example 354::US11440913, Example 355 Receptor-interacting serine/threonine-protein kinase 1 Human 212 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571280&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580782 473132446 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206452 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)N1CCCC(C1)C(O)c1ccc(F)cc1 InChI=1S/C27H27FN6O3/c1-16-22(27(37)33-11-3-4-19(14-33)26(36)18-5-7-21(28)8-6-18)12-20(13-29-16)23-9-10-25-31-24(30-17(2)35)15-34(25)32-23/h5-10,12-13,15,19,26,36H,3-4,11,14H2,1-2H3,(H,30,35) ISKARULSHNQEEJ-UHFFFAOYSA-N 571280 N-[6-(5-{3-[(4-fluorophenyl)(hydroxy)methyl]piperidine-1-carbonyl}-6-methylpyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide and N-[6-(5-{3-[(4-fluorophenyl)(hydroxy)methyl]piperidine-1-carbonyl}-6-methylpyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl] acetamide::US11440913, Example 354::US11440913, Example 355 Receptor-interacting serine/threonine-protein kinase 1 Human 223 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571280&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580782 473132446 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206453 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)NCC(C)(O)Cc1ccc(F)cc1 InChI=1S/C25H25FN6O3/c1-15-20(24(34)28-14-25(3,35)11-17-4-6-19(26)7-5-17)10-18(12-27-15)21-8-9-23-30-22(29-16(2)33)13-32(23)31-21/h4-10,12-13,35H,11,14H2,1-3H3,(H,28,34)(H,29,33) KXKRCSQPJDEJBA-UHFFFAOYSA-N 571282 US11440913, Example 356 Receptor-interacting serine/threonine-protein kinase 1 Human 150 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571282&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580854 473132447 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206454 CC(=O)Nc1cn2nc(ccc2n1)-c1cnc(C)c(c1)C(=O)N1CCCC(O)(Cc2ccc(F)cc2)C1 InChI=1S/C27H27FN6O3/c1-17-22(26(36)33-11-3-10-27(37,16-33)13-19-4-6-21(28)7-5-19)12-20(14-29-17)23-8-9-25-31-24(30-18(2)35)15-34(25)32-23/h4-9,12,14-15,37H,3,10-11,13,16H2,1-2H3,(H,30,35) HQAUYCNKOXMGEN-UHFFFAOYSA-N 571283 US11440913, Example 357 Receptor-interacting serine/threonine-protein kinase 1 Human 335 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571283&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580893 473132448 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206455 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)c(C)c(c1)C(=O)NCc1cc(ccc1F)-c1cnn(C)c1 InChI=1S/C27H23F2N7O2/c1-15-21(27(38)30-11-19-8-17(4-5-22(19)28)20-12-31-35(3)13-20)9-18(10-23(15)29)24-6-7-26-33-25(32-16(2)37)14-36(26)34-24/h4-10,12-14H,11H2,1-3H3,(H,30,38)(H,32,37) XYGDNSAQUWJSQD-UHFFFAOYSA-N 571284 US11440913, Example 358 Receptor-interacting serine/threonine-protein kinase 1 Human 15.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571284&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 154697493 473132449 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206456 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)c(C)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C24H18F5N5O3/c1-12-17(23(36)30-10-15-7-16(3-4-18(15)25)37-24(27,28)29)8-14(9-19(12)26)20-5-6-22-32-21(31-13(2)35)11-34(22)33-20/h3-9,11H,10H2,1-2H3,(H,30,36)(H,31,35) ZCYODDJUTJAOGL-UHFFFAOYSA-N 571285 5-{2- acetamidoimidazo [1,2-b] pyridazin-6-yl}- 3-fluoro-N-{[2- fluoro-5- (trifluoromethoxy) phenyl] methyl}-2- methylbenzamide::US11440913, Example 359 Receptor-interacting serine/threonine-protein kinase 1 Human 78.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571285&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155089158 473132450 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206457 C[C@H](NC(=O)c1cc(cc(F)c1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H20F5N5O3/c1-12-17(24(37)31-13(2)18-10-16(4-5-19(18)26)38-25(28,29)30)8-15(9-20(12)27)21-6-7-23-33-22(32-14(3)36)11-35(23)34-21/h4-11,13H,1-3H3,(H,31,37)(H,32,36)/t13-/m0/s1 KCYMQHLMKRFXTJ-ZDUSSCGKSA-N 571286 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-3-fluoro- N-[(1S)-1-[2- fluoro-5- (trifluoromethoxy) phenyl]ethyl]-2- methylbenzamide::US11440913, Example 360 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571286&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074276 473132451 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206458 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)c(C)c(c1)C(=O)NCc1cccc(OC(F)(F)F)c1F InChI=1S/C24H18F5N5O3/c1-12-16(23(36)30-10-14-4-3-5-19(22(14)26)37-24(27,28)29)8-15(9-17(12)25)18-6-7-21-32-20(31-13(2)35)11-34(21)33-18/h3-9,11H,10H2,1-2H3,(H,30,36)(H,31,35) RXTRUKYQXWIJKD-UHFFFAOYSA-N 571287 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-3-fluoro- N-{[2-fluoro-3- (trifluoromethoxy) phenyl]methyl}-2- methylbenzamide::US11440913, Example 361 Receptor-interacting serine/threonine-protein kinase 1 Human 42.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571287&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074279 473132452 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206459 CN(C)CC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)c(C)c(c1)C(=O)NCC[C@H](O)c1ccc(Cl)cc1 InChI=1S/C27H28ClFN6O3/c1-16-20(27(38)30-11-10-23(36)17-4-6-19(28)7-5-17)12-18(13-21(16)29)22-8-9-25-31-24(14-35(25)33-22)32-26(37)15-34(2)3/h4-9,12-14,23,36H,10-11,15H2,1-3H3,(H,30,38)(H,32,37)/t23-/m0/s1 SUSQHKDTKHHDIY-QHCPKHFHSA-N 571288 N-[(3S)-3-(4- chlorophenyl)-3- hydroxypropyl]- 5-{2-[2- (dimethylamino) acetamido] imidazo[1,2-b] pyridazin-6-yl}- 3-fluoro-2-::US11440913, Example 362 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571288&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090657 473132453 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206460 CNCC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)c(C)c(c1)C(=O)NCC[C@H](O)c1ccc(Cl)cc1 InChI=1S/C26H26ClFN6O3/c1-15-19(26(37)30-10-9-22(35)16-3-5-18(27)6-4-16)11-17(12-20(15)28)21-7-8-24-31-23(14-34(24)33-21)32-25(36)13-29-2/h3-8,11-12,14,22,29,35H,9-10,13H2,1-2H3,(H,30,37)(H,32,36)/t22-/m0/s1 UHWHFEBBZVWUQK-QFIPXVFZSA-N 571289 N-[(3S)-3-(4- chlorophenyl)-3- hydroxypropyl]- 3-fluoro-2- methyl-5-{2-[2- (methylamino) acetamido] imidazo[1,2-b] pyridazin-::US11440913, Example 363 Receptor-interacting serine/threonine-protein kinase 1 Human 65.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571289&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155091336 473132454 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206461 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)c(C)c(c1)C(=O)NCc1ccccc1Oc1ccccc1 InChI=1S/C29H24FN5O3/c1-18-23(29(37)31-16-20-8-6-7-11-26(20)38-22-9-4-3-5-10-22)14-21(15-24(18)30)25-12-13-28-33-27(32-19(2)36)17-35(28)34-25/h3-15,17H,16H2,1-2H3,(H,31,37)(H,32,36) DTLSTENMPRXZRN-UHFFFAOYSA-N 571290 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-3-fluoro- 2-methyl-N-[(2- phenoxyphenyl) methyl] benzamide::US11440913, Example 364 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571290&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074292 473132455 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206462 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)c(C)c(c1)C(=O)NCc1c(F)cccc1C(=O)N1CCC(F)(F)C1 InChI=1S/C28H24F4N6O3/c1-15-19(10-17(11-22(15)30)23-6-7-25-35-24(34-16(2)39)13-38(25)36-23)26(40)33-12-20-18(4-3-5-21(20)29)27(41)37-9-8-28(31,32)14-37/h3-7,10-11,13H,8-9,12,14H2,1-2H3,(H,33,40)(H,34,39) SJHZRWWODCVVGJ-UHFFFAOYSA-N 571291 N-{[2-(3,3- difluoropyrrolidine- 1-carbonyl)-6- fluorophenyl] methyl}-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-3-fluoro-2- methylbenzamide::US11440913, Example 365 Receptor-interacting serine/threonine-protein kinase 1 Human 37.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571291&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074071 473132456 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206463 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)c(F)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C23H15F6N5O3/c1-11(35)31-19-10-34-20(32-19)5-4-18(33-34)12-7-15(21(26)17(25)8-12)22(36)30-9-13-6-14(2-3-16(13)24)37-23(27,28)29/h2-8,10H,9H2,1H3,(H,30,36)(H,31,35) CMTAWEQOKDTPPC-UHFFFAOYSA-N 571292 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,3- difluoro-N- {[2-fluoro-5- (trifluoromethoxy) phenyl]methyl} benzamide::US11440913, Example 366 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571292&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580776 473132457 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206464 C[C@@H](NC(=O)c1cc(cc(F)c1F)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H17F6N5O3/c1-11(15-9-14(3-4-17(15)25)38-24(28,29)30)31-23(37)16-7-13(8-18(26)22(16)27)19-5-6-21-33-20(32-12(2)36)10-35(21)34-19/h3-11H,1-2H3,(H,31,37)(H,32,36)/t11-/m1/s1 DWXOYSJMUIQTQH-LLVKDONJSA-N 571293 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,3- difluoro-N- [(1R)-1-[2- fluoro-5- (trifluoromethoxy) phenyl]ethyl] benzamide::US11440913, Example 367 Receptor-interacting serine/threonine-protein kinase 1 Human 56.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571293&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074348 473132458 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206465 CC(=O)Nc1cn2nc(ccc2n1)-c1c(F)c(F)cc(C(=O)NCc2cc(OC(F)(F)F)ccc2F)c1F InChI=1S/C23H14F7N5O3/c1-10(36)32-17-9-35-18(33-17)5-4-16(34-35)19-20(26)13(7-15(25)21(19)27)22(37)31-8-11-6-12(2-3-14(11)24)38-23(28,29)30/h2-7,9H,8H2,1H3,(H,31,37)(H,32,36) VIWYSWFIWQKPGY-UHFFFAOYSA-N 571294 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,4,5- trifluoro-N-{[2- fluoro-5- (trifluoromethoxy) phenyl]methyl} benzamide::US11440913, Example 368 Receptor-interacting serine/threonine-protein kinase 1 Human 25.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571294&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090666 473132459 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206466 CC(=O)Nc1cn2nc(ccc2n1)-c1c(F)c(F)cc(C(=O)NCc2cc(ccc2F)C(F)(F)F)c1F InChI=1S/C23H14F7N5O2/c1-10(36)32-17-9-35-18(33-17)5-4-16(34-35)19-20(26)13(7-15(25)21(19)27)22(37)31-8-11-6-12(23(28,29)30)2-3-14(11)24/h2-7,9H,8H2,1H3,(H,31,37)(H,32,36) DKEHSOJUVCICQP-UHFFFAOYSA-N 571295 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,4,5- trifluoro-N-{[2- fluoro-5- (trifluoromethyl) phenyl]methyl} benzamide::US11440913, Example 369 Receptor-interacting serine/threonine-protein kinase 1 Human 97.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571295&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090048 473132460 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206467 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(F)cc(c1)C(=O)NCC[C@@H](O)c1ccc(Cl)cc1 InChI=1S/C24H21ClFN5O3/c1-14(32)28-22-13-31-23(29-22)7-6-20(30-31)16-10-17(12-19(26)11-16)24(34)27-9-8-21(33)15-2-4-18(25)5-3-15/h2-7,10-13,21,33H,8-9H2,1H3,(H,27,34)(H,28,32)/t21-/m1/s1 FLSNKMLDVVIQSR-OAQYLSRUSA-N 571296 N-[(3R)-3-(4- chlorophenyl)-3- hydroxypropyl]- 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-5- fluorobenzamide::US11440913, Example 370 Receptor-interacting serine/threonine-protein kinase 1 Human 34.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571296&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074315 473132461 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206468 COc1c(F)cc(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H18F5N5O4/c1-12(35)31-20-11-34-21(32-20)6-5-19(33-34)13-8-16(22(37-2)18(26)9-13)23(36)30-10-14-7-15(3-4-17(14)25)38-24(27,28)29/h3-9,11H,10H2,1-2H3,(H,30,36)(H,31,35) PFAOLAGTYPZUDG-UHFFFAOYSA-N 571297 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-3-fluoro- N-{[2-fluoro-5- (trifluoromethoxy) phenyl]methyl}-2- methoxybenzamide::US11440913, Example 371 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571297&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580852 473132462 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206469 COc1c(F)cc(cc1C(=O)NCc1cc(ccc1F)C(F)(F)F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H18F5N5O3/c1-12(35)31-20-11-34-21(32-20)6-5-19(33-34)13-8-16(22(37-2)18(26)9-13)23(36)30-10-14-7-15(24(27,28)29)3-4-17(14)25/h3-9,11H,10H2,1-2H3,(H,30,36)(H,31,35) JCUPPFFOOFNKRO-UHFFFAOYSA-N 571298 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-5-fluoro- N-{[2-fluoro-5- (trifluoromethyl) phenyl] methyl}-4- methylbenzamide::US11440913, Example 372 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571298&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165148038 473132463 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206470 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(cc(F)c1C)C(=O)NCC[C@@H](O)c1ccc(Cl)cc1 InChI=1S/C25H23ClFN5O3/c1-14-19(21-7-8-24-30-23(29-15(2)33)13-32(24)31-21)11-17(12-20(14)27)25(35)28-10-9-22(34)16-3-5-18(26)6-4-16/h3-8,11-13,22,34H,9-10H2,1-2H3,(H,28,35)(H,29,33)/t22-/m1/s1 TVGBHXRIIWUREH-JOCHJYFZSA-N 571299 N-[(3R)-3-(4- chlorophenyl)-3- hydroxypropyl]- 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-5-fluoro-4- methylbenzamide::US11440913, Example 373 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571299&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074386 473132464 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206471 COc1ccc(c(F)c1C(=O)N[C@@H](C)c1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H20F5N5O4/c1-12(16-10-14(4-6-17(16)26)39-25(28,29)30)31-24(37)22-19(38-3)8-5-15(23(22)27)18-7-9-21-33-20(32-13(2)36)11-35(21)34-18/h4-12H,1-3H3,(H,31,37)(H,32,36)/t12-/m0/s1 RAYAIAZIJCOQJA-LBPRGKRZSA-N 571300 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro-N- [(1S)-1[2-fluoro-5- (trifluoromethoxy) phenyl]ethyl]-6- methoxybenzamide::US11440913, Example 375 Receptor-interacting serine/threonine-protein kinase 1 Human 12.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571300&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074304 473132465 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206472 COc1ccc(c(F)c1C(=O)NCc1cc(F)ccc1C(=O)N1CCC(F)(F)C1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C28H24F4N6O4/c1-15(39)34-22-13-38-23(35-22)8-6-20(36-38)19-5-7-21(42-2)24(25(19)30)26(40)33-12-16-11-17(29)3-4-18(16)27(41)37-10-9-28(31,32)14-37/h3-8,11,13H,9-10,12,14H2,1-2H3,(H,33,40)(H,34,39) TUMAFQDBJSLKLV-UHFFFAOYSA-N 571301 N-{[2-(3,3- difluoropyrrolidine- 1-carbonyl)-5- fluorophenyl] methyl}-3- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2- fluoro-6- methoxybenzamide::US11440913, Example 376 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571301&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090672 473132466 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206473 COc1ccc(c(F)c1C(=O)NCc1cccc2CCCOc12)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C26H24FN5O4/c1-15(33)29-21-14-32-22(30-21)11-9-19(31-32)18-8-10-20(35-2)23(24(18)27)26(34)28-13-17-6-3-5-16-7-4-12-36-25(16)17/h3,5-6,8-11,14H,4,7,12-13H2,1-2H3,(H,28,34)(H,29,33) PIJASVGZEIILLO-UHFFFAOYSA-N 571302 N-{[2- (cyclopropylmethoxy) phenyl]methyl}-3-{2- acetamidoimidazo [1,2-b]pyridazin-6- yl}-2-fluoro-6- methoxybenzamide::US11440913, Example 377 Receptor-interacting serine/threonine-protein kinase 1 Human 67.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571302&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142581010 473132467 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206474 COc1ccc(c(F)c1C(=O)N[C@H](C)c1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H20F5N5O4/c1-12(16-10-14(4-6-17(16)26)39-25(28,29)30)31-24(37)22-19(38-3)8-5-15(23(22)27)18-7-9-21-33-20(32-13(2)36)11-35(21)34-18/h4-12H,1-3H3,(H,31,37)(H,32,36)/t12-/m1/s1 RAYAIAZIJCOQJA-GFCCVEGCSA-N 571303 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro-N- [(1R)-1-[2- fluoro-5- (trifluoromethoxy) phenyl](2,2,2-::US11440913, Example 378 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571303&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437149 473132468 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206475 C[C@H](NC(=O)c1c(F)ccc(c1F)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H17F6N5O3/c1-11(15-9-13(3-5-16(15)25)38-24(28,29)30)31-23(37)21-17(26)6-4-14(22(21)27)18-7-8-20-33-19(32-12(2)36)10-35(20)34-18/h3-11H,1-2H3,(H,31,37)(H,32,36)/t11-/m0/s1 MVKSEQIEJWREAL-NSHDSACASA-N 571304 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,6- difluoro-N- [(1S)-1-[2- fluoro-5- (trifluoromethoxy)::US11440913, Example 379 Receptor-interacting serine/threonine-protein kinase 1 Human 1.000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571304&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090221 473132469 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206476 C[C@@H](NC(=O)c1c(F)ccc(c1F)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H17F6N5O3/c1-11(15-9-13(3-5-16(15)25)38-24(28,29)30)31-23(37)21-17(26)6-4-14(22(21)27)18-7-8-20-33-19(32-12(2)36)10-35(20)34-18/h3-11H,1-2H3,(H,31,37)(H,32,36)/t11-/m1/s1 MVKSEQIEJWREAL-LLVKDONJSA-N 571305 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,6- difluoro-N- [(1R)-1-[2- fluoro-5- (trifluoromethoxy)::US11440913, Example 380 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571305&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437150 473132470 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206477 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(F)c(C(=O)NCc2cc(F)ccc2C(=O)N2CCC(F)(F)CC2)c1F InChI=1S/C28H23F5N6O3/c1-15(40)35-22-14-39-23(36-22)7-6-21(37-39)19-4-5-20(30)24(25(19)31)26(41)34-13-16-12-17(29)2-3-18(16)27(42)38-10-8-28(32,33)9-11-38/h2-7,12,14H,8-11,13H2,1H3,(H,34,41)(H,35,40) NJBNGRWAEJORIK-UHFFFAOYSA-N 571306 N-{[2-(4,4- difluoropiperidine- 1-carbonyl)-5- fluorophenyl] methyl}-3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,6- difluorobenzamide::US11440913, Example 381 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571306&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074096 473132471 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206478 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCC[C@@H](O)c2ccc(Cl)cc2)c(C)cc1C InChI=1S/C26H26ClN5O3/c1-15-12-16(2)21(26(35)28-11-10-23(34)18-4-6-19(27)7-5-18)13-20(15)22-8-9-25-30-24(29-17(3)33)14-32(25)31-22/h4-9,12-14,23,34H,10-11H2,1-3H3,(H,28,35)(H,29,33)/t23-/m1/s1 MFUNXFBUGQHGFB-HSZRJFAPSA-N 571307 N-[(3R)-3-(4- chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,4- dimethylbenzamide::US11440913, Example 382 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571307&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074213 473132472 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206479 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCC[C@H](O)c2ccc(Cl)cc2)c(C)cc1C InChI=1S/C26H26ClN5O3/c1-15-12-16(2)21(26(35)28-11-10-23(34)18-4-6-19(27)7-5-18)13-20(15)22-8-9-25-30-24(29-17(3)33)14-32(25)31-22/h4-9,12-14,23,34H,10-11H2,1-3H3,(H,28,35)(H,29,33)/t23-/m0/s1 MFUNXFBUGQHGFB-QHCPKHFHSA-N 571308 N-[(3S)-3-(4- chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,4- dimethylbenzamide::US11440913, Example 383 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571308&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074261 473132473 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206480 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(cc(Cl)c2F)C(F)(F)F)c(C)cc1C InChI=1S/C25H20ClF4N5O2/c1-12-6-13(2)18(24(37)31-10-15-7-16(25(28,29)30)8-19(26)23(15)27)9-17(12)20-4-5-22-33-21(32-14(3)36)11-35(22)34-20/h4-9,11H,10H2,1-3H3,(H,31,37)(H,32,36) IRFSAJHEZAFFSD-UHFFFAOYSA-N 571309 N-{[3- chloro-2-fluoro-5- (trifluoromethyl) phenyl]methyl}- 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2,4- dimethylbenzamide::US11440913, Example 384 Receptor-interacting serine/threonine-protein kinase 1 Human 48.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571309&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074233 473132474 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206481 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(c(c1)C(=O)NCc1cc(ccc1F)C(F)(F)F)C(F)(F)F InChI=1S/C24H16F7N5O2/c1-12(37)33-20-11-36-21(34-20)7-6-19(35-36)13-2-4-17(24(29,30)31)16(9-13)22(38)32-10-14-8-15(23(26,27)28)3-5-18(14)25/h2-9,11H,10H2,1H3,(H,32,38)(H,33,37) WTIQYYGJQGHNLJ-UHFFFAOYSA-N 571310 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-{[2- fluoro-5- (trifluoromethyl) phenyl]methyl}-2- (trifluoromethyl)::US11440913, Example 385 Receptor-interacting serine/threonine-protein kinase 1 Human 57.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571310&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090684 473132475 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206482 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(Cl)c(c1)C(=O)NCC[C@@H](O)c1ccc(Cl)cc1 InChI=1S/C24H21Cl2N5O3/c1-14(32)28-22-13-31-23(29-22)9-8-20(30-31)16-4-7-19(26)18(12-16)24(34)27-11-10-21(33)15-2-5-17(25)6-3-15/h2-9,12-13,21,33H,10-11H2,1H3,(H,27,34)(H,28,32)/t21-/m1/s1 AEBNWBTXIMMZJL-OAQYLSRUSA-N 571311 2-chloro-N- [(3R)-3-(4- chlorophenyl)-3- hydroxypropyl]- 5-{2- acetamidoimidazo [1,2-b]pyridazin-6- yl}benzamide::US11440913, Example 386 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571311&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074282 473132476 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206483 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(Cl)c(c1)C(=O)NCc1cc(F)ccc1C(=O)N1CCC(F)(F)C1 InChI=1S/C27H22ClF3N6O3/c1-15(38)33-23-13-37-24(34-23)7-6-22(35-37)16-2-5-21(28)20(11-16)25(39)32-12-17-10-18(29)3-4-19(17)26(40)36-9-8-27(30,31)14-36/h2-7,10-11,13H,8-9,12,14H2,1H3,(H,32,39)(H,33,38) HILFJTDXYWFUTH-UHFFFAOYSA-N 571312 2-chloro- N-{[2-(3,3- difluoropyrrolidine- 1-carbonyl)-5- fluorophenyl] methyl}-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}benzamide::US11440913, Example 387 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571312&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074374 473132477 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206484 C[C@@H](NC(=O)c1c(Cl)ccc(c1F)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H17ClF5N5O3/c1-11(15-9-13(3-6-17(15)26)38-24(28,29)30)31-23(37)21-16(25)5-4-14(22(21)27)18-7-8-20-33-19(32-12(2)36)10-35(20)34-18/h3-11H,1-2H3,(H,31,37)(H,32,36)/t11-/m1/s1 GIMVPZXTISYXEO-LLVKDONJSA-N 571313 6-chloro-3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro- N-[(1R)-1-[2- fluoro-5- (trifluoromethoxy) phenyl]ethyl]::US11440913, Example 388 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571313&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155091331 473132478 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206485 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(Cl)c(C(=O)NCc2cc(ccc2F)-c2cnn(C)c2)c1F InChI=1S/C26H20ClF2N7O2/c1-14(37)32-22-13-36-23(33-22)8-7-21(34-36)18-4-5-19(27)24(25(18)29)26(38)30-10-16-9-15(3-6-20(16)28)17-11-31-35(2)12-17/h3-9,11-13H,10H2,1-2H3,(H,30,38)(H,32,37) GAQLHGNRTGXWHQ-UHFFFAOYSA-N 571314 6-chloro-3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro- N-{[2-fluoro-5- (1-methyl-1H- pyrazol-4-yl) phenyl]methyl}::US11440913, Example 389 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571314&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155089157 473132479 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206486 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(Cl)c(C(=O)NCC[C@H](O)c2ccc(Cl)cc2)c1F InChI=1S/C24H20Cl2FN5O3/c1-13(33)29-20-12-32-21(30-20)9-8-18(31-32)16-6-7-17(26)22(23(16)27)24(35)28-11-10-19(34)14-2-4-15(25)5-3-14/h2-9,12,19,34H,10-11H2,1H3,(H,28,35)(H,29,33)/t19-/m0/s1 VSQFNQGNCDMMAW-IBGZPJMESA-N 571315 6-chloro-N-[(3S)- 3-(4-chlorophenyl)- 3-hydroxypropyl]- 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2- fluorobenzamide::US11440913, Example 390 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571315&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074130 473132480 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206487 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(Cl)c(C(=O)NCc2ccc(OC(F)(F)F)cc2)c1F InChI=1S/C23H16ClF4N5O3/c1-12(34)30-18-11-33-19(31-18)9-8-17(32-33)15-6-7-16(24)20(21(15)25)22(35)29-10-13-2-4-14(5-3-13)36-23(26,27)28/h2-9,11H,10H2,1H3,(H,29,35)(H,30,34) OLRDESKFMOHURK-UHFFFAOYSA-N 571316 6-chloro-3-{2- acetamidoimidazo [1,2-b]pyridazin-6- yl}-2-fluoro-N-{[4- (trifluoromethoxy) phenyl]methyl} benzamide::US11440913, Example 391 Receptor-interacting serine/threonine-protein kinase 1 Human 105 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571316&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090052 473132481 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206488 C[C@@H](NC(=O)c1cc(c(F)cc1Cl)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C24H17ClF5N5O3/c1-11(14-7-13(3-4-18(14)26)38-24(28,29)30)31-23(37)15-8-16(19(27)9-17(15)25)20-5-6-22-33-21(32-12(2)36)10-35(22)34-20/h3-11H,1-2H3,(H,31,37)(H,32,36)/t11-/m1/s1 MQMGMZMPNCUPDQ-LLVKDONJSA-N 571317 2-chloro-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-4-fluoro- N-[(1R)-1-[2- fluoro-5- (trifluoromethoxy) phenyl]ethyl]::US11440913, Example 392 Receptor-interacting serine/threonine-protein kinase 1 Human 36.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571317&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155091317 473132482 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206489 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(OC(F)(F)F)ccc2F)c(Cl)cc1C InChI=1S/C24H18ClF4N5O3/c1-12-7-18(25)17(23(36)30-10-14-8-15(3-4-19(14)26)37-24(27,28)29)9-16(12)20-5-6-22-32-21(31-13(2)35)11-34(22)33-20/h3-9,11H,10H2,1-2H3,(H,30,36)(H,31,35) CUMAPNTUSDTVAY-UHFFFAOYSA-N 571318 2-chloro-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-{[2- fluoro-5- (trifluoromethoxy) phenyl]methyl}-4- methylbenzamide::US11440913, Example 393 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571318&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074231 473132483 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206490 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C24H19F4N5O3/c1-13-3-4-15(20-7-8-22-31-21(30-14(2)34)12-33(22)32-20)10-18(13)23(35)29-11-16-9-17(5-6-19(16)25)36-24(26,27)28/h3-10,12H,11H2,1-2H3,(H,29,35)(H,30,34) QMVOKNDZESMLAS-UHFFFAOYSA-N 571319 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-{[2- fluoro-5- (trifluoromethoxy) phenyl]methyl}-2- methylbenzamide::US11440913, Example 394 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571319&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074133 473132484 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206491 COc1ccc(c(F)c1C(=O)NCC[C@@H](O)c1ccc(Cl)cc1)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H23ClFN5O4/c1-14(33)29-21-13-32-22(30-21)10-8-18(31-32)17-7-9-20(36-2)23(24(17)27)25(35)28-12-11-19(34)15-3-5-16(26)6-4-15/h3-10,13,19,34H,11-12H2,1-2H3,(H,28,35)(H,29,33)/t19-/m1/s1 GGPMVKIKPRUJCA-LJQANCHMSA-N 571320 (S)-N-(2-fluoro-5- (trifluoromethoxy) benzyl)-5-(2-(2- hydroxypropanamido) imidazo[1,2-b] pyridazin-6-yl)-2- methylbenzamide::US11440913, Example 395 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571320&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074163 473132485 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206492 C[C@@H](NC(=O)c1cc(ccc1C)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H21F4N5O3/c1-13-4-5-16(21-8-9-23-32-22(31-15(3)35)12-34(23)33-21)10-18(13)24(36)30-14(2)19-11-17(6-7-20(19)26)37-25(27,28)29/h4-12,14H,1-3H3,(H,30,36)(H,31,35)/t14-/m1/s1 OBRPQVFAPLRLCW-CQSZACIVSA-N 571321 (R)-5-(2- acetamidoimidazo [1,2-b]pyridazin- 6-yl)-N-(1- (2-fluoro-5- (trifluoromethoxy) phenyl)ethyl)-2- methylbenzamide::US11440913, Example 396 Receptor-interacting serine/threonine-protein kinase 1 Human 1.000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571321&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074162 473132486 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206493 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCC[C@@H](O)c1ccc(Cl)cc1 InChI=1S/C25H24ClN5O3/c1-15-3-4-18(21-9-10-24-29-23(28-16(2)32)14-31(24)30-21)13-20(15)25(34)27-12-11-22(33)17-5-7-19(26)8-6-17/h3-10,13-14,22,33H,11-12H2,1-2H3,(H,27,34)(H,28,32)/t22-/m1/s1 HVCQPAWBHULIJM-JOCHJYFZSA-N 571322 N-[(3R)-3-(4- chlorophenyl)-3- hydroxypropyl]-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2- methylbenzamide::US11440913, Example 397 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571322&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074077 473132487 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206494 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCC[C@H](O)c1ccc(Cl)cc1 InChI=1S/C25H24ClN5O3/c1-15-3-4-18(21-9-10-24-29-23(28-16(2)32)14-31(24)30-21)13-20(15)25(34)27-12-11-22(33)17-5-7-19(26)8-6-17/h3-10,13-14,22,33H,11-12H2,1-2H3,(H,27,34)(H,28,32)/t22-/m0/s1 HVCQPAWBHULIJM-QFIPXVFZSA-N 571323 N-[(3S)-3-(4- chlorophenyl)-3- hydroxypropyl]- 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2- methylbenzamide::US11440913, Example 398 Receptor-interacting serine/threonine-protein kinase 1 Human 5.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571323&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074341 473132488 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206495 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCC(O)COc1ccccc1 InChI=1S/C25H25N5O4/c1-16-8-9-18(22-10-11-24-28-23(27-17(2)31)14-30(24)29-22)12-21(16)25(33)26-13-19(32)15-34-20-6-4-3-5-7-20/h3-12,14,19,32H,13,15H2,1-2H3,(H,26,33)(H,27,31) OULKVDTUBKSZON-UHFFFAOYSA-N 571324 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-(2- hydroxy-3- phenoxypropyl)-2- methylbenzamide::US11440913, Example 400 Receptor-interacting serine/threonine-protein kinase 1 Human 11.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571324&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074391 473132489 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206496 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NC[C@H]1C[C@@H]1c1ccc(F)cc1 InChI=1S/C26H24FN5O2/c1-15-3-4-18(23-9-10-25-30-24(29-16(2)33)14-32(25)31-23)11-21(15)26(34)28-13-19-12-22(19)17-5-7-20(27)8-6-17/h3-11,14,19,22H,12-13H2,1-2H3,(H,28,34)(H,29,33)/t19-,22-/m1/s1 YJWNMTMOJTZFDQ-DENIHFKCSA-N 571325 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-{[(1S, 2S)-2-(4- fluorophenyl) cyclopropyl] methyl}-2-::US11440913, Example 401 Receptor-interacting serine/threonine-protein kinase 1 Human 105 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571325&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155606944 473132490 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206497 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCc1c(F)cccc1-c1cnn(C)c1 InChI=1S/C27H24FN7O2/c1-16-7-8-18(24-9-10-26-32-25(31-17(2)36)15-35(26)33-24)11-21(16)27(37)29-13-22-20(5-4-6-23(22)28)19-12-30-34(3)14-19/h4-12,14-15H,13H2,1-3H3,(H,29,37)(H,31,36) YSCVHZFBWJIMDO-UHFFFAOYSA-N 571326 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-{[2- fluoro-6-(1- methyl-1H- pyrazol-4- yl)phenyl] methyl}-2- methylbenzamide::US11440913, Example 402 Receptor-interacting serine/threonine-protein kinase 1 Human 56.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571326&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074371 473132491 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206498 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCc1cc(F)ccc1-c1cnn(C)c1 InChI=1S/C27H24FN7O2/c1-16-4-5-18(24-8-9-26-32-25(31-17(2)36)15-35(26)33-24)11-23(16)27(37)29-12-19-10-21(28)6-7-22(19)20-13-30-34(3)14-20/h4-11,13-15H,12H2,1-3H3,(H,29,37)(H,31,36) AHRRWJBGRMROSY-UHFFFAOYSA-N 571327 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-{[5- fluoro-2-(1- methyl-1H- pyrazol-4- yl)phenyl] methyl}-2- methylbenzamide::US11440913, Example 403 Receptor-interacting serine/threonine-protein kinase 1 Human 67.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571327&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074083 473132492 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206499 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCc1cc(ccc1F)C(=O)N1CC(F)(F)C1 InChI=1S/C27H23F3N6O3/c1-15-3-4-17(22-7-8-24-33-23(32-16(2)37)12-36(24)34-22)10-20(15)25(38)31-11-19-9-18(5-6-21(19)28)26(39)35-13-27(29,30)14-35/h3-10,12H,11,13-14H2,1-2H3,(H,31,38)(H,32,37) HMCBGLMYWSNCKR-UHFFFAOYSA-N 571328 N-{[5-(3,3- difluoroazetidine- 1-carbonyl)-2- fluorophenyl] methyl}-5-{2- acetamidoimidazo [1,2-b]pyridazin-::US11440913, Example 404 Receptor-interacting serine/threonine-protein kinase 1 Human 52.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571328&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090053 473132493 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206500 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCc1ccc(F)cc1C(=O)N1CCC(F)(F)C1 InChI=1S/C28H25F3N6O3/c1-16-3-4-18(23-7-8-25-34-24(33-17(2)38)14-37(25)35-23)11-21(16)26(39)32-13-19-5-6-20(29)12-22(19)27(40)36-10-9-28(30,31)15-36/h3-8,11-12,14H,9-10,13,15H2,1-2H3,(H,32,39)(H,33,38) OXCSLLBPZJDZCS-UHFFFAOYSA-N 571329 N-{[2-(3,3- difluoropyrrolidine- 1-carbonyl)-4- fluorophenyl] methyl}-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2- methylbenzamide::US11440913, Example 405 Receptor-interacting serine/threonine-protein kinase 1 Human 14.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571329&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074074 473132494 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206501 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCc1cc(ccc1F)C(=O)N1CCC(C)(C)C1 InChI=1S/C30H31FN6O3/c1-18-5-6-20(25-9-10-27-34-26(33-19(2)38)16-37(27)35-25)14-23(18)28(39)32-15-22-13-21(7-8-24(22)31)29(40)36-12-11-30(3,4)17-36/h5-10,13-14,16H,11-12,15,17H2,1-4H3,(H,32,39)(H,33,38) AHHXFMSMZQUYDZ-UHFFFAOYSA-N 571330 N-{[5-(3,3- dimethylpyrrolidine- 1-carbonyl)-2- fluorophenyl] methyl}-5-{2- acetamidoimidazo [1,2-b]pyridazin-::US11440913, Example 406 Receptor-interacting serine/threonine-protein kinase 1 Human 163 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571330&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090054 473132495 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206502 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCc1cc(F)cc(F)c1C(=O)N1CC[C@H](O)C1 InChI=1S/C28H26F2N6O4/c1-15-3-4-17(23-5-6-25-33-24(32-16(2)37)14-36(25)34-23)10-21(15)27(39)31-12-18-9-19(29)11-22(30)26(18)28(40)35-8-7-20(38)13-35/h3-6,9-11,14,20,38H,7-8,12-13H2,1-2H3,(H,31,39)(H,32,37)/t20-/m0/s1 ZVDDIYJPTGNJAO-FQEVSTJZSA-N 571331 N-({3,5- difluoro-2-[(3S)-3- hydroxypyrrolidine- 1-carbonyl]phenyl} methyl)-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2- methylbenzamide::US11440913, Example 407 Receptor-interacting serine/threonine-protein kinase 1 Human 37.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571331&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074107 473132496 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206503 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(c1)C(=O)NCc1cc(F)ccc1C(=O)N1CCCCC1 InChI=1S/C29H29FN6O3/c1-18-6-7-20(25-10-11-27-33-26(32-19(2)37)17-36(27)34-25)15-24(18)28(38)31-16-21-14-22(30)8-9-23(21)29(39)35-12-4-3-5-13-35/h6-11,14-15,17H,3-5,12-13,16H2,1-2H3,(H,31,38)(H,32,37) GJOXPCPYAZTXJR-UHFFFAOYSA-N 571332 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-{[5- fluoro-2- (piperidine-1- carbonyl)phenyl] methyl}-2- methylbenzamide::US11440913, Example 408 Receptor-interacting serine/threonine-protein kinase 1 Human 8.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571332&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074402 473132497 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206504 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(C(=O)NCc2cc(ccc2F)-c2cnn(c2)C2CC2)c1F InChI=1S/C29H25F2N7O2/c1-16-3-7-22(24-9-10-26-35-25(34-17(2)39)15-38(26)36-24)28(31)27(16)29(40)32-12-19-11-18(4-8-23(19)30)20-13-33-37(14-20)21-5-6-21/h3-4,7-11,13-15,21H,5-6,12H2,1-2H3,(H,32,40)(H,34,39) GRVUOIDRNHOGCG-UHFFFAOYSA-N 571333 N-{[5-(1- cyclopropyl-1H- pyrazol-4-yl)-2- fluorophenyl] methyl}-3-{2- acetamidoimidazo [1,2-b]pyridazin-::US11440913, Example 409 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571333&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155091354 473132498 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206505 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(C(=O)NCc2cc(F)ccc2-c2cnn(c2)C2CC2)c1F InChI=1S/C29H25F2N7O2/c1-16-3-7-23(24-9-10-26-35-25(34-17(2)39)15-38(26)36-24)28(31)27(16)29(40)32-12-18-11-20(30)4-8-22(18)19-13-33-37(14-19)21-5-6-21/h3-4,7-11,13-15,21H,5-6,12H2,1-2H3,(H,32,40)(H,34,39) KASJCFGRZHHUAV-UHFFFAOYSA-N 571334 N-{[2-(1- cyclopropyl- 1H-pyrazol-4-yl)- 5-fluorophenyl] methyl}-3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro-6- methylbenzamide::US11440913, Example 410 Receptor-interacting serine/threonine-protein kinase 1 Human 39.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571334&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074329 473132499 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206506 CC(=O)Nc1cn2nc(ccc2n1)-c1ccc(C)c(C(=O)NCc2ccc(F)c(F)c2C(=O)N2CCC(F)(F)C2)c1F InChI=1S/C28H23F5N6O3/c1-14-3-5-17(19-7-8-21-36-20(35-15(2)40)12-39(21)37-19)24(30)22(14)26(41)34-11-16-4-6-18(29)25(31)23(16)27(42)38-10-9-28(32,33)13-38/h3-8,12H,9-11,13H2,1-2H3,(H,34,41)(H,35,40) PGSXGACWRRNEEN-UHFFFAOYSA-N 571335 N-{[2-(3,3- difluoropyrrolidine- 1-carbonyl)-3,4- difluorophenyl] methyl}-3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro-6- methylbenzamide::US11440913, Example 411 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571335&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074174 473132500 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206507 C[C@@H](NC(=O)c1c(C)ccc(c1F)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H20F5N5O3/c1-12-4-6-16(19-8-9-21-33-20(32-14(3)36)11-35(21)34-19)23(27)22(12)24(37)31-13(2)17-10-15(5-7-18(17)26)38-25(28,29)30/h4-11,13H,1-3H3,(H,31,37)(H,32,36)/t13-/m1/s1 NNRFKUNBELLPEB-CYBMUJFWSA-N 571336 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro- N-[(1R)-1-[2- fluoro-5- (trifluoromethoxy) phenyl](2,2,2-::US11440913, Example 412 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571336&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437151 473132501 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206508 C[C@@H](NC(=O)c1c(C)ccc(-c2ccc3nc(NC(C)=O)cn3n2)c1F)c1cc(ccc1F)C(F)(F)F InChI=1S/C25H20F5N5O2/c1-12-4-6-16(19-8-9-21-33-20(32-14(3)36)11-35(21)34-19)23(27)22(12)24(37)31-13(2)17-10-15(25(28,29)30)5-7-18(17)26/h4-11,13H,1-3H3,(H,31,37)(H,32,36)/t13-/m1/s1 XVJJDXCBQZEHMJ-CYBMUJFWSA-N 571337 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro- N-[(1R)-1-[2- fluoro-5- (trifluoromethyl) phenyl](2,2,2-::US11440913, Example 413 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571337&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437152 473132502 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206509 COc1c(F)cc(F)cc1CNC(=O)c1c(C)ccc(c1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H20F3N5O3/c1-12-4-5-16(18-6-7-20-30-19(29-13(2)33)11-32(20)31-18)22(27)21(12)24(34)28-10-14-8-15(25)9-17(26)23(14)35-3/h4-9,11H,10H2,1-3H3,(H,28,34)(H,29,33) JKYMILPBZXFNJK-UHFFFAOYSA-N 571338 N-[(3,5-difluoro- 2-methoxyphenyl) methyl]-3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro-6- methylbenzamide::US11440913, Example 414 Receptor-interacting serine/threonine-protein kinase 1 Human 91.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571338&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074135 473132503 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206510 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(C(=O)NCc2cc(ccc2F)C(=O)N2CCCC2(C)C)c(C)cc1F InChI=1S/C30H30F2N6O3/c1-17-12-24(32)22(25-8-9-27-35-26(34-18(2)39)16-38(27)36-25)14-21(17)28(40)33-15-20-13-19(6-7-23(20)31)29(41)37-11-5-10-30(37,3)4/h6-9,12-14,16H,5,10-11,15H2,1-4H3,(H,33,40)(H,34,39) BFQUGEXLCVBKNO-UHFFFAOYSA-N 571339 N-{[5-(2,2- dimethylpyrrolidine-1- carbonyl)-2- fluorophenyl] methyl}-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-4-fluoro-2-::US11440913, Example 416 Receptor-interacting serine/threonine-protein kinase 1 Human 13.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571339&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090746 473132504 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206511 COc1cc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H21F4N5O4/c1-13-8-21(37-3)18(24(36)30-11-15-9-16(4-5-19(15)26)38-25(27,28)29)10-17(13)20-6-7-23-32-22(31-14(2)35)12-34(23)33-20/h4-10,12H,11H2,1-3H3,(H,30,36)(H,31,35) WVBRDHUOKVQECG-UHFFFAOYSA-N 571340 5-{2- acetamidoimidazo [1,2-b]pyridazin-6- yl}-N-{[2-fluoro-5- (trifluoromethoxy) phenyl]methyl}-2-$#194;2H$#226;,f)methoxy- 4-methylbenzamid::US11440913, Example 417::US11440913, Example 421 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571340&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155089160 473132505 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206512 COc1cc(F)c(cc1C(=O)NCc1cc(F)ccc1C(=O)N1CCCC1(C)C)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C30H30F2N6O4/c1-17(39)34-26-16-38-27(35-26)9-8-24(36-38)21-13-22(25(42-4)14-23(21)32)28(40)33-15-18-12-19(31)6-7-20(18)29(41)37-11-5-10-30(37,2)3/h6-9,12-14,16H,5,10-11,15H2,1-4H3,(H,33,40)(H,34,39) MDELGLHWQXRVRA-UHFFFAOYSA-N 571341 N-{[2-(2,2- dimethylpyrrolidine- 1-carbonyl)-5- fluorophenyl] methyl}-5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-4- fluoro-2- methoxybenzamide::US11440913, Example 419 Receptor-interacting serine/threonine-protein kinase 1 Human 4.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571341&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074153 473132506 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206513 COc1cccc(F)c1CNC(=O)c1cc(c(F)cc1OC)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C24H21F2N5O4/c1-13(32)28-22-12-31-23(29-22)8-7-19(30-31)14-9-15(21(35-3)10-18(14)26)24(33)27-11-16-17(25)5-4-6-20(16)34-2/h4-10,12H,11H2,1-3H3,(H,27,33)(H,28,32) TVSKVFMQRACBBS-UHFFFAOYSA-N 571342 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-4-fluoro- N-[(2-fluoro-6- methoxyphenyl) methyl]-2- methoxybenzamide::US11440913, Example 420 Receptor-interacting serine/threonine-protein kinase 1 Human 90.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571342&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074289 473132507 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206514 COc1cc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(C)=O)cn2n1 InChI=1S/C25H21F4N5O4/c1-13-8-21(37-3)18(24(36)30-11-15-9-16(4-5-19(15)26)38-25(27,28)29)10-17(13)20-6-7-23-32-22(31-14(2)35)12-34(23)33-20/h4-10,12H,11H2,1-3H3,(H,30,36)(H,31,35) WVBRDHUOKVQECG-UHFFFAOYSA-N 571340 5-{2- acetamidoimidazo [1,2-b]pyridazin-6- yl}-N-{[2-fluoro-5- (trifluoromethoxy) phenyl]methyl}-2-$#194;2H$#226;,f)methoxy- 4-methylbenzamid::US11440913, Example 417::US11440913, Example 421 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571340&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155089160 473132505 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206515 COc1cc(C)c(cc1C(=O)NCc1cc(OC(F)(F)F)ccc1F)-c1ccc2nc(NC(=O)CO)cn2n1 InChI=1S/C25H21F4N5O5/c1-13-7-20(38-2)17(24(37)30-10-14-8-15(3-4-18(14)26)39-25(27,28)29)9-16(13)19-5-6-22-31-21(11-34(22)33-19)32-23(36)12-35/h3-9,11,35H,10,12H2,1-2H3,(H,30,37)(H,32,36) JVKHUOMSTZOSBS-UHFFFAOYSA-N 571344 N-(2-fluoro-5- (trifluoromethoxy) benzyl)-5-(2-(2- hydroxyacetamido) imidazo[1,2-b] pyridazin-6-yl)- 2-methoxy-4- methylbenzamide::US11440913, Example 422 Receptor-interacting serine/threonine-protein kinase 1 Human 6.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571344&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155074120 473132508 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206516 CC(=O)Nc1cn2nc(ccc2n1)-c1cccc(C(=O)NCc2cc(OC(F)(F)F)ccc2F)c1F InChI=1S/C23H16F5N5O3/c1-12(34)30-19-11-33-20(31-19)8-7-18(32-33)15-3-2-4-16(21(15)25)22(35)29-10-13-9-14(5-6-17(13)24)36-23(26,27)28/h2-9,11H,10H2,1H3,(H,29,35)(H,30,34) AAKFJZRYRJEPGW-UHFFFAOYSA-N 571345 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro- N-{[2-fluoro-5- (trifluoromethoxy) phenyl]methyl} benzamide::US11440913, Example 424::US11440913, Example 426 Receptor-interacting serine/threonine-protein kinase 1 Human 2.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571345&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155089163 473132509 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206517 CC(=O)Nc1cn2nc(ccc2n1)-c1cccc(C(=O)NCc2cc(ccc2F)C(=O)N2CCC2(C)C)c1F InChI=1S/C28H26F2N6O3/c1-16(37)32-23-15-36-24(33-23)10-9-22(34-36)19-5-4-6-20(25(19)30)26(38)31-14-18-13-17(7-8-21(18)29)27(39)35-12-11-28(35,2)3/h4-10,13,15H,11-12,14H2,1-3H3,(H,31,38)(H,32,37) QCLCJKRWCIENES-UHFFFAOYSA-N 571346 5-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-[(1R)- 1-[2-fluoro-5- (trifluoromethyl) phenyl](2,2,2-$#194;2H$#226;,f) ethyl]-2::US11440913, Example 425 Receptor-interacting serine/threonine-protein kinase 1 Human >5000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571346&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090225 473132510 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206518 CC(=O)Nc1cn2nc(ccc2n1)-c1cccc(C(=O)NCc2cc(OC(F)(F)F)ccc2F)c1F InChI=1S/C23H16F5N5O3/c1-12(34)30-19-11-33-20(31-19)8-7-18(32-33)15-3-2-4-16(21(15)25)22(35)29-10-13-9-14(5-6-17(13)24)36-23(26,27)28/h2-9,11H,10H2,1H3,(H,29,35)(H,30,34) AAKFJZRYRJEPGW-UHFFFAOYSA-N 571345 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro- N-{[2-fluoro-5- (trifluoromethoxy) phenyl]methyl} benzamide::US11440913, Example 424::US11440913, Example 426 Receptor-interacting serine/threonine-protein kinase 1 Human 1.000 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571345&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155089163 473132509 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206519 Fc1ccc(OC(F)(F)F)cc1CNC(=O)c1cccc(c1F)-c1ccc2nc(NC(=O)CN3CCC(F)(F)CC3)cn2n1 InChI=1S/C28H23F7N6O3/c29-20-5-4-17(44-28(33,34)35)12-16(20)13-36-26(43)19-3-1-2-18(25(19)30)21-6-7-23-37-22(14-41(23)39-21)38-24(42)15-40-10-8-27(31,32)9-11-40/h1-7,12,14H,8-11,13,15H2,(H,36,43)(H,38,42) KQMCJRXOTADOJD-UHFFFAOYSA-N 571348 3-{2-[2-(4,4- difluoropiperidin-1- yl)acetamido]imidazo [1,2-b]pyridazin-6- yl}-2-fluoro-N- {[2-fluoro-5- (trifluoromethoxy) phenyl]methyl} benzamide::US11440913, Example 427 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571348&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155089164 473132511 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206520 Cc1ccc(cc1)[C@H](O)CCNC(=O)c1cccc(c1F)-c1ccc2nc(NC(=O)CN3CCC(CC3)C(F)(F)F)cn2n1 InChI=1S/C31H32F4N6O3/c1-19-5-7-20(8-6-19)25(42)11-14-36-30(44)23-4-2-3-22(29(23)32)24-9-10-27-37-26(17-41(27)39-24)38-28(43)18-40-15-12-21(13-16-40)31(33,34)35/h2-10,17,21,25,42H,11-16,18H2,1H3,(H,36,44)(H,38,43)/t25-/m1/s1 XSASZNIZHSCWEN-RUZDIDTESA-N 571349 N-[(3R)-3-(4- chlorophenyl)-3- hydroxypropyl]- 2-fluoro-3-(2-{2- [4-(trifluoromethyl) piperidin- 1-yl]acetamido} imidazo[1, 2-b]pyridazin-6- yl)benzamide::US11440913, Example 428 Receptor-interacting serine/threonine-protein kinase 1 Human 12.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571349&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090224 473132512 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206521 C[C@H](NC(=O)c1ccc(C)c(c1F)-c1ccc2nc(NC(C)=O)cn2n1)c1cc(OC(F)(F)F)ccc1F InChI=1S/C25H20F5N5O3/c1-12-4-6-16(24(37)31-13(2)17-10-15(5-7-18(17)26)38-25(28,29)30)23(27)22(12)19-8-9-21-33-20(32-14(3)36)11-35(21)34-19/h4-11,13H,1-3H3,(H,31,37)(H,32,36)/t13-/m0/s1 BOZGLZDKEAXMFW-ZDUSSCGKSA-N 571350 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro- N-[(1S)-1-[2- fluoro-5- (trifluoromethoxy) phenyl](2,2,2-::US11440913, Example 429 Receptor-interacting serine/threonine-protein kinase 1 Human 9.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571350&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 165437153 473132513 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206522 CC(=O)Nc1cn2nc(ccc2n1)-c1c(C)ccc(C(=O)NCc2cc(OC(F)(F)F)ccc2F)c1F InChI=1S/C24H18F5N5O3/c1-12-3-5-16(23(36)30-10-14-9-15(4-6-17(14)25)37-24(27,28)29)22(26)21(12)18-7-8-20-32-19(31-13(2)35)11-34(20)33-18/h3-9,11H,10H2,1-2H3,(H,30,36)(H,31,35) RSHCVMPDEIZBFY-UHFFFAOYSA-N 571351 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-2-fluoro- N-{[2-fluoro-5- (trifluoromethoxy) phenyl] ($#194;2H$#226;,,)methyl}::US11440913, Example 430 Receptor-interacting serine/threonine-protein kinase 1 Human 3.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571351&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142580881 473132514 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206523 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(ccc1Cl)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C23H16ClF4N5O3/c1-12(34)30-20-11-33-21(31-20)7-6-19(32-33)16-9-13(2-4-17(16)24)22(35)29-10-14-8-15(3-5-18(14)25)36-23(26,27)28/h2-9,11H,10H2,1H3,(H,29,35)(H,30,34) BOSLPQFFOJEOPY-UHFFFAOYSA-N 571352 4-chloro-3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-N-{[2- fluoro-5- (trifluoromethoxy) phenyl]methyl} benzamide::US11440913, Example 431 Receptor-interacting serine/threonine-protein kinase 1 Human 7.00 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571352&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155089165 473132515 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33 1206524 CC(=O)Nc1cn2nc(ccc2n1)-c1cc(ccc1F)C(=O)NCc1cc(OC(F)(F)F)ccc1F InChI=1S/C23H16F5N5O3/c1-12(34)30-20-11-33-21(31-20)7-6-19(32-33)16-9-13(2-4-18(16)25)22(35)29-10-14-8-15(3-5-17(14)24)36-23(26,27)28/h2-9,11H,10H2,1H3,(H,29,35)(H,30,34) MINJUIWEOBONEZ-UHFFFAOYSA-N 571353 3-{2- acetamidoimidazo [1,2-b]pyridazin- 6-yl}-4-fluoro-N- {[2-fluoro-5- (trifluoromethoxy) phenyl]methyl} benzamide::US11440913, Example 432 Receptor-interacting serine/threonine-protein kinase 1 Human 36.0 US Patent 10.7270/Q29K4FGF aid1806802 US11440913 Mertzman, ME; Dzierba, CD; Guernon, JM; Hart, AC; Luo, G; Macor, JE; Pitts, WJ; Shi, J; Spergel, SH 9/13/2022 11/19/2022 Bristol-Myers Squibb Company http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=571353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=586&target=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=571353&enzyme=Receptor-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 155090736 473132516 1 MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN 4NEU,6AC5 Receptor-interacting serine/threonine-protein kinase 1 RIPK1_HUMAN Q13546 A0AV89 B2RAG1 B4E3F9 Q13180 Q59H33